Advertisement

Literaturverzeichnis

  • Albrecht Michael Ehrly
Chapter

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. 1.
    Aarts PAMM, Banga JD, van Houwelingen HC, Heethaar RM, Sixma JJ (1985) Influence of isoxsu-prine on red cell deformability in vivo and effects on platelet adherence in vitro (Abstract). Clin Hemorheol 5: 753.Google Scholar
  2. 2.
    Aarts PAMM, Banga JD, van Houwelingen HC, Heethaar RM, Sixma JJ (1986) Increased red blood cell deformability due to isoxsuprine administration decreases platelet adherence in a perfusion chamber: A double-blind cross-over study in patients with intermittent claudication. Blood 67: 1474.PubMedGoogle Scholar
  3. 3.
    Abel JJ, Rowntree LG, Turner BB (1914) Plasma removal with return of the corpuscles. J Pharmacol Exp Ther 5: 625.Google Scholar
  4. 4.
    Abruzzo JL, Heimer R, Giuliano V, Martinez J (1970) The hyperviscosity syndrome, polysynovitis, polymyositis and an unusual 13 S serum IgG component. Am J Med 49: 258.PubMedCrossRefGoogle Scholar
  5. 5.
    Adam H (1909) Zur Viskosität des Blutes. Z Klin Med 68: 177.Google Scholar
  6. 6.
    Akiyama M, Isogai Y, Yokose T, Okabe M, Ashikaga M, Ikemoto S, Maeda T, Abe M (1981) Changes in hemorheological factors of diabetics during use of artificial pancreas (Abstract). Clin Hemorheol 1: 300.Google Scholar
  7. 7.
    Albanese B (1983) Modificazioni dell’emoreologia indotte dal farmaco α-litico timoxamina. Ric Clin Lab 13(Suppl 3): 469.PubMedGoogle Scholar
  8. 8.
    Albers D (1937) Die Viskosität des Blutes in der kardialen Herzinsuffizienz. Z Kreislaufforsch 29: 914.Google Scholar
  9. 9.
    Albers D (1937) Multiple Myelome und Viscosität. Z Klin Med 132: 807.Google Scholar
  10. 10.
    Alderman MJ, Ridge A, Morley AA, Ryall RG, Walsh JA (1981) Effect of total leucocyte count on whole blood filterability in patients with peripheral vascular disease. J Clin Pathol 34: 163.PubMedCrossRefGoogle Scholar
  11. 11.
    Allan TL (1981) Plasma exchange in macroglobulinaemia. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p235.Google Scholar
  12. 12.
    Alwall N (1939) Jodtherapie bei Hypertonie und Arteriosklerose. Acta Med Scand 101: 83.CrossRefGoogle Scholar
  13. 13.
    Amtoft A (1973) The effect of Dextran 40 on capillary blood flow and capillary diffusion capacity in the anterior tibial muscle of subjects with intermittent claudication. Scand J Clin Lab Invest 31: 263.PubMedCrossRefGoogle Scholar
  14. 14.
    Anadere I, Chmiel H, Witte S (1985) Hemorheological findings in patients with completed stroke and the influence of a ginkgo biloba extract. Clin Hemorheol 5: 411.Google Scholar
  15. 15.
    Angelkort B (1979) Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Curr Med Res Opin 6: 255.PubMedCrossRefGoogle Scholar
  16. 16.
    Angelkort B, Boateng K, Maurin N (1980) Blood fluidity and coagulation phenomena in chronic arterial occlusive disease. J Int Med Res 8: 242.PubMedGoogle Scholar
  17. 17.
    Angelkort B, Kiesewetter H (1981) Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease — Effects of pentoxifylline. Scand J Clin Lab Invest 41(Suppl 156): 185.CrossRefGoogle Scholar
  18. 18.
    Angelkort B, Kiesewetter H, Maurin N (1981) Einfluß von Hämodilution und oraler Pentoxifyllin-Medikation auf Muskeldurchblutung, Fließverhalten und Hämostase des Blutes bei chronischer arterieller Verschlußkrankheit. In: Breddin K (ed) Thrombose und Atherogenese. Pathophysiologic und Therapie der arteriellen Verschlußkrankheit. Bein-Beckenvenen-Thrombose. Witzstrock, Baden-Baden, p 114.Google Scholar
  19. 19.
    Angelkort B, Frömel M (1981) Influence of hemodilution on fluidity and hemostasis in chronic occlusive arterial disease — Study with high molecular hydroxyethyl starch solution (Abstract). Clin Hemorheol 1: 453.Google Scholar
  20. 20.
    Angelkort B, Spürk P, Ludwig P (1984) An appraisal of interrelationship between blood fluidity and walking performance in peripheral arterial occlusive disease. IRCS Med Sci 12: 360.Google Scholar
  21. 21.
    Angelkort B, Spürk P, Habbaba A, Mähder M (1985) Blood flow properties and walking performance in chronic arterial occlusive disease. Angiology 36: 285.PubMedCrossRefGoogle Scholar
  22. 22.
    Annoni F, Monti D, Mozzi E, Chiurazzi D, Marincola F (1983) Ciclonicate in patients with chronic occlusive peripheral arterial disease: Haemodynamic and rheologic effects. Acta Ther 9: 29.Google Scholar
  23. 23.
    4th Annual meeting of Japan Society of Biorheology (1982) (Abstracts). Biorheology 19: 375.Google Scholar
  24. 24.
    Antignani PL, Todini AR, Saliceti F, Pacino G, Bartolo M (1985) Clinical, instrumental and hemo-rheological effects after acute therapy with pentoxifylline (Abstract). Clin Hemorheol 5: 731.Google Scholar
  25. 25.
    Apsatarov EA, Goryachev SP, Lyubinsky VL, Timukhina RA, Stakhov OV (1985) Changes of microcirculation and blood rheologic properties in patients with Leriche’s syndrome. Khirurgiia (Mosk) 6: 44.Google Scholar
  26. 26.
    Arntz HR, Leonhardt H, Dreykluft HR (1979) Influence of Clofibrate on blood viscosity in primary hyperlipoproteinemia. Klin Wochenschr 57: 43.PubMedCrossRefGoogle Scholar
  27. 27.
    Arntz HR, Heitz J, Schäfer JH, Zingler G, Schröder R (1985) High-dose intravenous streptokinase (SK) in acute myocardial infarction (AMI): Hemorheological aspects (Abstract). Clin Hemorheol 5: 729.Google Scholar
  28. 28.
    Aronson HB, Magora F, London M (1970) The influence of droperidol on blood viscosity in man. Br J Anaesth 42: 1089.PubMedCrossRefGoogle Scholar
  29. 29.
    Aronson HB, Magora F, Schenker JG (1971) Effect of oral contraceptives on blood viscosity. Am J Obstet Gynecol 110: 997.PubMedGoogle Scholar
  30. 30.
    Artale F, Sergio G, Di Palma A, Giunti P, Perego MA (1980) Effetto dell’infusione venosa di pentos-sifillina sulla deformabilità eritrocitaria nell’arteriopatia ostruttiva periferica. II Policlinico, Sez Medica 87: 338.Google Scholar
  31. 31.
    Artale F, Francisci A, Espureo M, Sergio G, Cramarossa L, Di Palma A, Perego MA (1982) Effects of S-adenosyl-L-methionine on hemorheological changes induced by exercise in patients with peripheral occlusive arterial diseases. Curr Ther Res 32: 520.Google Scholar
  32. 32.
    Aukland A, Hurlow RA, George AJ, Stuart J (1982) Platelet inhibition with ticlopidine in atherosclerotic intermittent claudication. J Clin Pathol 35: 740.PubMedCrossRefGoogle Scholar
  33. 33.
    Auteri A, Pieragalli D, Blardi P (1984) Azione della CDP-colina sulla sindrome da iperviscosità ematica secondaria delle vasculopatie croniche ischemizzanti. Minerva Cardioangiol 32: 53.PubMedGoogle Scholar
  34. 34.
    Avellone G, Pinto A, Mandalà V, Galati D, Di Garbo V, Strano A (1985) Modificazioni emoreologiche indotte dalla somministrazione di buflomedil cloridrato nelle arteriopatie obliteranti degli arti inferiori. Ric Clin Lab 15(Suppl 1): 577.Google Scholar
  35. 35.
    Ayres ML, Jarrett PEM, Browse NL (1981) Blood viscosity, Raynaud’s phenomenon and the effect of fibrinolytic enhancement. Br J Surg 68: 51.PubMedCrossRefGoogle Scholar
  36. 36.
    Azzena D, Costa U, Ghigliotti G, Astengo F (1968) Serum hyperviscosity in multiple myeloma and its clinical and neuropsychiatric implications. Confin Neurol 30: 65.PubMedCrossRefGoogle Scholar
  37. 37.
    Bach R, Kiesewetter H, Jung F, Kotitschke G, Witt R, Nüttgens HP, Ladwig KH, Waterloh E, Roebruck P, Gerhards M, Schieffer H, Bette L, Wenzel E (1987) Koronare Herzkrankheit: Prävalenz, Risikofaktoren-Profil und rheologisches Profil. Erste Ergebnisse der Aachen-Studie. In: Strauer BE, Ehrly AM, Leschke M (eds) Fortschritte in der kardiovaskulären Hämorheologie (5.DGKHKongreß, Marburg, 1986). Münchner Wissenschaftliche Publikationen, München, p7.Google Scholar
  38. 38.
    Bada HS, Korones SB, Kolni HW, Fitch CW, Ford DL, Magill HL, Anderson GD, Wong SP (1986) Partial plasma exchange transfusion improves cerebral hemodynamics in symptomatic neonatal polycythemia. Am J Med Sci 291: 157.PubMedCrossRefGoogle Scholar
  39. 39.
    Baer MR, Stein RS, Dessypris EN (1985) Chronic lymphocytic leukemia with hyperleukocytosis. The hyperviscosity syndrome. Cancer 56: 2865.PubMedCrossRefGoogle Scholar
  40. 40.
    Bäumler H, Lerche D, Scherf HP, Bilsing R, Meier W, Kucera W, Wiesner S (1982) Experimentelle Untersuchungen zum Theologischen Verhalten von Blut bei Ultraviolettbestrahlung (UVB). Z Ges Inn Med 37: 458.PubMedGoogle Scholar
  41. 41.
    Balabanova RM, Guseva NG, Apenysheva NP, Oskilko TG, Anikina NV (1983) Effect of reopoly-glucin on the microcirculation of patients with sclerodermia systematica. Revmatologiia (Moskva) 3: 26.Google Scholar
  42. 42.
    Bapistella B (1972) Untersuchungen über den Einfluß der Streptokinase auf die Blutviskosität und die Aggregation der Erythrozyten. Dissertationsschrift, Frankfurt am Main.Google Scholar
  43. 43.
    Barnard RJ, Hall JA, Pritikin N (1985) Effects of diet and exercise on blood pressure and viscosity in hypertensive patients. J Cardiac Rehabil 5: 185.Google Scholar
  44. 44.
    Barnes AJ, Oughton J, Willars EJ, Clark PA, Kohner EM (1983) Effect of o-(β-hydroxyethyl)-rutosides (HR) on blood rheology in normals and diabetic patients (Abstract). Clin Hemorheol 3: 287.Google Scholar
  45. 45.
    Baron M, Fam AG, Elkan I, Underdown B (1982) Hyperviscosity syndrome in rheumatoid arthritis. J Rheumatol 9: 843.PubMedGoogle Scholar
  46. 46.
    Barras JP (1969) The capillary flow of suspensions of human red blood cells in plasma substitutes. Bibl Anat 10: 38.PubMedGoogle Scholar
  47. 47.
    Barras JP, Maibach E (1971) Effect du HR sur la viscosite sanguine dans l’insuffisance veineuse chronique. Abstract-Booklet 4th Int Congr Phlebol, Lucerne, p93.Google Scholar
  48. 48.
    Barras JP, Graf C (1980) Hyperviscosity in diabetic retinopathy treated with Doxium (calcium do-besilate). Vasa 9: 161.PubMedGoogle Scholar
  49. 49.
    Barras JP, Graf C (1981) Effects of medication on blood and plasma viscosity in diabetic subjects with retinopathy. Horm Metab Res 13(Suppl 11): 120.Google Scholar
  50. 50.
    Barras JP, Blattner J (1985) Viscoelastic properties of blood and plasma in diabetes. Vasa 14: 216.PubMedGoogle Scholar
  51. 51.
    Bartolo M (1985) Emodiluizione, defibrinogenazione e plasmaferesi in emoreologia. Ric Clin Lab 15(Suppl 1): 439.PubMedGoogle Scholar
  52. 52.
    Baum RS (1967) Hyperviscous blood and perinatal pathology (Abstract). Pediatr Res 1: 288.Google Scholar
  53. 53.
    Bayliss LE (1960) The anomalous viscosity of blood. In: Copley AL, Stainsby G (eds) Flow properties of blood and other biological systems. Pergamon, London, p 29.Google Scholar
  54. 54.
    Beck JR, Quinn BM, Meier FA, Rawnsley HM (1982) Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests. Transfusion 22: 51.PubMedCrossRefGoogle Scholar
  55. 55.
    Becker B (1976) Untersuchungen über den Einfluß einiger Medikamente auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  56. 56.
    Bedi SS, Eberl R, Million R, Silas AM (1984) Fenclofenac and diclofenac in the treatment of rheumatoid arthritis. Br J Rheumatol 23: 214.PubMedCrossRefGoogle Scholar
  57. 57.
    Begg TB, Hearns JB (1966) Components in blood viscosity. The relative contribution of haematocrit, plasma fibrinogen and other proteins. Clin sci 31: 87.PubMedGoogle Scholar
  58. 58.
    Belch JJF, Lowe GDO, Drummond MM, Forbes CD, Prentice CRM (1981) Prostacyclin reduces red cell deformability (Leserbrief). Thromb Haemost 45: 189.PubMedGoogle Scholar
  59. 59.
    Benarroch IS, Brodsky M, Rubinstein A, Viggiano C, Salama EA (1985) Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy. Ophthalmic Res 17: 131.PubMedCrossRefGoogle Scholar
  60. 60.
    Benda L, Redtenbacher L, Spieß A, Steinbach T (1971) Fibrinolytische Behandlung bei schwerer Angina pectoris. Dtsch Med Wochenschr 96: 771.PubMedCrossRefGoogle Scholar
  61. 61.
    Benda L (1972) Streptokinase und Blutviskosität bei akutem Herzinfarkt. In: Sailer S (ed) Aktuelle Probleme der Fibrinolyse-Behandlung. Hollinek, Wien, p 27.Google Scholar
  62. 62.
    Benda L (1973) Influence of streptokinase on blood rheology and coagulation. Postgrad Med J 49(Suppl 5): 129.Google Scholar
  63. 63.
    Benda L, Klösel W, Redtenbacher L, Spieß A, Zenz W (1976) Fibrinolyse und Antikoagulation bei schwerer Angina pectoris. Wien Med Wochenschr 126: 1.PubMedGoogle Scholar
  64. 64.
    Benda L, Redtenbacher L (1977) Zur Dosierung der Streptokinase beim akuten Herzinfarkt. In: Sailer S (ed) Die Fibrinolyse — Behandlung des akuten Myokardinfarktes. Hollinek, Wien, p 19.Google Scholar
  65. 65.
    Benninger GW, Kreps SI (1971) Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndrome. Am J Med 51: 287.PubMedCrossRefGoogle Scholar
  66. 66.
    Bergentz S, Gelin L, Rudenstam C, Zederfeldt B (1963) The viscosity of whole blood in trauma. Acta Chir Scand 126: 289.PubMedGoogle Scholar
  67. 67.
    Bergqvist G, Zetterström R (1974) Blood viscosity and peripheral circulation in newborn infants. Acta Paediatr Scand 63: 865.PubMedCrossRefGoogle Scholar
  68. 68.
    Bernstein EF, Castaneda AR (1968) Studies of shear-dependent blood viscosity in extracorporal circulation. In: Copley AL (ed) Hemorheology. Pergamon, New York, p 433.Google Scholar
  69. 69.
    Blarney SL, McArdle BM, Burns P, Lowe GDO, Forbes CD, Carter DC, Prentice CRM (1983) Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol. Thromb Res 31: 451.CrossRefGoogle Scholar
  70. 70.
    Blendin R (1975) Untersuchungen über den Einfluß einiger vasoaktiver Pharmaka auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  71. 71.
    Block KJ, Maki DG (1973) Hyperviscosity syndromes associated with immunoglobulin abnormalities. Hematology 10: 113.Google Scholar
  72. 72.
    Blume J, Kiesewetter H, Bulling BJ, Gerhards M (1984) Einfluß von Betablockern auf klinische und hämorheologische Parameter bei AVK-Patienten. In: Heilmann L, Kiesewetter H, Ernst E (eds) Klinische Rheologie und Beta-1-Blockade. Zuckschwerdt, München, p 153.Google Scholar
  73. 73.
    Bode WA, Fonk T, van der Veen EA, van der Meer J (1982) Effects of long-term treatment with isox-suprine on the blood viscosity profile in maturity-onset diabetics. Clin Hemorheol 2: 189.Google Scholar
  74. 74.
    Böhme H, Everts B (1981) Hemodilution combined with defibrinogenation. Bibl Haematol 47: 165.PubMedGoogle Scholar
  75. 75.
    Böhme H, Everts B (1985) Hämodilution und Defibrinogenierung in der Behandlung arterieller Durchblutungsstörungen. Int Welt 8: 225.Google Scholar
  76. 76.
    Bös W (1976) Wirkungen zweier Diuretika auf die Fließeigenschaften des Blutes bei Patienten mit chronisch venösen ödemen. Dissertationsschrift, Frankfurt am Main.Google Scholar
  77. 77.
    Bogar L, Matrai A, Walker RT, Flute PT, Dormandy JA (1985) Haemorheological effects of a 5-HT2receptor antagonist (ketanserin). Clin Hemorheol 5: 115.Google Scholar
  78. 78.
    Bogar L, Flute PT, Walker RT, Dormandy JA (1985) Haemorheological effects of a 5-HT2 receptor antagonist (ketanserin) in patients with leg ischaemia (Abstract). Clin Hemorheol 5: 739.Google Scholar
  79. 79.
    Boisseau MR (1985) Changes in blood filtration during acute C. V. A. Effect of treatment (Abstract). Clin Hemorheol 5: 712.Google Scholar
  80. 80.
    Boisseau MR, Freyburger G, Louit F, Roudaut MF, Sense JM, Manciet G, Julien J (1985) Vascular pathology and hemorheological disorders: trial of buflomedil, pentosan polysulfate and vinburnin (Abstract). Clin Hemorheol 5: 724.Google Scholar
  81. 81.
    Bollinger A, Simon HJ, Köhler R, Lüthy E (1968) Wirkung von niedermolekularem Dextran auf die Blutviskosität und Extremitätendurchblutung. Z Kreislaufforsch 57: 456.PubMedGoogle Scholar
  82. 82.
    Bonniot R, Quemada D, Dufaux J, Hazard B, Lamberth M (1980) Traitement des arteriopathies par l’acetylsalicylate de lysine — Resultats cliniques chez 68 malades avec 97 etudes rheologiques. Arch Méd Ouest 12: 577.Google Scholar
  83. 83.
    Borgolte H (1981) Veränderungen der Blutviskosität und-elastizität bei der Gabe von Dextran 40. In: Breddin K (ed) Thrombose und Atherogenese. Pathophysiologic und Therapie der arteriellen Verschlußkrankheit. Bein-Beckenvenen-Thrombose. Witzstrock, Baden-Baden, p 119.Google Scholar
  84. 84.
    Botas L, Freitas JP, Teresa Laginha M, Barroca JP, Martins JM, Fátima Silva M, Martins E Silva J (1983) The effects of pentoxyfilline on blood filterability and functional capacity in patients with stable angina pectoris under a beta-blocking trial (Abstract). Clin Hemorheol 3: 328.Google Scholar
  85. 85.
    Boyan CP, Underwood PS, Howland WS (1966) The effect of operation, anesthesia and plasma expanders on blood viscosity. Anesthesiology 27: 279.PubMedGoogle Scholar
  86. 86.
    Breddin K, Ehrly AM, Fechler L, Frick D, König H, Kraft H, Krause H, Krzywanek HJ, Kutschera J, Lösch HW, Ludwig O, Mikat B, Rausch F, Rosenthal P, Sartory S, Voigt G, Wylicil P (1973) Die Kurzzeitfibrinolyse beim akuten Myokardinfarkt. Dtsch Med Wochenschr 98: 861.PubMedCrossRefGoogle Scholar
  87. 87.
    Brinkmann R, Zijlstra WG, Jansonius NJ (1963) Quantitative evaluation of the rate of rouleaux formation of erythrocytes by measuring light reflection (“Syllectometry ”). Proc Kon Ned Akad Wet (Ser C) 66: 236.Google Scholar
  88. 88.
    Brown MM, Pearson TC, Marshall J (1981) Effect of changes in plasma viscosity on cerebral blood flow in man (Abstract). Clin Hemorheol 1: 457.Google Scholar
  89. 89.
    Brown MM, Marshall J (1982) Effect of plasma exchange on blood viscosity and cerebral blood flow. Br Med J 284: 1733.CrossRefGoogle Scholar
  90. 90.
    Browning GG, Gatehouse S, Lowe GDO (1986) Blood viscosity as a factor in sensorineural hearing impairment. Lancet 1: 121.PubMedCrossRefGoogle Scholar
  91. 91.
    Brügger W, Imhof P, Müller P, Moser P, Reubi F (1985) Effect of nitroglycerin on blood rheology in healthy subjects. Eur J Clin Pharmacol 29: 331.PubMedCrossRefGoogle Scholar
  92. 92.
    Buchan PC, MacDonald HN (1980) Altered haemorheology in oral-contraceptive users. Br Med J 280: 978.PubMedCrossRefGoogle Scholar
  93. 93.
    Buchan PC (1982) Haemorheological consequences of oestrogen and progestagen therapy. Int J Microcirc Clin Exp 1: 262.Google Scholar
  94. 94.
    Buffet E, Adjizian JC, Pignon B, Droulle C, Potron G (1985) Rheological and haemostatic parameters in geriatric population under pentosane polysulfate treatment (Abstract). Clin Hemorheol 5: 738.Google Scholar
  95. 95.
    Burch GE, De Pasquale NP (1962) Hematocrit, blood viscosity and myocardial infarction. Am J Med 32: 161.CrossRefGoogle Scholar
  96. 96.
    Burch GE, De Pasquale NP (1963) Phlebotomy — Use in patients with erythrocytosis and ischemic heart disease. Arch Intern Med 111: 687.PubMedGoogle Scholar
  97. 97.
    Burch GE (1965) Hematocrit, viscosity and coronary blood flow. Dis Chest 48: 225.PubMedCrossRefGoogle Scholar
  98. 98.
    Burke AM, Chien S, McMurty JG (1979) Effects of low molecular weight dextran on blood viscosity after craniotomy for intracranial aneurysms. Surg Gynecol Obstet 148: 9.PubMedGoogle Scholar
  99. 99.
    Burns P, Small M, Blarney SL, Lowe GDO, Forbes CD (1983) Effects of stanozolol on viscosity in volunteers and in surgical patients (Abstract). Clin Hemorheol 3: 287.Google Scholar
  100. 100.
    Burton-Opitz R (1900) Vergleich der Viscosität des normalen Blutes mit der des Oxalatblutes, des defibrinirten Blutes und des Blutserums bei verschiedener Temperatur. Arch Ges Physiol 82: 464.CrossRefGoogle Scholar
  101. 101.
    Burton-Opitz R (1904) The changes in the viscosity of the blood produced by alcohol. J Physiol 32: 8.PubMedGoogle Scholar
  102. 102.
    Burton-Opitz R (1906) Weitere Studien über die Viskosität des Blutes. Arch Ges Physiol 112: 189.CrossRefGoogle Scholar
  103. 103.
    Burton-Opitz R (1911) The viscosity of the blood. JAMA 57: 353.Google Scholar
  104. 104.
    Buskard NA, Galton DA, Goldman JM, Kohner EM, Grindle CF, Newman DL, Twinn KW, Lowenthal RM (1977) Plasma exchange in the long term management of Waldenström’s macroglobulinaemia. Can Med Assoc J 117: 135.PubMedGoogle Scholar
  105. 105.
    Buskard NA (1981) Blood flow studies in the hyperviscosity syndrome before and after plasma exchange. In: Borberg H, Reuter P (eds) Plasma exchange therapy. Thieme, Stuttgart, p 89.Google Scholar
  106. 106.
    Cabannes R, Pistonne M, Faget P, Meite M, Bassembie J (1983) Rheological study of sickle-cells in S.C.D. patients treated with pentoxifylline — A comparative study (Abstract). Clin Hemorheol 3: 232.Google Scholar
  107. 107.
    Cäsar K, Wegener B, Hossmann K (1980) Wirkung von Isosorbiddinitrat auf Blutdruck, peripheren Gefäßwiderstand und venöse Kapazität bei Patienten mit arterieller Hypertonie. In: Rudolph W, Schrey A (eds) Nitrate II — Wirkung auf Herz und Kreislauf. Urban und Schwarzenberg, München, p 58.Google Scholar
  108. 108.
    Caimi G, Frazzetta F, Capobianco D, Catania A, Francavilla G, Sarno A (1982) Comportamento del pattern emoreologico in soggetti con ipertensione essenziale trattati con beta-bloccanti. Clin Ter 103: 383.PubMedGoogle Scholar
  109. 109.
    Caimi G, Catania A, Frazzetta F, Capobianco D, Sarno A (1983) Essential hypertension — The behaviour of the haemorheological determinants and their trends during beta-blocker treatment. Jpn Heart J 24: 723.PubMedCrossRefGoogle Scholar
  110. 110.
    Caimi G, Catania A, Frazzetta F, Capobianco D, Francavilla G, Romano A, Sarno A (1983) Relievi emoreologici in un gruppo di vasculopatici aterosclerotici trattati con suloctidil. Ric Clin Lab 13(Suppl 3): 465.PubMedGoogle Scholar
  111. 111.
    Calabrò A, Rossi A, Piarulli F, Coscetti G, Baiocchi MR, Fellin R, Crepaldi G (1985) Effect of sulo-dexide administration in a group of patients with peripheral atherosclerosis (Abstract). Clin Hemorheol 5: 723.Google Scholar
  112. 112.
    Calabrò A, Rossi A, Baiocchi MR, Coscetti G, Fellin R, Crepaldi G (1985) Effetto del sulodexide su alcuni parametri emoreologici in un gruppo di pazienti con vasculopatia arteriosclerotica periferica. Ric Clin Lab 15(Suppl 1): 455.PubMedGoogle Scholar
  113. 113.
    Calvert GD, Blight L, Franklin J, Oliver J, Wise P, Gallus AS (1980) The effects of Clofibrate on plasma glucose, lipoproteins, fibrinogen and other biochemical and haematological variables in patients with mature onset diabetes mellitus. Eur J Clin Pharmacol 17: 355.PubMedCrossRefGoogle Scholar
  114. 114.
    Canovi MC, Spandri A, Lambrughi S, Marcelli D, Piovella C (1985) Confronto in vivo ed in vitro del sangue di soggetti trattati con pentossifillina nei riguardi dell’aggregazione intravasale degli eritrociti. Ric Clin Lab 15(Suppl 1): 603.Google Scholar
  115. 115.
    Cappelli R, Pecchi S, Pieragalli D, Acciavatti A, Galigani C, Messa GL, Vittoria A, Guerrini M, Forconi S, Di Perri T (1985) Effect on rheological and some peripheral haemodynamic parameters of defibrotide (Abstract). Clin Hemorheol 5: 741.Google Scholar
  116. 116.
    Carey JS (1972) Colloids and crystalloids for volume replacement during and after surgery. In: Messmer K, Schmid-Schönbein H (eds) Hemodilution — Theoretical basis and clinical application. Karger, Basel, p 229.Google Scholar
  117. 117.
    Case DC jr (1982) Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan and prednisone) for Waldenström’s macroglobulinemia: Preliminary report. Blood 59: 934.PubMedGoogle Scholar
  118. 118.
    Catalano M, Sacchi E, Tomasini M, Coazzoli E, Parolini A, Dall’Oglio A, Libretti A (1985) La fluna-rizina nel trattamento delle arteriopatie degli arti inferiori. Ric Clin Lab 15(Suppl 1): 475.PubMedGoogle Scholar
  119. 119.
    Cavestri R, Agosti R, Clivati A, Pelucchi A, Cherubini P, Mastropasqua D, Longhini E (1985) Effects of isovolemic hemodilution on cerebral blood flow and on hemorheologic parameters in acute ischemic stroke (Abstract). Clin Hemorheol 5: 668.Google Scholar
  120. 120.
    Challoner T, Briggs C, Thomas DJ (1981) The effect of reducing haematocrit and viscosity on blood pressure (Abstract). Clin Hemorheol 1: 462.Google Scholar
  121. 121.
    Challoner T, Briggs C, Rampling MW, Thomas DJ (1986) A study of the haematological and haemorheological consequences of venesection. Br J Haematol 62: 671.PubMedCrossRefGoogle Scholar
  122. 122.
    Chazan BI, Ferguson BD, Castelli WP, Touborg JNF, Balodimos MC, Rutstein DD (1969) Lipernia retinalis: Microcirculatory changes and lipid studies in family. Metabolism 18: 978.PubMedCrossRefGoogle Scholar
  123. 123.
    Chevreaud C, Voisin P, Burdin D, Guimont C, Laxenaire MC, Stoltz JF (1985) Deliberate normovolemic hemodilution during the medical treatment of arteriopathy of the lower limbs: Rheological effects (Abstract). Clin Hemorheol 5: 722.Google Scholar
  124. 124.
    Chien S, Usami S, Taylor HM, Lundberg JL (1966) Effect of hematocrit and plasma proteins on human blood rheology at low rates of shear. J Appl Physiol 21: 81.PubMedGoogle Scholar
  125. 125.
    Chien S (1972) Present state of rheology. In: Messmer K, Schmid-Schönbein H (eds) Hemodilution — Theoretical basis and clinical application. Karger, Basel, p 1.Google Scholar
  126. 126.
    Chien S, Schmalzer EA, Lee MML, Impelluso T, Skalak R (1983) Role of white cells in filtration of blood cell suspensions. Biorheology 20: 11.PubMedGoogle Scholar
  127. 127.
    Chien S, Letcher RL, Pickering TG, Devereaux RB (1983) Blood rheology in hypertension (Abstract). Clin Hemorheol 3: 240.Google Scholar
  128. 128.
    Chmiel H (1973) Zur Blutrheologie in Medizin und Technik. Habilitationsschrift, Aachen.Google Scholar
  129. 129.
    Chmiel H, Pavlovic Z (1974) Der Einfluß von Carbocromen-HCl (Intensain) auf die Blutviskosität bei starken Rauchern und frischem Herzinfarkt. Z Kardiol 63(Suppl 1): 53.Google Scholar
  130. 130.
    Chmiel H, Pavlovic Z, Effert S (1975) Neue rheologische Methoden zur Differenzierung pathologischer Veränderungen der Blutviskosität. Verh Dtsch Ges Kreislaufforsch 41: 282.PubMedGoogle Scholar
  131. 131.
    Chmiel H, Schweizer P, Krause KH, Framing W (1976) New methods of measuring the different rheological parameters in blood (Abstract). Microcirculation 1: 94.Google Scholar
  132. 132.
    Chmiel H, Anadere I, Heimburg P (1981) The influence of i.v. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders. Ric Clin Lab 11(Suppl 1): 189.PubMedGoogle Scholar
  133. 133.
    Ciuffetti G, Lupattelli G, Cusco S, Pistola L, Mercuri M, Susta A, Palazzetti D, Mannarino E (1985) Effetti del sulodexide sui parametri emoreologici, lipidici, lipoproteici ed apoproteici di pazienti iperlipemici con arteriopatia obliterante periferica. Ric Clin Lab 15(Suppl 1): 529.Google Scholar
  134. 134.
    Ciuffetti G, Parnetti L, Lupattelli G, Mercuri M, Orecchini G, Senin U (1985) II pattern emoreologico deterioramento mentale senile primitivo: Risultati di uno studio a lungo termine con l’impiego piracetam e pentossifillina. Ric Clin Lab 15(Suppl 1): 583.Google Scholar
  135. 135.
    Cline MJ, Solomon A, Berlin NI, Fahey JL (1963) Anemia in macroglobulinemia. Am J Med 34: 213.PubMedCrossRefGoogle Scholar
  136. 136.
    Clinical Hemorheology 7 (1987) Nr 1 (Special issue).Google Scholar
  137. 137.
    Clivati A, Agosti R, Cherubini P, Ogliari L, Belloni A, Longhini E (1985) Effetti del salasso isovolumetrico sulle proprietà reologiche del sangue in corso di insufficienza respiratoria e policitemia secondaria. Ric Clin Lab 15(Suppl 1): 611.Google Scholar
  138. 138.
    Clivati A, Agosti R, Cherubini P, Spelta P, Bonvini G, Ricciardi G, Pagliano L (1985) Hemorheologic properties in beta-thalassemia (Abstract). Clin Hemorheol 5: 686.Google Scholar
  139. 139.
    Coccheri S, Palareti G, Poggi M, Tricarico MG (1982) Improvements in the rheologic properties of blood induced by medium-term treatment with buflomedil in diabetic patients. J Int Med Res 10: 394.PubMedGoogle Scholar
  140. 140.
    Coccheri S, Palareti G, Parenti M, Poggi M, Tricarico MG (1982) Buflomedil improves erythrocyte deformability in diabetic patients (Abstract). Haemostasis 12: 119.Google Scholar
  141. 141.
    Cokelet GR, Merrill EW, Gilliland ER, Shin H, Britten A, Wells RE (1963) The rheology of human blood. Measurements near and at zero shear rate. Trans Soc Rheol 7: 303.CrossRefGoogle Scholar
  142. 142.
    Copley AL (1949) Rheological problems in biology. In: Burgers JM et al. (eds) Proceedings of the International Congress on Rheology, Holland, 1948. North-Holland, Amsterdam, 1–47; III-8.Google Scholar
  143. 143.
    Copley AL (1952) The rheology of blood. A survey. J Colloid sci 7: 323.CrossRefGoogle Scholar
  144. 144.
    Copley AL, Stainsby G (eds) (1960) Flow properties of blood and other biological systems. Pergamon, London.Google Scholar
  145. 145.
    Copley AL (1962) The endoendothelian fibrin film and fibrinolysis. In: Proceedings of the 8th International Congress on Hematology, Tokyo, 1960, vol 3. Pan-Pacific, Tokyo, p 1648.Google Scholar
  146. 146.
    Copley AL (1968) Hemorheology. Pergamon, New York.Google Scholar
  147. 147.
    Copley AL, Seaman GVF (1981) The meaning of the terms rheology, biorheology and hemorheology (Editorial). Clin Hemorheol 1: 117.Google Scholar
  148. 148.
    Copley AL (1982) The future of the science of biorheology. Biorheology 19: 47.PubMedGoogle Scholar
  149. 149.
    Copley AL (1985) The history of clinical hemorheology. Clin Hemorheol 5: 765.Google Scholar
  150. 150.
    Couette M (1890) Etudes sur le frottement des liquides. Ann Chim Phys 21: 433.Google Scholar
  151. 151.
    Crawford J, Cox EB, Cohen HJ (1985) Evaluation of hyperviscosity in monoclonal gammopathies. Am J Med 79: 13.PubMedCrossRefGoogle Scholar
  152. 152.
    Crolle G, Cucca S, Gosparini B, Baso G, Martechini A, Urbani N, Vattolo S (1985) E’possibile migliorare la deformabilità eritrocitaria nell’anziano vasculopatico? Minerva Med 76: 1349.PubMedGoogle Scholar
  153. 153.
    Crowell JW, Ford RG, Lewis VM (1959) Oxygen transport in hemorrhagic shock as a function of the hematocrit ratio. Am J Physiol 196: 1033.PubMedGoogle Scholar
  154. 154.
    Danilov IP, Makarevich AE (1985) Correction of hemorheological disorders in patients with chronic obstructive bronchitis. Klin Med (Mosk) 63(7): 49.Google Scholar
  155. 155.
    Davis E, Rozov H (1973) The effects of xanthinol nicotinate on the small blood vessels. Bibl Anat 11: 334.PubMedGoogle Scholar
  156. 156.
    Davis E, Rozov H (1975) Xanthinol nicotinate in peripheral vascular disease. Practitioner 215: 793.PubMedGoogle Scholar
  157. 157.
    Dawidson I, Barrett J, Miller E, Litwin MS (1975) Blood viscosity studies in postoperative patients. Bibl Haematol 41: 76.PubMedGoogle Scholar
  158. 158.
    De Clerck F, De Cree J, Brugmans J, Wellens D (1977) Reduction by flunarizine of the increase of blood viscosity after ischemic forearm occlusion. Arch Int Pharmacodyn Ther 230: 321.PubMedGoogle Scholar
  159. 159.
    De Clerck F (1985) Rheological effects of flunarizine, a Ca2+-entry blocker: rationale and mechanism (Abstract). Clin Hemorheol 5: 759.Google Scholar
  160. 160.
    De Cree J, De Cock W, Geukens H, De Clerck F, Beerens M, Verhaegen H (1979) The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions. Angiology 30: 505.PubMedCrossRefGoogle Scholar
  161. 161.
    De Cree J, Leempoels J, Geukens H, De Cock W, Verhaegen H (1981) RBC deformability in patients with essential hypertension and acute myocardial infarction. Improvement by treatment with a selective 5-HT2 antagonist (R 41468). Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 31.Google Scholar
  162. 162.
    De Cree J, Leempoels J, De Cock W, Geukens H, Verhaegen H (1983) Hemorheological effects of ketanserin, a 5-HT2 receptor antagonist. Abstract-Booklet 1st Europ Meeting Hypertension, Milan, Italy.Google Scholar
  163. 163.
    De Cree J, Leempoels J, Geukens H, De Cock W, Verhaegen H (1983) Oral treatment with ketanserin in intermittent claudication. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.Google Scholar
  164. 164.
    Deguchi K, Ito T, Shima H, Uno N, Nakamori I, Ueno H, Umemoto D, Ito U, Kobayashi T, Li S, Tanaka T, Kato M, Konishi M, Kudo M, Kusunose K, Yamada S (1977) Pentoxifylline. Clinical use of pentoxifylline — Concerning blood viscosity and platelet function. Mie Med 21(3): 375.Google Scholar
  165. 165.
    Delsignore R, David S, Francia MT, Bottazzi G, Crotti G (1985) Alterazioni emoreologiche determinate dall’uremia. Effetti dell’emodialisi. Ric Clin Lab 15(Suppl 1): 335.PubMedGoogle Scholar
  166. 166.
    De Quiros JFB, Hess H (1976) Über den Einfluß von Isoxsuprin-HCl auf die Fließfähigkeit des Blutes. Fortschr Med 94: 1661.PubMedGoogle Scholar
  167. 167.
    Derksen RHWM, Hene RJ, Gmelig Meyling FHJ, Kater L (1983) Plasma exchange in the treatment of cryoglobulinemia. Neth J Med 26: 294.PubMedGoogle Scholar
  168. 168.
    Determann H (1908) Das Verhalten der Blutviskosität bei Joddarreichung. Dtsch Med Wochenschr 34: 871.CrossRefGoogle Scholar
  169. 169.
    Diamantopoulos EJ, Raptis S, Karaiskos K, Hadjidakis D, Moulopoulos S (1981) Haemorheo-logical parameters in diabetics under different modes of treatment (Abstract). Clin Hemorheol 1: 465.Google Scholar
  170. 170.
    Diehm C, Gallasch G, Wirth A, Schettler G (1984) Hämorheologische Veränderungen nach körperlichem Training. Dtsch Z Sportmed 8: 286.Google Scholar
  171. 171.
    Di Lollo F, Fazzini G, Avanzi G (1983) L’emodiluizione e la plasmaferesi nella terapia delle sindromi da iperviscosità. Ric Clin Lab 13(Suppl 3): 225.PubMedGoogle Scholar
  172. 172.
    Dintenfass L (1966) A preliminary outline of the blood high viscosity syndromes. Arch Intern Med 118: 427.PubMedCrossRefGoogle Scholar
  173. 173.
    Dintenfass L, Rozenberg MC (1967) Some observations on the viscosity of blood in various diseases. Effect of intravenous heparin. Angiologica 4: 116.PubMedGoogle Scholar
  174. 174.
    Dintenfass L (1968) Fluidity (internal viscosity) of the erythrocyte and its role in physiology and pathology of circulation. Haematologia 2: 19.Google Scholar
  175. 175.
    Dintenfass L (1971) Blood microrheology — Viscosity factors in blood flow, ischaemia and thrombosis. Butterworths, London.Google Scholar
  176. 176.
    Dintenfass L, Milton GW (1973) Blood viscosity factors and prognosis in malignant melanoma. Effect of ABO blood groups. Med J Aust 1: 1091.PubMedGoogle Scholar
  177. 177.
    Dintenfass L, Lake B (1976) Beta blockers and blood viscosity. Lancet 1: 1026.PubMedCrossRefGoogle Scholar
  178. 178.
    Dintenfass L (1976) Rheology of blood in diagnostic and preventive medicine. An introduction to clinical haemorheology. Butterworths, London.Google Scholar
  179. 179.
    Dintenfass L, Seaman GVF (1981) Blood viscosity in heart disease and cancer. Pergamon, New York.Google Scholar
  180. 180.
    Dintenfass L (1981) Hyperviscosity in hypertension. Pergamon, New York.Google Scholar
  181. 181.
    Dintenfass L (1983) Action of drugs on the aggregation and deformability of red cells: effect of ABO blood groups. Ann NY Acad sci 416: 611.PubMedCrossRefGoogle Scholar
  182. 182.
    Dintenfass L (1983) Effect of drugs and diet on blood viscosity, red cell aggregation and red cell rigidity (Abstract). Clin Hemorheol 3: 288.Google Scholar
  183. 183.
    Dintenfass L (1985) Blood viscosity. Hyperviscosity and hyperviscosaemia. MTP Press, Lancaster.Google Scholar
  184. 184.
    Di Perri T, Forconi S, Guerrini M, Laghi Pasini F, Del Cipolla R, Rossi C, Agnusdei D (1977) Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease. Proc R Soc Med 70(Suppl 8): 25.PubMedGoogle Scholar
  185. 185.
    Di Perri T, Forconi S, Agnusdei D, Guerrini M, Laghi Pasini F (1978) The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease. Br J Clin Pharmacol 5: 255.PubMedGoogle Scholar
  186. 186.
    Di Perri T, Forconi S, Guerrini M, Laghi Pasini F, Del Cipolla R, Rossi R, Agnusdei D (1979) Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative disease. Angiology 30: 13.PubMedCrossRefGoogle Scholar
  187. 187.
    Di Perri T, Forconi S, Guerrini M, Pecchi S, Pieragalli D, Cappelli R, Acciavatti A (1981) Influence of non-selective and selective beta adrenoceptor blockade on isoxsuprine-dependent hemodynamic and rheologic changes. Angiology 32: 257.PubMedCrossRefGoogle Scholar
  188. 188.
    Di Perri T, Forconi S, Di Lollo F, Pozza G (1984) Le sindromi da iperviscosità ematica. Fisiologia, patologia e clinica. Pozzi, Roma.Google Scholar
  189. 189.
    Ditzel J, Bang HC, Thorsen N (1969) The effect of Dextran 40 on hemorheological factors during the course of acute myocardial infarction. Bibl Anat 10: 132.PubMedGoogle Scholar
  190. 190.
    Djurdjevic L, Bräuer H, Rahlfs V (1976) Kontrollierte klinische Prüfung von Chemotherapeutika zur Senkung der Blutfette Cholesterin und Triglyzeride sowie deren Einfluß auf die Fluidität des Blutes. Therapiewoche 26: 5556.Google Scholar
  191. 191.
    Dodds AJ, O’Reilly MJG, Yates CJP, Cotton LT, Flute PT, Dormandy JA (1979) Haemorheological response to plasma exchange in Raynaud’s syndrome. Br Med J 2: 1186.PubMedCrossRefGoogle Scholar
  192. 192.
    Dodds AJ (1981) Plasma exchange. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, New York, p 227.Google Scholar
  193. 193.
    Doletskii AS, Dallakian NO, Aksel’rov AM, Nazarova NB, Sokolova VA (1985) Correction of disorders of peripheral circulation with trental in children in the postoperative period. Anesteziol Reanimatol 4: 56.PubMedGoogle Scholar
  194. 194.
    Donaldson DR, Kester RC, Russell CW, Wiggins PA, Hall TJ (1981) Does oxpentifylline (Trental) have a place in the treatment of intermittent claudication? (Abstract). Clin Hemorheol 1: 469.Google Scholar
  195. 195.
    Donaldson DR, Hall TJ, Kester RC, Ramsden CW, Wiggins PA (1984) Does oxpentifylline (“Trental ”) have a place in the treatment of intermittent claudication? Curr Med Res Opin 9: 35.PubMedCrossRefGoogle Scholar
  196. 196.
    Dorigo B, Raspanti D, Trapani M, Albanese B, Cameli AM, Digiesi V (1985) Studio flussimetrico, termometrico e reologico nelle arteriopatie obliteranti degli arti inferiori trattate con buflomedil. Minerva Med 76: 269.PubMedGoogle Scholar
  197. 197.
    Dormandy JA (1970) Clinical significance of blood viscosity. Ann R Coll Surg Engl 47: 211.PubMedGoogle Scholar
  198. 198.
    Dormandy JA (1971) Influence of blood viscosity on blood flow and the effect of low molecular weight dextran. Br Med J 4: 716.PubMedCrossRefGoogle Scholar
  199. 199.
    Dormandy JA, Edelman JB (1973) High blood viscosity: An aetiological factor in venous thrombosis. Br J Surg 60: 187.PubMedCrossRefGoogle Scholar
  200. 200.
    Dormandy JA, Hoare E, Khattab AH, Arrowsmith DE, Dormandy TL (1973) Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J 4: 581.PubMedCrossRefGoogle Scholar
  201. 201.
    Dormandy JA, Gutteridge JMC, Hoare E, Dormandy TL (1974) Effect of Clofibrate on blood viscosity in intermittent claudication. Br Med J 4: 259.PubMedCrossRefGoogle Scholar
  202. 202.
    Dormandy JA, Goyle KB, Postlethwaite J (1976) Improvement in the rate of vascular graft patency with controlled postoperative defibrinogenation (Abstract). Br J Surg 63: 661.Google Scholar
  203. 203.
    Dormandy JA, Goyle KB (1976) Clinical improvement in peripheral circulation by controlled defibrinogenation (Abstract). Br J Surg 63: 661.Google Scholar
  204. 204.
    Dormandy JA, Hoare E, Postlethwaite H (1976) Blood viscosity of patients with intermittent claudication — Concept of “Rheological Claudication ”. Biorheology 13: 161.PubMedGoogle Scholar
  205. 205.
    Dormandy J, Postlethwaite J, Goyle K (1977) Haemorheological therapy. Bibl Anat 16: 481.PubMedGoogle Scholar
  206. 206.
    Dormandy JA, Goyle KB, Reid HL (1977) Treatment of severe intermittent claudication by controlled defibrination. Lancet 1: 625.PubMedCrossRefGoogle Scholar
  207. 207.
    Dormandy JA, Reid HL (1978) Controlled defibrination in the treatment of peripheral vascular disease. Angiology 29: 80.PubMedCrossRefGoogle Scholar
  208. 208.
    Dormandy JA (1981) Drug modification of erythrocyte deformability. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p 251.Google Scholar
  209. 209.
    Dormandy JA, Ernst E (1981) Effects of buflomedil on erythrocyte deformability. Angiology 32: 714.PubMedCrossRefGoogle Scholar
  210. 210.
    Dormandy JA, Yates CJP, Berent GA (1981) Clinical relevance of blood viscosity and red cell deformability including newer therapeutic aspects. Angiology 32: 236.PubMedCrossRefGoogle Scholar
  211. 211.
    Dormandy J (ed) (1983) Red cell deformability and filterability. Martinus Nijhoff, Boston.Google Scholar
  212. 212.
    Dormandy JA, Matrai A (1983) Assessment of pharmacological agents with a hemorheological action. Ann NY Acad sci 416: 599.PubMedCrossRefGoogle Scholar
  213. 213.
    Dormandy JA (1984) Effects of anaesthesia and surgery on the flow properties of blood. Microcirculation, Endothelium and Lymphatics 1: 151.Google Scholar
  214. 214.
    Dormandy J, Ernst E, Matrai A (1986) Clinical aspects of white cell rheology. Clin Hemorheol 6: 455.Google Scholar
  215. 215.
    Dowd PM, Kovacs IB, Bland CJH, Kirby JDT (1981) Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud’s phenomenon and systemic sclerosis. Br Med J 283: 350.CrossRefGoogle Scholar
  216. 216.
    Dowd PM, Kovacs IB, Kirby JDT, Turner P (1981) Decreased deformability of red blood cells in patients with systemic sclerosis and the effect of prostaglandins I2 and E1 on red blood cell deformability (Abstract). Clin Hemorheol 1: 469.Google Scholar
  217. 217.
    Droßbach M (1923) Beziehungen zwischen Blutviskosität und Blutkörperchen, ihre Beeinflussung durch Coffein. Z Gesamte Exp Med 34: 84.CrossRefGoogle Scholar
  218. 218.
    Drouin P, Rousselle D, Pointel JP, Voisin G, Stoltz JF, Clemens AH, Debry G (1979) Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas. Horm MetabResll (Suppl 18): 107.Google Scholar
  219. 219.
    Drouin P, Rousselle D, Stoltz JF, Guimont C, Gaillard S, Vernhes G, Debry G (1981) Study of blood viscosity and erythrocyte parameters in diabetic patients using an artificial pancreas. Scand J Clin Lab Invest 41(Suppl 156): 165.CrossRefGoogle Scholar
  220. 220.
    Drummond AR, Drummond MM, Mackenzie PJ, Lowe GDO, Smith G, Forbes CD, Wishart HY (1980) The effect of general and spinal anaesthesia on red cell deformability and blood viscosity in patients undergoing surgery for fractured neck of femur. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 445.Google Scholar
  221. 221.
    Durocher JR, Weir MS, Lundblad EG, Patow WE, Conrad ME (1975) Effect of oral contraceptives and pregnancy on erythrocyte deformability and surface charge (39037). Proc Soc Exp Biol Med 150: 368.PubMedGoogle Scholar
  222. 222.
    Easthope PL, Brooks DE (1980) A comparison of rheological constitutive functions for whole human blood. Biorheology 17: 235.PubMedGoogle Scholar
  223. 223.
    Ehringer H, Dudczak R, Kleinberger G, Lechner K, Reiterer W (1971) Arvin: Schlangengift als neue Therapiemöglichkeit bei Durchblutungsstörungen. Wien Klin Wochenschr 83: 411.Google Scholar
  224. 224.
    Ehringer H (1971) Effects of the purified fraction of the malayan pit viper (Arvin) alone and in combination with streptokinase in patients with arterial occlusion. Abstract-Booklet Symposium ”Problems related to fibrinolysis ”, Capo Boi, Sardinia.Google Scholar
  225. 225.
    Ehringer H, Dudczak R, Lechner K, Widhalm F (1972) Therapeutische Defibrinierung mit Schlangengift (Arwin) bei arteriellen Durchblutungsstörungen. Verh Dtsch Ges Inn Med 78: 624.PubMedGoogle Scholar
  226. 226.
    Ehringer H, Dudczak R, Widhalm F, Lechner K (1972) Thrombolytische Therapie bei subakuten und chronischen Gliedmaßenarterienverschlüssen. In: Sailer S (ed) Aktuelle Probleme der Fibrino-lyse-Behandlung. Hollinek, Wien, p 41.Google Scholar
  227. 227.
    Ehringer H, Dudczak R, Lechner K (1973) Therapeutische Defibrinierung mit Ancrod. Dtsch Med Wochenschr 98: 2298.PubMedCrossRefGoogle Scholar
  228. 228.
    Ehringer H, Dudczak R, Widhalm F, Lechner K (1974) Wirkung und Möglichkeiten einer Defibrinierung in der Therapie arterieller Durchblutungsstörungen (Untersuchungen mit Arwin). In: Ehringer H (ed) Fortschritte der konservativen Therapie der peripheren arteriellen Verschlußkrankheiten (Aktuelle Probleme der Angiologie, Bd 24). Huber, Stuttgart, p 110.Google Scholar
  229. 229.
    Ehringer H, Dudczak R, Lechner K (1974) A new approach in the treatment of peripheral arterial occlusions: Defibrination with arvin. Angiology 25: 279.PubMedCrossRefGoogle Scholar
  230. 230.
    Ehrly AM (1966) Wirkung von niedermolekularem Dextran auf Erythrozytenaggregate beim Sludge-phänomen. Med Klin 61: 982.Google Scholar
  231. 231.
    Ehrly AM (1967) Hämorheologische Probleme bei Venenerkrankungen. Zentralbl Phlebol 6: 338.PubMedGoogle Scholar
  232. 232.
    Ehrly AM (1969) Warum Hämorheologie? Med Trib 4;42a: 13.Google Scholar
  233. 233.
    Ehrly AM (1969) The effect of plasma substitutes on erythrocyte aggregation and blood viscosity. Bibl Haematol 33: 302.PubMedGoogle Scholar
  234. 234.
    Ehrly AM (1969) Untersuchungen über die Senkung der Strukturviskosität menschlichen Blutes im Hinblick auf angiologische Erkrankungen unter besonderer Berücksichtigung der Blutlipide. Habilitationsschrift, Frankfurt am Main.Google Scholar
  235. 235.
    Ehrly AM, Lange B (1969) Senkung der Blutviskosität und Desaggregation von Erythrocytenaggregaten durch Streptokinase. Abstract-Booklet 2nd Int Conf Int Soc Hemorheol, Heidelberg, p 22.Google Scholar
  236. 236.
    Ehrly AM (1970) Rheologische und mikrozirkulatorische Aspekte bei angiologischen Erkrankungen. Med Trib 5;10a: 13.Google Scholar
  237. 237.
    Ehrly AM (1970) Therapie mit Arwin bei peripheren Durchblutungsstörungen. Arbeitsgespräch bei Knoll AG, Ludwigshafen (siehe: Therapeutische Defibrinierung mit Ancrod. Dtsch Med Wochenschr 99 (1974), 112).Google Scholar
  238. 238.
    Ehrly AM (1971) Hemorheology and thrombosis. Abstract-Booklet 2nd Congr Int Soc Thromb Haemost, Oslo, Norway, p 72.Google Scholar
  239. 239.
    Ehrly AM (1971) Zur Wirkung von Arvin auf die Fließeigenschaften des Blutes (vorläufige Mitteilung). Herrenalber Angiologisches Gespräch.Google Scholar
  240. 240.
    Ehrly AM (1971) Therapie der venösen Stauung durch Verbesserung der Fließeigenschaften des Blutes. Abstract-Booklet 4th Int Congr Phlebol, Lucerne, p 92.Google Scholar
  241. 241.
    Ehrly AM, Fink MM (1971) Blutkörperchensenkungsgeschwindigkeit (BSG) bei verschiedenen Hämatokritwerten. Med Welt 22: 1960.Google Scholar
  242. 242.
    Ehrly AM (1971) Disaggregation of erythrocyte aggregates and decrease of the structural viscosity of human blood by 2-phenyl-benzyl-aminomethyl-imidazolidine (Antazolin). In: Hartert HH, Copley AL (eds) Theoretical and Clinical Hemorheology. Springer, Berlin, p 184.Google Scholar
  243. 243.
    Ehrly AM, Lange B (1971) Reduction in blood viscosity and disaggregation of erythrocyte aggregate by streptokinase. In: Hartert HH, Copley AL (eds) Theoretical and Clinical Hemorheology. Springer, Berlin, p 366.Google Scholar
  244. 244.
    Ehrly AM (1972) Rheological changes due to fibrinolytic therapy. In: Messmer K, Schmid-Schönbein H (eds) Hemodilution — Theoretical basis and clinical application. Karger, Basel, p 289.Google Scholar
  245. 245.
    Ehrly AM (1972) Verbesserung der Fließeigenschaften des Blutes über eine therapeutische Defibrinierung mit Arwin. Gefäßwand und Blutplasma 4: 247.Google Scholar
  246. 246.
    Ehrly AM (1972) Influence of arwin on the flow properties of blood (Abstract). Biorheology 9: 151.Google Scholar
  247. 247.
    Ehrly AM (1972) Das Verhalten der Blutviskosität bei der Therapie mit Salidiuretika. Verh Dtsch Ges Inn Med 78: 617.PubMedGoogle Scholar
  248. 248.
    Ehrly AM, Breddin K (1972) Verbesserung der Fließeigenschaften des Blutes durch Arwin. Verh Dtsch Ges Inn Med 78: 620.PubMedGoogle Scholar
  249. 249.
    Ehrly AM (1973) Influence of arwin on the flow properties of blood. Biorheology 10: 453.PubMedGoogle Scholar
  250. 250.
    Ehrly AM, Jung G (1973) Circadian rhythm of blood viscosity. Biorheology 10: 577.PubMedGoogle Scholar
  251. 251.
    Ehrly AM, Jung HJ (1973) Verbesserung der Fließeigenschaften menschlichen Blutes durch subcutane Applikation von Arwin. Verh Dtsch Ges Inn Med 79: 1397.PubMedGoogle Scholar
  252. 252.
    Ehrly AM (1973) Verbesserung der Fließeigenschaften des Blutes: Ein neues Prinzip der medikamentösen Therapie chronischer peripherer arterieller Durchblutungsstörungen. Vasa 2 (Suppl 1).Google Scholar
  253. 253.
    Ehrly AM (1973) Senkung der Blutviskosität durch Arwin. Herz/Kreislauf 5: 133.Google Scholar
  254. 254.
    Ehrly AM, Bapistella B (1973) Verbesserung der Fließeigenschaften des Blutes bei der Therapie mit Streptokinase und Arwin. In: Gottstein U (ed) Koronarinsuffizienz, periphere Durchblutungsstörungen. Huber, Bern, p 315.Google Scholar
  255. 255.
    Ehrly AM (1974) Increased blood flow by improvement of the flow properties of blood: A new concept of the treatment of vascular diseases. In: De Temes Cordeiro GC, Mayal RC (eds) Progress on Angiology — Proceedings of the 1972 8th International Congress of Angiology, Rio de Janeiro. I.So-ciedade Brasileira de Angiologia 3: 986.Google Scholar
  256. 256.
    Ehrly AM (1974) Therapeutische Aspekte bei Störungen der Mikrozirkulation bei peripheren arteriellen Verschlußkrankheiten. Vasa 3: 312.PubMedGoogle Scholar
  257. 257.
    Ehrly AM, Blendin R (1974) Untersuchungen zur Frage des Einflusses von Bencyclan auf die Fließeigenschaften des Blutes. Therapiewoche 24: 2894.Google Scholar
  258. 258.
    Ehrly AM, Scheinpflug W (1975) Improved deformability of crenated red cells in hyperosmolar human blood by adenosin. Bibl Anat 13: 13.Google Scholar
  259. 259.
    Ehrly AM (1975) The effect of pentoxifylline on the flow properties of hyperosmolar blood. IRCS Med sci 3: 456.Google Scholar
  260. 260.
    Ehrly AM (1975) Dosis-Wirkungs-Beziehung von subcutan appliziertem Arwin® bei Patienten mit chronischen arteriellen Durchblutungsstörungen. Vasa 4: 161.PubMedGoogle Scholar
  261. 261.
    Ehrly AM, Köhler HJ, Schroeder W, Müller R (1975) Sauerstoffdruckwerte im ischämischen Muskelgewebe von Patienten mit chronischen peripheren arteriellen Verschlußkrankheiten. Klin Wochenschr 53: 687.PubMedCrossRefGoogle Scholar
  262. 262.
    Ehrly AM (1975) über die Bedeutung der Erythrozytenverformbarkeit bei angiologischen Erkrankungen. Der Praktische Arzt (österreich Monatsschr Allg Med), Kongreß ”Pentoxifyllin Colloquium ”, Wien, 1975, p9.Google Scholar
  263. 263.
    Ehrly AM (1975) Therapie chronischer peripherer arterieller Verschlußkrankheiten mit dem Schlangengift-Enzym Arwin. Eine übersicht. Med Welt 26: 446.PubMedGoogle Scholar
  264. 264.
    Ehrly AM (1975) Ödemausschwemmung und Thrombose. Forschung und Praxis. Med Welt 26: 1877.PubMedGoogle Scholar
  265. 265.
    Ehrly AM (1975) Veränderungen der Fließeigenschaften des Blutes und der Erythrozyten bei arteriellen Verschlußerkrankungen. Med Welt 26: 1971.PubMedGoogle Scholar
  266. 266.
    Ehrly AM (1975) Beeinflussung der Verformbarkeit der Erythrozyten durch Pentoxifyllin. Med Welt 26: 2300.PubMedGoogle Scholar
  267. 267.
    Ehrly AM, Saeger-Lorenz K (1976) Kombinierte hämodiluierende und defibrinogenierende Therapie chronischer arterieller Verschlußerkrankungen (vorläufige Mitteilung). Abstract-Band Jahrestagung Ges Mikrozirkul, Aachen.Google Scholar
  268. 268.
    Ehrly AM (1976) Therapy of occlusive arterial disease with Ancrod. Artery 2: 98.Google Scholar
  269. 269.
    Ehrly AM, Köhler HJ (1976) Modifiziertes Dosisschema für die subcutane Anwendung von Arwin bei Patienten mit chronischen arteriellen Durchblutungsstörungen. Vasa 5: 155.PubMedGoogle Scholar
  270. 270.
    Ehrly AM, Köhler HJ (1976) Altered deformability of erythrocytes from patients with chronic occlusive arterial disease. Vasa 5: 319.PubMedGoogle Scholar
  271. 271.
    Ehrly AM, Köhler HJ (1976) Impaired erythrocyte deformability in patients with chronic arterial occlusive disease. In: Seki K, Mishima Y (eds) Proceedings of the 10th International Congress on Angiology, Tokyo. seis Printing, Tokyo, p 407.Google Scholar
  272. 272.
    Ehrly AM, Blendin R (1976) Influence of essential phospholipids on the flow properties of the blood. In: Peeters P (ed) Phosphatidylcholine. Springer, Berlin, p 228.Google Scholar
  273. 273.
    Ehrly AM (1976) Improvement of the flow properties of blood: A new therapeutical approach in occlusive arterial disease. Angiology 27: 188.PubMedCrossRefGoogle Scholar
  274. 274.
    Ehrly AM, Saeger-Lorenz K (1977) Kombinierte hämodiluierende und defibrinogenierende Therapie chronischer arterieller Verschlußerkrankungen. Verh Dtsch Ges Kreislaufforsch 43: 332.PubMedGoogle Scholar
  275. 275.
    Ehrly AM (1977) Hemorheological in vitro findings. Are they transferable to the in vivo situation? Microvasc Res 13: 267.Google Scholar
  276. 276.
    Ehrly AM, Bös W (1977) Hämorheologische Untersuchungen bei der saluretischen Therapie chronisch venöser ödeme mit dehydro sanol tri®. Phlebol Proktol 6: 124.Google Scholar
  277. 277.
    Ehrly AM, Schmitt HJ (1977) Verfahren und Vorrichtung zum Messen der Aggregationsgeschwindigkeit von roten Blutkörperchen im Blut. Deutsches Patent Nr 2707962.Google Scholar
  278. 278.
    Ehrly AM, Schroeder W, Dannhof S (1977) The effect of pentoxifylline on the oxygen pressure of ischemic muscle tissue in patients with chronic arterial occlusions. IRCS Med sci 5: 411.Google Scholar
  279. 279.
    Ehrly AM (1978) The effect of pentoxifylline on the flow properties of human blood. Curr Med Res Opin 5: 608.PubMedCrossRefGoogle Scholar
  280. 280.
    Ehrly AM, Landgraf H, Saeger-Lorenz K, Wodniok M (1979) Fließeigenschaften des Blutes bei Behandlung der essentiellen Hypertonie mit Xipamid. Dtsch Med Wochenschr 104: 218.PubMedCrossRefGoogle Scholar
  281. 281.
    Ehrly AM, Schroeder W (1979) Sauerstoffdruckmessungen im ischämischen Muskelgewebe als Kontrolle therapeutischer Maßnahmen bei chronischen peripheren Durchblutungsstörungen. In: Hild R, Spaan G (eds) Therapiekontrolle in der Angiologie. Witzstrock, Baden-Baden, p 83.Google Scholar
  282. 282.
    Ehrly AM, Schroeder W (1979) Zur Pathophysiologic der chronischen arteriellen Verschlußerkrankung. I. Mikrozirkulatorische Blutverteilungsstörung in der Skelettmuskulatur. Herz/Kreislauf 11: 275.Google Scholar
  283. 283.
    Ehrly AM (1979) The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease. J Med 10: 331.PubMedGoogle Scholar
  284. 284.
    Ehrly AM (1979) Vergleich der Fließeigenschaften des Blutes venengesunder Probanden und Patienten mit primärer Varikosis unter verschiedenen hydrostatischen Bedingungen. Phlebol Proktol 8: 169.Google Scholar
  285. 285.
    Ehrly AM, Köhler HJ, Schroeder W (1979) Zeitliche Beziehungen zwischen den Zunahmen des muskulären Gewebesauerstoffdruckes und der schmerzfreien Gehstrecke bei der Therapie der schweren Claudicatio intermittens mit Ancrod. Vasa 8: 28.PubMedGoogle Scholar
  286. 286.
    Ehrly AM (1979) New pathophysiological concept of ischemic diseases. Microcirculatory Maldistribution (MBM). In: Puel P, Boccolon H, Enjalbert A (eds) Hemodynamics of the limbs. Toulouse, p 429.Google Scholar
  287. 287.
    Ehrly AM, Landgraf H, Saeger-Lorenz K (1980) Quantification of the effects of rheologically active drugs in patients with vascular diseases. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 665.Google Scholar
  288. 288.
    Ehrly AM (1980) New pathophysiological concept of ischemic diseases. Microcirculatory Blood Maldistribution (MBM). Bibl Anat 20: 456.Google Scholar
  289. 289.
    Ehrly AM (1980) Mikrozirkulatorische Blutverteilungsstörung als pathophysiologisches Prinzip bei chronischen arteriellen Verschlußerkrankungen. In: Müller-Wiefel H (ed) Mikrozirkulation und Blutrheologie. Witzstrock, Baden-Baden, p 59.Google Scholar
  290. 290.
    Ehrly AM (1981) Therapeutische Hypofibrinogenämie. In: Vinazzer H (ed) Thrombose und Embolic (Anaesthesiologie und Intensivmedizin, Bd 134). Springer, Berlin, p 307.Google Scholar
  291. 291.
    Ehrly AM (1981) Welchen Stellenwert haben Gesamtblutviskosität, Erythrozytenverformbarkeit und Erythrozytenaggregation? Dtsch Med Wochenschr 106: 35.PubMedCrossRefGoogle Scholar
  292. 292.
    Ehrly AM, Landgraf H (1981) Analysis of the specific hemorheological effects of low molecular weight dextran (LMWD)-and saline-infusions in healthy volunteers. Clin Hemorheol 1: 99.Google Scholar
  293. 293.
    Ehrly AM, Landgraf H (1981) Influence of vincamine on the flow properties of blood (Abstract). Clin Hemorheol 1: 471.Google Scholar
  294. 294.
    Ehrly AM (1982) Are there haemorheological reasons for using drugs acting on red cell deformability? Clin Hemorheol 2: 305.Google Scholar
  295. 295.
    Ehrly AM (ed) (1983) Determination of tissue oxygen pressure in patients. Pergamon, Oxford.Google Scholar
  296. 296.
    Ehrly AM (ed) (1983) Klinische Hämorheologie: Eine Bestandsaufnahme. Zuckschwerdt, München.Google Scholar
  297. 297.
    Ehrly AM (1983) Verbesserungen der nutritiven Durchblutung bei peripheren ischämischen Erkrankungen. Vasa 12 (Suppl 11).Google Scholar
  298. 298.
    Ehrly AM (1983) Hemorheological therapy by fibrinogen-lowering drugs (Abstract). Clin Hemorheol 3: 550.Google Scholar
  299. 299.
    Ehrly AM, Landgraf H (1983) Einfluß von Isosorbiddinitrat auf die Fließeigenschaften des Blutes von Patienten mit chronischer arterieller Verschlußkrankheit. Abstract-Band 2. Kongr Dtsch Ges Klin Hämorheol, München.Google Scholar
  300. 300.
    Ehrly AM, Landgraf H (1984) Einfluß von Isosorbiddinitrat auf die Fließeigenschaften des Blutes von Patienten mit chronischer arterieller Verschlußkrankheit. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 145.Google Scholar
  301. 301.
    Ehrly AM, Landgraf H (1984) Effects on muscle tissue oxygen tension in claudicants: Infusions of 5% albumin versus 10% hydroxyethyl starch solution (200/0,5). Int J Microcirc Clin Exp 3(3-4): 521.Google Scholar
  302. 302.
    Ehrly AM (ed) (1984) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München.Google Scholar
  303. 303.
    Ehrly AM (1984) Evaluation of enzymatic defibrinogenation. Clin Hemorheol 4: 151.Google Scholar
  304. 304.
    Ehrly AM (1985) Zum Stellenwert der Erythrozytenaggregation für die gestörte Mikrozirkulation. In: Kiesewetter H, Ehrly AM, Jung F (eds) Hämorheologische Meßmethoden. Münchner Wissenschaftliche Publikationen, München, p 17.Google Scholar
  305. 305.
    Ehrly AM (1985) Correlation between tissue oxygen supply and flow properties of blood in patients with ischemic diseases. Acta Cardiol Mediterr 3: 433.Google Scholar
  306. 306.
    Ehrly AM (1985) Rheoregulation: Influence of vasoconstriction and vasodilation on the flow properties of blood (Abstract). Clin Hemorheol 5: 617.Google Scholar
  307. 307.
    Ehrly AM (1985) Influence of urokinase on the flow properties of blood (Abstract). Clin Hemorheol 5: 728.Google Scholar
  308. 308.
    Ehrly AM, Landgraf H, Saeger-Lorenz K (1985) Einfluß einer Infusion von 500 ml 5%iger Humanalbumin-Lösung auf den Muskelgewebesauerstoffdruck von Patienten mit Claudicatio intermittens. In: Ehrly AM, Hauss J, Huch R (eds) Klinische Sauerstoffdruckmessung — Gewebesauerstoffdruck und transkutaner Sauerstoffdruck bei Erwachsenen. Münchner Wissenschaftliche Publikationen, München, p 96.Google Scholar
  309. 309.
    Ehrly AM (1986) Rheoregulation: Zeitsynchrone Veränderungen der Fließeigenschaften des Bluts in Abhängigkeit vom Sympathikotonus. In: Tillmann W, Ehrly AM (eds) Hämorheologie und Hämatologie. Münchner Wissenschaftliche Publikationen, München, p 75.Google Scholar
  310. 310.
    Ehrly AM (1986) Heißt bessere Durchblutung immer auch bessere Versorgung? Fortschr Med 104: 492.PubMedGoogle Scholar
  311. 311.
    Ehrly AM (1986) Diagnostic and prognostic relevance of ”extra vivum ” rheological results in vascular diseases. Clin Hemorheol 6: 211.Google Scholar
  312. 312.
    Ehrly AM (1986) Circadian rhythm of blood viscosity. Clin Hemorheol 6: 279.Google Scholar
  313. 313.
    Ehrly AM (1986) Hemorheology and tissue oxygen supply: Relationship to pharmacological treatment. Clin Hemorheol 6: 325.Google Scholar
  314. 314.
    Ehrly AM, Brecht HM (1987) Einfluß von Etilefrin auf verschiedene mikrozirkulatorische Parameter von Patienten mit Claudicatio intermittens. In: Strauer BE, Ehrly AM, Leschke M (eds) Fortschritte in der kardiovaskulären Hämorheologie (5. DGKH-Kongreß, Marburg, 1986). Münchner Wissenschaftliche Publikationen, München, p 71 [Abstract: Klin Wochenschr 64 (1986), 1156].Google Scholar
  315. 315.
    Ehrly AM, Hauss J, Huch R (eds) (1987) Clinical oxygen pressure measurement. Tissue oxygen pressure and transcutaneous oxygen pressure. Springer, Berlin.Google Scholar
  316. 316.
    Ehrly AM, Landgraf H, Moschner PV, Saeger-Lorenz K (1987) Hydroxyäthylstärke gegen Dextran: Verhalten des Gewebesauerstoffdruckes und der Fließeigenschaften des Blutes bei Patienten mit Claudicatio intermittens. Med Welt 38: 976.Google Scholar
  317. 317.
    Eisenberg S (1964) Changes in blood viscosity, hematocrit value and fibrinogen concentration in subjects with congestive heart failure. Circulation 30: 686.PubMedGoogle Scholar
  318. 318.
    Erdi A, Thomas DP, Kakkar VV, Lane DA, Dormandy JA (1976) Effects of low-dose subcutaneous heparin on whole-blood viscosity. Lancet 2: 342.PubMedCrossRefGoogle Scholar
  319. 319.
    Ernst E, Dormandy J (1981) The effects of arvin and surgery on red cell filterability. Scand J Clin Lab Invest 41(Suppl 156): 317.CrossRefGoogle Scholar
  320. 320.
    Ernst E (1983) Therapie-Ansatz: Fließeigenschaften des Blutes. Münch Med Wochenschr 125: 8.Google Scholar
  321. 321.
    Ernst E (1984) Sind ”Rheologika ” therapeutisch von Nutzen? Z Allg Med 60: 192.Google Scholar
  322. 322.
    Ernst E, Magyarosy I, Scherer A, Schmidlechner C (1984) Der Einfluß physikalischer Reize auf die Blutfluidität. Z Phys Med Baln Med Klim 13: 359.Google Scholar
  323. 323.
    Ernst E, Marshall M (1984) Verbesserung der reduzierten Erythrozytenflexibilität durch Calcium-dobesilat. Ergebnisse einer Pilotstudie. Münch Med Wochenschr 124: 125.Google Scholar
  324. 324.
    Ernst E, Marshall M (1984) Acetyl salicylic acid is Theologically inactive and hence an ideal reference medication for clinical trials in hemorheology. Clin Hemorheol 4: 563.Google Scholar
  325. 325.
    Ernst E, Matrai A (1984) Increased mortality in hypertensives treated with diuretics — A hemorheological problem? Clin Hemorheol 4: 589.Google Scholar
  326. 326.
    Ernst E, Rose M, Lee R (1984) Modification of transoperative changes in blood fluidity by hydroxychloroquine: A possible explanation for the drug’s antithrombotic effect. Pharmatherapeutica 4: 48.PubMedGoogle Scholar
  327. 327.
    Ernst E (1985) Mit Erfolg gegen den Hirnschlag (Editorial). Fortschr Med 103: 10.Google Scholar
  328. 328.
    Ernst E, Matrai A (1985) Exercise and blood fluidity (Abstract). Clin Hemorheol 5: 653.Google Scholar
  329. 329.
    Ernst E, Matrai A, Kollar L (1985) A randomized, double blind, placebo-controlled, crossover trial on hemodilution in claudicants — preliminary results (Abstract). Clin Hemorheol 5: 756.Google Scholar
  330. 330.
    Ernst E, Matrai A, Weihmayr T, Bushe B, Paulsen F (1985) Behandlung der arteriellen Verschlußkrankheit Stadium IL Hämorheologische und klinische Parameter nach oraler Applikation von Pentoxifyllin (Rentylin®). Münch Med Wochenschr 127: 917.Google Scholar
  331. 331.
    Ernst E, Matrai A, Weihmayr T, Paulsen F (1985) Hemorheological and clinical effects of pentoxifylline in claudicants (Abstract). Clin Hemorheol 5: 730.Google Scholar
  332. 332.
    Ernst E (1986) Hämorheologie für den Praktiker. Zuckschwerdt, München.Google Scholar
  333. 333.
    Ernst E, Matrai A, Kollar L (1986) A randomized, double-blind, placebo-controlled, crossover trial on isovolemic hemodilution in claudicants — Preliminary results. Clin Hemorheol 6: 297.Google Scholar
  334. 334.
    Ernst E, Matrai A, Schönhaber H, Paulsen HF, Magyarosy I (1986) Schlaganfallrehabilitation im Spiegel hämorheologischer Meßgrößen. Herz/Kreislauf 18: 30.Google Scholar
  335. 335.
    2nd European Conference on Clinical Hemorheology, London (1981) (Abstracts). Clin Hemorheol 1: 451.Google Scholar
  336. 336.
    3rd European Conference on Clinical Hemorheology, Baden-Baden (1983) (Abstracts). Clin Hemorheol 3: 221.Google Scholar
  337. 337.
    4th European Conference on Clinical Hemorheology, Siena (1985) (Abstracts). Clin Hemorheol 5: 611.Google Scholar
  338. 338.
    Everts B, Böhme H (1980) Haemostaseological and rheological changes induced by contrast media after catheter angiography. Abstract-Booklet World Congr Angiol, Athen, 1980, p 486.Google Scholar
  339. 339.
    Everts B, Böhme H (1981) Kontrastmittelbedingte hämostaseologische und rheologische Veränderungen nach Katheterangiographie. Münch Med Wochenschr 123: 1180.Google Scholar
  340. 340.
    Everts B, Böhme H (1983) Haemostaseological and rheological changes by a nonionic contrast medium after lower limb phlebography. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.Google Scholar
  341. 341.
    Ewald CA (1877) Ueber die Transpiration des Blutes. Arch Anat Physiol, p 208.Google Scholar
  342. 342.
    Fahey JL (1963) Serum protein disorders causing clinical symptoms in malignant neoplastic disease. J Chronic Dis 16: 703.PubMedCrossRefGoogle Scholar
  343. 343.
    Fahey JL, Barth WE, Solomon A (1965) Serum hyperviscosity syndrome. JAMA 192: 464.PubMedGoogle Scholar
  344. 344.
    Fahraeus R, Lindqvist T (1931) The viscosity of blood in narrow capillary tubes. Am J Physiol 96: 562.Google Scholar
  345. 345.
    Falchi Delitala G, Falchi Delitala N, Casali R, Crescenzi GS, Attorri L, Lombardi R, Martinangeli A, Amici S, De Santis M (1984) Studio a medio termine, in doppio cieco versus placebo, con CDP-colina nella insufficienza cerebrale senile — Aspetti psichici, endocrinologici, emoreologici e biochimico ematologici. Gazz Med Ital Arch sci Med 143: 789.Google Scholar
  346. 346.
    Fazzini GP, Albanese B, Manescalchi PG, Lombardi C, Pasquini G, Bartoli V (1981) Biochemical and haemorheological findings during treatment of plasma cell dyscrasias by plasmapheresis or plasma exchange (Abstract). Clin Hemorheol 1: 473.Google Scholar
  347. 347.
    Fazzini GP, Albanese B, Manescalchi PG, Lombardi C, Pasquini G, Bartoli V (1981) Biochemical and haemorheological findings during treatment of plasma cell dyscrasias by plasmapheresis or plasma exchange. Clin Hemorheol 1: 565.Google Scholar
  348. 348.
    Fendler K, Horváth L (1983) Effect of oral SP 54 treatment on the primary lipoproteinemias and on the viscosity of blood (Abstract). Clin Hemorheol 3: 293.Google Scholar
  349. 349.
    Ferretti PG, Gelmini G, Dall’Asta D, Butturini L, Marchini L, Passeri M (1985) L’emodiluizione normovolemica in pazienti anziani poliglobulici con insufficienza respiratoria cronica. Ric Clin Lab 15(Suppl 1): 617.Google Scholar
  350. 350.
    Folkow B, Mellander S (1964) Veins and venous tone. Am Heart J 68: 397.PubMedCrossRefGoogle Scholar
  351. 351.
    Fontányi S, Baranyi P, Kotányi P, Sikos G (1981) Relative whole blood viscosity measurements in long term heparin treatment of atherosclerotic claudicants. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 94.Google Scholar
  352. 352.
    Forbes CD, Barbenell J, Prentice CRM (1976) Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase — Clinical pharmacology and rheology. Haemostasis 5: 348.PubMedGoogle Scholar
  353. 353.
    Forconi S (1981) Clinical pharmacology of some so-called rheological drugs. Is a rheological treatment of chronic vascular disease possible? (Abstract). Clin Hemorheol 1: 473.Google Scholar
  354. 354.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T (1984) Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients. J Int Med Res 12: 188.PubMedGoogle Scholar
  355. 355.
    Forconi S, Pieragalli D, Acciavatti A, Galigani C, Materazzi M, Ralli L, Franchi M, Laghi Pasini F, Messa GL, Bianciardi A, Rigato M, Blardi P, Guerrini M, Di Perri T (1985) Blood hyperviscosity and peripheral ischemia; the secondary hyperviscosity syndrome of ischemizing vascular diseases (Abstract). Clin Hemorheol 5: 708.Google Scholar
  356. 356.
    Franke I (1974) Die medikamentöse Beeinflussung der Blutviskosität unter besonderer Berücksichtigung von BL 191. Dissertationsschrift, München.Google Scholar
  357. 357.
    Fritz KW, Piehl W, Freyland MD (1970) Zur Frage des Zusammenhanges von renalem hyperfunktionellem Syndrom und Hyperviscosität beim Plasmocytom. Klin Wochenschr 48: 1126.PubMedCrossRefGoogle Scholar
  358. 358.
    Furkalo NK, Ivashchenko TI, Romanenko AI (1985) Therapeutic efficiency of anti-anginal drugs in coronary patients in relation to their effects on blood rheological properties. Kardiologiya 25(9): 55.PubMedGoogle Scholar
  359. 359.
    Gaethgens P (1970) Die Hämodynamik der terminalen Strombahn. Untersuchungen zur Analyse des peripheren Widerstandes im Bereich des mesenterialen Gefäßbettes. Habilitationsschrift, Köln.Google Scholar
  360. 360.
    Gaethgens P, Kreutz F, Albrecht KH (1979) Optimal hematocrit for canine skeletal muscle during rhythmic isotonic exercise. Eur J Appl Physiol 41: 27.CrossRefGoogle Scholar
  361. 361.
    Gaillard S, Schooneman F, Voisin P, Pointel JP, Rousselle D, Drouin P, Stoltz JF (1979) Effets compares sur la filtrabilité in vivo chez l’homme de deux formes galeniques de la pentoxifylline. Ann Méd Nancy 105: 1099.Google Scholar
  362. 362.
    Galigani C, Pieragalli D, Acciavatti A, Guerrini M, Di Perri T (1985) Activity of calcium dobesylate on plasmatic hyperviscosity of diabetic microangiopathy (Abstract). Clin Hemorheol 5: 738.Google Scholar
  363. 363.
    Gallasch G, Diehm C, Dörfer C, Schmitt T, Stage A, Mörl H (1985) Einfluß von körperlichem Training auf die Blutfließeigenschaften bei Claudicatio intermittens-Patienten. Klin Wochenschr 63: 554.PubMedCrossRefGoogle Scholar
  364. 364.
    Gallasch G, Dörfer C, Schmitt T, Stage A (1985) Wirksamkeit von Troxerutin auf die Fließeigenschaften des Blutes unter definierten Strömungsbedingungen. Eine Doppelblindstudie an Patienten mit Retinopathia diabetica und Retinopathia arteriosclerotica. Klin Monatsbl Augenheilkd 187: 30.PubMedCrossRefGoogle Scholar
  365. 365.
    Gallus AS, Gleadow F, Dupont P, Walsh J, Morley AA, Wenzel A, Alderman M, Chivers D (1985) Intermittent claudication: A double-blind crossover trial of pentoxifylline. Aust NZ J Med 15: 402.CrossRefGoogle Scholar
  366. 366.
    Gelin LE (1961) Disturbance of the flow properties of blood and its counteraction in surgery. Acta Chir Scand 122: 287.PubMedGoogle Scholar
  367. 367.
    Gelin LE, Ingelman B (1961) Rheomacrodex — a new dextran solution for rheological treatment of impaired capillary flow. Acta Chir Scand 122: 294.PubMedGoogle Scholar
  368. 368.
    Gelin LE, Thorén OKA (1961) Influence of low viscous dextran on peripheral circulation in man. A Plethysmographic study. Acta Chir Scand 122: 303.PubMedGoogle Scholar
  369. 369.
    Gelin LE (1962) Flüssigkeitsersatz im Schock. In: Bock KD (ed) Schock — Pathogenese und Therapie. Springer, Berlin, p 372.Google Scholar
  370. 370.
    Gelin LE (1962) Rheologic disturbances and the use of low viscosity dextran in surgery. Rev Surg 19: 385.PubMedGoogle Scholar
  371. 371.
    Gelin LE (1965) Rheologie disturbances following tissue injury. In: Copley AL (ed) Symposium on Biorheology. Part 4 of the Proceedings of the Fourth International Congress on Rheology, Brown University, Providence, Rhode Island, 1963. Interscience, New York, p 299.Google Scholar
  372. 372.
    Gelin LE, Kerstell J, Svanborg A (1967) The effect of dietary fat on whole-blood and plasma viscosity in normal and hypercholesterolemic subjects. Acta Med Scand 181: 41.PubMedCrossRefGoogle Scholar
  373. 373.
    Gelin LE (1969) Rheological aspects on shock and the experimental and clinical use of dextrans. In: Ingelman B, Grönwall A, Gelin LE, Eliasson R (eds) Properties and application of dextrans. Alm-qvist & Wiksell, Stockholm, p 43.Google Scholar
  374. 374.
    Gelin LE (1971) Rheological effects of dextran. In: Derrick JR, Guest M (eds) Dextrans — Current concepts of basic actions and clinical application. CC Thomas, Springfield/Illinois (USA), p 137.Google Scholar
  375. 375.
    Gibbs NM, Oh TE, Chester A (1984) Blood viscosity and blood film morphology during prolonged sedation with althesin. Br J Anaesth 56: 1179.PubMedCrossRefGoogle Scholar
  376. 376.
    Girolami A, Cella G (1976) Effect of low-dose subcutaneous heparin on whole-blood viscosity. Lancet 2: 909.PubMedCrossRefGoogle Scholar
  377. 377.
    Girolami A, Patrassi G, Bova G (1978) No change of whole blood or plasma viscosity in cardiac patients after subcutaneous calcium heparin. Folia Haematol 105: 391.Google Scholar
  378. 378.
    Glöckner WM, Malotta H, Sieberth HG (1983) Cascade filtration without any substitution as long-term treatment of Waldenström’s macroglobulinemia with hyperviscosity syndrome (Abstract). Clin Hemorheol 3: 337.Google Scholar
  379. 379.
    Glöckner WM, Sieberth HG, Schmid-Schönbein H (1985) Cascade filtration for the control of hyperviscosity by the removal of IgM-paraprotein in Waldenstrom’s macroglobulinaemia. Clin Hemorheol 5: 71.Google Scholar
  380. 380.
    Gluskowski J, Jedrzejewska-Makowska M, Hawrylkiewicz I, Vertun B, Zielinski J (1983) Effects of prolonged oxygen therapy on pulmonary hypertension and blood viscosity in patients with advanced cor pulmonale. Respiration 44: 177.PubMedCrossRefGoogle Scholar
  381. 381.
    Goldberg K, Wirth FH, Hathaway WE, Guggenheim MA, Murphy JR, Braithwaite WR, Lubchenco LO (1982) Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion. Pediatrics 69: 419.PubMedGoogle Scholar
  382. 382.
    González de Zárate Apiñaniz J, García Domínguez R, Rodríguez Abela J, Baeza Gil C, Girón Mon-táñez R (1985) Efectos reológicos de la propanidida-cremophor EL. Rev Española Anest Rean 32: 264.Google Scholar
  383. 383.
    Gormsen G (1954) Does rapid dehydration in cardiac decompensation produce thrombembolic complications? Acta Med Scand 148: 61.PubMedCrossRefGoogle Scholar
  384. 384.
    Gottschalk M (1985) Infusionsbedingte Blutviskositätsänderungen im Kindesalter. Kinderarztl Prax 53: 579.PubMedGoogle Scholar
  385. 385.
    Gottstein U, Held K (1969) Effekt der Hämodilution nach intravenöser Infusion von niedermolekularen Dextranen auf die Hirnzirkulation des Menschen. Dtsch Med Wochenschr 94: 522.PubMedCrossRefGoogle Scholar
  386. 386.
    Gottstein U, Sedlmeyer I, Schöttler M, Gülk V (1970) Der Effekt von niedermolekularem Dextran auf die Unterschenkeldurchblutung von Gesunden und Kranken mit peripheren arteriellen Zirkulationsstörungen. Dtsch Med Wochenschr 95: 1955.PubMedCrossRefGoogle Scholar
  387. 387.
    Gottstein U (1972) Allgemeine Behandlungsrichtlinien einer medikamentösen Therapie der Hirn-arterienverschlußfolgen. Verh Dtsch Ges Inn Med 78: 466.PubMedGoogle Scholar
  388. 388.
    Gottstein U (1984) Evaluation of isovolemic hemodilution. Clin Hemorheol 4: 133.Google Scholar
  389. 389.
    Gousios A, Shearn MA (1959) Effect of intravenous heparin on human blood viscosity. Circulation 10: 1063.Google Scholar
  390. 390.
    Gramstad L, Stovner J (1979) Plasma viscosity and cremophor-containing anaesthetics. Br J Anaesth 51: 1175.PubMedCrossRefGoogle Scholar
  391. 391.
    Grasselli S, Parise P, Berrettini M, De Cunto M, Nenci GG (1985) Red blood cell (RBC) deformabil-ity during prostacyclin therapy (Abstract). Clin Hemorheol 5: 750.Google Scholar
  392. 392.
    Grindle CFJ, Buskard NA, Newman DL (1976) Hyperviscosity retinopathy — A scientific approach to therapy. Trans Ophthalmol Soc UK 96: 216.PubMedGoogle Scholar
  393. 393.
    Gross GP, Hathaway WE, McGaughey HR (1973) Hyperviscosity in the neonate. J Pediatr 82: 1004.PubMedCrossRefGoogle Scholar
  394. 394.
    Groth CG, Thorsén HGR (1965) Effect of Rheomacrodex® on factors of importance for the flow properties of blood. Bibl Anat 7: 267.PubMedGoogle Scholar
  395. 395.
    Groth CG, Thorsén G (1965) The effect of Rheomacrodex and Macrodex on factors governing the flow properties of the human blood. Acta Chir Scand 130: 507.PubMedGoogle Scholar
  396. 396.
    Groth CG (1966) The effect of infused albumin and Rheomacrodex on factors governing the flow properties of the human blood. Acta Chir Scand 131: 290.PubMedGoogle Scholar
  397. 397.
    Groth CG (1968) Plasmaexpanders and the flow properties of blood. In: Copley AL (ed) Hemorheology. Pergamon, New York, p445.Google Scholar
  398. 398.
    Groth CG (1969) Hemorheology, plasma expanders and nutritional blood flow. Int Anesthesiol Clin 7: 239.PubMedCrossRefGoogle Scholar
  399. 399.
    Gueguen M, Durand F, Grosbois B, Godinot B, Leblay R, Genetet B (1983) Haemorheology applies in the diagnosis of monoclonal dysglobulinemia and in the following-up of their plasma exchange therapy (Abstract). Clin Hemorheol 3: 335.Google Scholar
  400. 400.
    Gueguen M, Le Pogamp P, Avril Y, Le Goff MC, Durand F, Joyeux V, Genetet B, Chevet D (1985) Effects of haemodialysis on the rheological parameters: preliminary results (Abstract). Clin Hemorheol 5: 675.Google Scholar
  401. 401.
    Gülzow K, Euler HH, Löffler H (1984) Therapeutische Apheresen bei Hyperviskositätssyndromen: Klinischer Einsatz einer einfachen Methode der Viskosimetrie. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 121.Google Scholar
  402. 402.
    Guerrini M, Pieragalli D, Messa GL (1981) Changes in blood viscosity after acute administration of l-eburnamonine. Drugs Exp Clin Res 7: 103.Google Scholar
  403. 403.
    Guerrini M, Pecchi S, Rossi C, Cappelli R, Pieragalli D, Acciavatti A (1981) Azione della pentossifil-lina sull’iperviscosità ematica e sulla emodinamica periferica in pazienti affetti da arteriopatia obliterante periferica. Ric Clin Lab 11(Suppl 1): 265.PubMedGoogle Scholar
  404. 404.
    Guerrini M, Acciavatti A, Pecchi S, Cappelli R, Sacchetti S, Forconi S, Di Perri T (1981) Effects of a single i.v. dose of nicergoline on hemorheological and hemodynamic parameters in peripheral vascular disease. A double-blind crossover study. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 114.Google Scholar
  405. 405.
    Guerrini M, Pecchi S, Rossi C, Cappelli R, Pieragalli D, Forconi S, Di Perri T (1981) Possibility of treating vascular diseases from a rheological point of view. Study of the effects of isoxsuprine (Abstract). Clin Hemorheol 1: 475.Google Scholar
  406. 406.
    Guerrini M, Rossi C, Acciavatti A, Pieragalli D, Pecchi S, Cappelli R, Forconi S, Di Perri T (1981) Possibility of treating vascular diseases from a rheological point of view. Study of the effects of flunarizine and cinnarizine (Abstract). Clin Hemorheol 1: 476.Google Scholar
  407. 407.
    Guerrini M, Rossi C, Acciavatti A, Pieragalli D, Pecchi S, Cappelli R, Forconi S, Di Perri T (1981) Possibility of treating vascular diseases from a rheological point of view. Study of the effects of pentoxifilline (Abstract). Clin Hemorheol 1: 476.Google Scholar
  408. 408.
    Guerrini M, Acciavatti A, Materazzi M, Rossi C, Del Bigo C, Forconi S, Di Perri T (1982) Protective effects of buflomedil against exercise-induced reductions in regional erythrocyte deformability of patients with peripheral arterial disease. J Int Med Res 10: 387.PubMedGoogle Scholar
  409. 409.
    Guerrini M, Pieragalli D, Acciavatti A, Cappelli R, Pecchi S, Forconi S, Di Perri T (1983) L’emodi-luizione normovolemica può realmente modificare il flusso ematico degli arti? Ric Clin Lab 13(Suppl 3): 439.PubMedGoogle Scholar
  410. 410.
    Gustafsson L, Appelgren L, Myrvold HE (1985) Effects of hemodilution on skeletal muscle blood flow and blood viscosity in vivo after splanchnic stasis. Eur Surg Res 17: 366.PubMedCrossRefGoogle Scholar
  411. 411.
    Haass A, Kroemer H, Brenner M, Jäger H, Weiss H, Oest A (1986) Hämorheologische und hämodynamische Effekte von Dextran 40-und HAES-200-Langzeitinfusionen. In: Tillmann W, Ehrly AM (eds) Hämorheologie und Hämatologie. Münchner Wissenschaftliche Publikationen, München, p 130.Google Scholar
  412. 412.
    Hagen G (1839) über die Bewegung des Wassers in engen zylindrischen Röhren. Poggendorff’s Annalen der Physik und Chemie 46: 423.CrossRefGoogle Scholar
  413. 413.
    Hagenbach E (1860) über die Bestimmung der Zähigkeit einer Flüssigkeit durch Ausfluß aus Röhren. Poggendorff’s Annalen der Physik und Chemie 109: 385.CrossRefGoogle Scholar
  414. 414.
    Hall JA, Barnard RJ, Pritikin N (1983) Effects of a high-complex-carbohydrate, low-fat, low-salt diet and daily exercise on blood viscosity and blood pressure in hypertensive patients (Abstract). Medicine Science Sports Exercise Madison 15: 91.CrossRefGoogle Scholar
  415. 415.
    Hamazaki T, Hasunuma K, Kobayashi S, Shishido H, Yano S (1985) The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritol (Perycit®) and a low dose of acetylsalicylic acid. Atherosclerosis 55: 107.PubMedCrossRefGoogle Scholar
  416. 416.
    Hansen LL, Wiek J, Arntz HR (1985) Effect of isovolemic hemodilution on visual outcome of patients with ischemic and non-ischemic retinal vein occlusion (Abstract). Clin Hemorheol 5: 691.Google Scholar
  417. 417.
    Harke H, Pieper C, Meredig J, Rahman S, Rüssler P (1980) Rheologische und gerinnungsphysiologische Untersuchungen nach Infusion von HäS 200/0,5 und Dextran 40. Anaesthesist 29: 71.PubMedGoogle Scholar
  418. 418.
    Harkness J, Whittington RB (1971) The viscosity of human blood plasma: Its change in disease and on the exhibition of drugs. Rheol Acta 10: 55.CrossRefGoogle Scholar
  419. 419.
    Haro A (1873) Essai sur la transpirabilité du sang. Gazette Hebdomadaire 11.Google Scholar
  420. 420.
    Hartert HH, Copley AL (eds) (1971) Theoretical and Clinical Hemorheology. Springer, Berlin.Google Scholar
  421. 421.
    Heidrich H, Ott M (1974) Vasodilatantien und Blutviskosität. Herz/Kreislauf 6: 542.Google Scholar
  422. 422.
    Heidrich H, Ott M, Schlichting K (1974) Blutviskosität unter Fludilat. In-vivo-und In-vitro-Untersuchungen. Therapiewoche 24: 2900.Google Scholar
  423. 423.
    Heidrich H, Schlichting K, Ott M (1975) Untersuchungen zum Einfluß von Pentoxifyllin auf die Blutviskosität und die Erythrozytenoberfläche. Med Welt 26: 1977.PubMedGoogle Scholar
  424. 424.
    Heidrich H (1975) Klinisch-experimentelle Untersuchungen zu neuen Wirkungsmechanismen sogenannter Vasodilatantien und gefäßaktiver Pharmaka. Habilitationsschrift, Berlin.Google Scholar
  425. 425.
    Heidrich H, Schlichting K, Ott M (1976) Changes in blood viscosity due to pentoxifylline. IRCS Med sci 4: 368.Google Scholar
  426. 426.
    Heidrich H, Wachta T (1977) Verhalten der Blutviskosität unter 2-, 4-und 6stündiger intravenöser Rheomakrodex-und Kochsalz-Infusion. Verh Dtsch Ges Kreislaufforsch 43: 433.PubMedGoogle Scholar
  427. 427.
    Heidrich H, Wachta T (1978) Blutviskosität unter intravenöser Langzeitinfusion von niedermolekularem Dextran (Rheomacrodex 10%). Dtsch Med Wochenschr 103: 298.PubMedCrossRefGoogle Scholar
  428. 428.
    Heilmann E, Zimmermann B, Gruss P (1982) Effect of pentoxifylline on hypercoagulability in patients with polycythemia vera. IRCS Med sci 10: 594.Google Scholar
  429. 429.
    Heilmann E, Laage HM, Zimmermann E, Dorst KG (1982) Medikamentöse Beeinflussung der Erythrozytenflexibilität bei Sichelzellanämie. Innere Med 9: 277.Google Scholar
  430. 430.
    Heilmann E (1984) Hämatologische und rheologische Untersuchungen bei Polycythaemia vera. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 186.Google Scholar
  431. 431.
    Heilmann L (1980) Hämorheologische Veränderungen bei Risikoschwangerschaften unter der Therapie mit Flunarizin. Vasa 9: 338.PubMedGoogle Scholar
  432. 432.
    Heilmann L, Tauber PF, Siekmann U, Ludwig H (1981) Die Fließfähigkeit des Blutes unter Einnahme von Ovulationshemmern. Zentralbl Gynakol 103: 678.PubMedGoogle Scholar
  433. 433.
    Heilmann L (1983) Hypervolemic hemodilution in the treatment of preeclampsia (Abstract). Clin Hemorheol 3: 550.Google Scholar
  434. 434.
    Heilmann L, Siekmann U (1983) Hämorheologische Veränderungen unter Beta-Blocker-Therapie. In: Irmer M, Weidinger H (eds) Neuere Aspekte zu: Betablockade und Tokolyse. Beltz, Weinheim, p91.Google Scholar
  435. 435.
    Heilmann L, Siekmann U (1983) Die hypervolämische Hämodilution bei der Präeklampsie. Infusionsther Klin Ernahr 10: 311.PubMedGoogle Scholar
  436. 436.
    Heilmann L, Siekmann U (1983) Effect of betamimeticum hexoprenaline on the erythrocyte deform-ability and sodium/potassium-cotransport system of pregnant women (Abstract). Clin Hemorheol 3: 293.Google Scholar
  437. 437.
    Heilmann L (1984) Hämorheologisch orientierte Therapieprinzipien in der Geburtshilfe. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p88.Google Scholar
  438. 438.
    Heilmann L, Kiesewetter H, Ernst E (eds) (1984) Klinische Rheologie und Beta-1-Blockade. Zuckschwerdt, München.Google Scholar
  439. 439.
    Heilmann L, Hirche H (1986) Rheologische Veränderungen unter Naftidrofuryl bei der Gestose. Angio 8: 33.Google Scholar
  440. 440.
    Heilmann L, Beez M (eds) (1987) Neuere klinische Aspekte zur Hämodilution. Schattauer, Stuttgart.Google Scholar
  441. 441.
    Heinen A, Brunner R, Wawer T, Roll K, Konen W, Hossmann V (1983) Randomized double-blind trial of isovolaemic haemodilution (IHD) in retinal vessel occlusion (Abstract). Clin Hemorheol 3: 233.Google Scholar
  442. 442.
    Hess H (1970) Neue überlegungen zur Physiopathologie obliterierender Angiopathien. 1. Zur Regulation der Durchblutung. Fortschr Med 88: 833.Google Scholar
  443. 443.
    Hess H (1970) Neue überlegungen zur Physiopathologie obliterierender Angiopathien. 2. Zur Pathogenese und Therapie. Fortschr Med 88: 923.Google Scholar
  444. 444.
    Hess H, Franke J, Jauch M (1973) Medikamentöse Verbesserung der Fließeigenschaften des Blutes. Ein wirksames Prinzip zur Behandlung von arteriellen Durchblutungsstörungen. Fortschr Med 91: 743.PubMedGoogle Scholar
  445. 445.
    Hess H, Wagner G (1974) Untersuchungen über den Einfluß von Fludilat auf die Blutviskosität. Therapiewoche 24: 2898.Google Scholar
  446. 446.
    Hess W (1907) Die Bestimmung der Viskosität des Blutes. Münch Med Wochenschr 45: 2225.Google Scholar
  447. 447.
    Hess WR (1912) Der Strömungswiderstand des Blutes gegenüber kleinen Druckweiten. Arch Anat Physiol, Physiolog Abt, Leipzig, p 197.Google Scholar
  448. 448.
    Hildebrandt HG (1980) Einfluß von Buflomedil auf die Fließeigenschaften des Blutes und die Gewebesauerstoffdruckwerte in der Muskulatur bei Patienten mit Claudicatio intermittens. Dissertationsschrift, Frankfurt am Main.Google Scholar
  449. 449.
    Hirsch C, Beck C (1901) Studien zur Lehre von der Viscosität (inneren Reibung) des lebenden, menschlichen Blutes. Dtsch Arch Klin Med 69: 503.Google Scholar
  450. 450.
    Hoffmann LS, Ritzmann SE (1965) Plasmapheresis — Application of modified technic in patients with monoclonal gammopathies. Tex Rep Biol Med 23: 651.Google Scholar
  451. 451.
    Holti G (1979) An experimentally controlled evaluation of the effect of inositol nicotinate upon the digital blood flow in patients with Raynaud’s phenomenon. J Int Med Res 7: 473.PubMedGoogle Scholar
  452. 452.
    Hossmann V, Bewermeyer H, Heiss WD (1981) A controlled trial of ancrod in the treatment of acute ischaemic stroke. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p41.Google Scholar
  453. 453.
    Hossmann V, Wegener H, Wegener B, Saborowski F, Cäsar K (1982) Hämorheologische und hämo-dynamische Wirkungen von Isosorbiddinitrat bei essentieller Hypertonie und arterieller Verschlußkrankheit. In: Engel HJ, Schrey A, Lichtlen PR (eds) Nitrate III — Kardiovaskuläre Wirkungen. Springer, Berlin, p287.Google Scholar
  454. 454.
    Hossmann V, Auel H (1983) Haemorheologische Therapie der arteriellen Verschlußkrankheit: Eine kontrollierte, prospektive Studie mit isovolämischer Haemodilution, Arwin und einer Kombination beider Methoden. In: Nobbe F, Rudofsky G (eds) Probleme der Vor-und Nachsorge und der Narkoseführung bei invasiver angiologischer Diagnostik und Therapie. Begutachtung arterieller und venöser Gefäßschäden. Pflaum, München, p 325.Google Scholar
  455. 455.
    Hossmann V, Heiss WD, Bewermeyer H, Wiedemann G (1983) Controlled trial of ancrod in ischemic stroke. Arch Neurol 40: 803.PubMedGoogle Scholar
  456. 456.
    Hossmann V (1983) Controlled study of the hemorheological effects of ancrod, isovolemic hemodilution and combined treatment in advanced stages of peripheral arterial diseases (Abstract). Clin Hemorheol 3: 309.Google Scholar
  457. 457.
    Hudomel J, Németh B, Palfalvy M, Farkas A (1977) Effect of calcium dobesilate (Doxium) on blood hyperviscosity in cases of diabetic retinopathy. Ophthalmic Res 9: 25.CrossRefGoogle Scholar
  458. 458.
    Hudomel J, Németh B, Palfalvy M, Farkas A (1979) Wirkung von Kalzium-Dobesilat auf die Hyperviskosität des Blutes. Fortschr Med 97: 422.Google Scholar
  459. 459.
    Hürthle K (1900) Ueber eine Methode zur Bestimmung der Viscosität des lebenden Blutes und ihre Ergebnisse. Arch Ges Physiol 82: 415.CrossRefGoogle Scholar
  460. 460.
    Humphrey PRD, Michael J, Pearson TC (1980) Management of relative polycythaemia: Studies of cerebral blood flow and viscosity. Br J Haematol 46: 427.PubMedCrossRefGoogle Scholar
  461. 461.
    Humphrey PRD, Michael J, Pearson TC (1980) Red cell mass, plasma volume and blood volume before and after venesection in relative polycythaemia. Br J Haematol 46: 435.PubMedCrossRefGoogle Scholar
  462. 462.
    Humphrey PRD, Du Boulay GH, Marshall J, Pearson TC, Ross Russell RW, Symon L, WetherleyMein G, Zilkha E (1981) Venesection in relative polycythaemia: Measurement of cerebral blood flow, viscosity and blood volume. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 38.Google Scholar
  463. 463.
    Humphrey PRD, Du Boulay GH, Marshall J, Pearson TC, Ross Russell RW, Symon L, WetherleyMein G, Zilkha E (1981) Management of relative polycythaemia: Comparative effects of venesection, dextran and fludrocortisone. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 112.Google Scholar
  464. 464.
    Humphreys WV, Walker A, Cave FD, Charlesworth D (1976) The effect of an infusion of low molecular weight dextran on peripheral resistance in patients with arteriosclerosis. Br J Surg 63: 691.PubMedCrossRefGoogle Scholar
  465. 465.
    Humphreys WV, Walker A, Charlesworth D (1977) A report on the use of arvin in patients with pregangrene of the lower limb. Br J Surg 64: 31.PubMedCrossRefGoogle Scholar
  466. 466.
    5th International Congress of Biorheology, Baden-Baden (1983) (Abstracts). Biorheology 20: 361.Google Scholar
  467. 467.
    International Symposium on filterability and red blood cell deformability, Göteborg, Sweden (1980). Scand J Clin Lab Invest 41 (Suppl 156).Google Scholar
  468. 468.
    Itoh C, Ishii A, Iwafune Y, Yoshimoto H (1982) Fibrinolytic therapy and blood viscosity in simple diabetic retinopathy. Nippon Ganka Kiyo 33: 2469.Google Scholar
  469. 469.
    Iwamoto H, Nakagowa S, Matsui N, Yoshiyama N, Shinoda T, Shibamoto T, Takenchi J (1980) An experience of plasma exchange by membrane separator for IgA myeloma. In: Sieberth HG (ed) Plasma exchange. Schattauer, Stuttgart, p377.Google Scholar
  470. 470.
    Jacobs MJ, Lemmens HAJ, Slaaf DW, Reneman RS (1983) The effect of ketanserin on microcirculation in patients with ischaemic handsyndromes. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.Google Scholar
  471. 471.
    Jahnsen T, Skovborg F, Hansen F, Larsen J, Nordin H, Storm T (1983) Variations in blood viscosity in patients with acute cardiogenic pulmonary oedema treated with frusemide. Scand J Clin Lab Invest 43: 297.PubMedCrossRefGoogle Scholar
  472. 472.
    Jahnsen T, Skovborg F, Jahnsen F, Storm TL (1985) Blood viscosity in patients receiving continuous treatment with bendroflumethiazide (Centyl® with potassium chloride). Ugeskr Laeger 147: 409.PubMedGoogle Scholar
  473. 473.
    James DR, Holland BM, Hughes MR, Jones JG, Wardrop CAJ (1984) Oxpentifylline: Effects on red cell deformability and oxygen availability from the blood in intermittent claudication. Clin Hemorheol 4: 525.Google Scholar
  474. 474.
    Jan K, Usami S, Smith JA (1982) Effects of transfusion on rheological properties of blood in sickle cell anemia. Transfusion 22: 17.PubMedCrossRefGoogle Scholar
  475. 475.
    Jauch M (1973) Der Einfluß von verschiedenen Medikamenten auf die Viskosität des Blutes. Dissertationsschrift, München.Google Scholar
  476. 476.
    Johnsson R (1979) Effect of pentoxifylline on red cell flexibility and cation transport in healthy subjects and patients with hereditary spherocytosis. Scand J Haematol 23: 81.PubMedCrossRefGoogle Scholar
  477. 477.
    Johnsson R, Harjola PT, Siltanen P (1981) Effect of pentoxifylline on red cell flexibility in arteriosclerotic patients and in patients with heart valve prosthesis. Scand J Clin Lab Invest 41(Suppl 156): 297.CrossRefGoogle Scholar
  478. 478.
    Juhan I, Buonocore M, Calas-Aillaud MF, Moulin JP, Verdot JJ, Vague P (1980) Effects of insulin on erythrocyte deformability and platelet aggregation in diabetics on an artificial pancreas. Abstract-Booklet Int Symp filterability and red cell deformability, Göteborg, Sweden, p 53.Google Scholar
  479. 479.
    Juhan I, Vague P, Buonocore M, Moulin JP, Calas MF, Vialettes B, Verdot JJ (1981) Effects of insulin on erythrocyte deformability in diabetics — relationship between erythrocyte deformability and platelet aggregation. Scand J Clin Lab Invest 41(Suppl 156): 159.CrossRefGoogle Scholar
  480. 480.
    Juhan I, Vague P, Buonocore M, Muratore R (1981) Deformabilite des hematies chez les diabétiques. Effets de l’insuline. Relations avec l’agrégation plaquettaire. Sem Hop Paris 57: 466.PubMedGoogle Scholar
  481. 481.
    Juhan I, Vague P, Buonocore M, Moulin JP, Jouve R, Vialettes B (1982) Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1: 535.PubMedCrossRefGoogle Scholar
  482. 482.
    Jung F, Waldhausen P, Schwab J, Braun B, Molter A, Scheffler P, Kiesewetter H, Wenzel E (1986) Wirkung von Naftidrofuryl auf Mikrozirkulation und Hämorheologie bei peripherer arterieller Verschlußkrankheit im Stadium IIb. In: Tillmann W, Ehrly AM (eds) Hämorheologie und Hämatologie. Münchner Wissenschaftliche Publikationen, München, p 163.Google Scholar
  483. 483.
    Jung F, Waldhausen P, Schwab J, Molter A, Scheffler P, Kiesewetter H, Wenzel E (1986) Einfluß von Naftidrofuryl auf die Mikrozirkulation bei der peripheren arteriellen Verschlußkrankheit. Med Welt 37: 132.Google Scholar
  484. 484.
    Kallio V, Salmivalli M, Brummer P (1967) Blood viscosity changes in patients hospitalized because of acute chest pain. Cardiologia 50: 323.CrossRefGoogle Scholar
  485. 485.
    Karasawa T, Hayano Y, Imai N (1982) Significance and treatment of abnormal blood viscosities in pre-eclamptic patients. Acta Obstet Gynecol Jpn 34: 599.Google Scholar
  486. 486.
    Keller F, Leonhardt H (1979) Amelioration of blood viscosity in sickle cell anemia by pentoxifylline — A case report. J Med 10: 429.PubMedGoogle Scholar
  487. 487.
    Keller F, Leonhardt H (1980) Verbesserung der Blutviskosität bei Sichelzellanämie durch Pentoxifyllin. Dtsch Med Wochenschr 105: 898.PubMedCrossRefGoogle Scholar
  488. 488.
    Kennedy MS, Domen RE (1983) Therapeutic apheresis. Applications and future directions. Vox Sang 45: 261.PubMedCrossRefGoogle Scholar
  489. 489.
    Keppeler D (1977) Untersuchungen über den Einfluß von Hydroxyäthylstärke auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  490. 490.
    Kharkharov MA, Tirulov MT (1986) Changes in blood viscosity and central hemodynamics in patients with essential hypertension during treatment with sulfide baths. Vopr Kurortol Fizioter Lech Fiz Kult 1: 13.PubMedGoogle Scholar
  491. 491.
    Kiesewetter H, Dauer U, Gerhards M, Gesch M, Schmid-Schönbein H (1981) The single erythrocyte rigidometer (SER) as a reference for RBC-deformability tests. Biorheology 18: 157.Google Scholar
  492. 492.
    Kiesewetter H, Radtke H, Schneider R, Mußler K, Scheffler A, Schmid-Schönbein H (1982) Das Mini-Erythrozytenaggregometer: Ein neues Gerät zur schnellen Quantifizierung des Ausmaßes der Erythrozytenaggregation. Biomed Techn 27: 209.CrossRefGoogle Scholar
  493. 493.
    Kiesewetter H, Blume J, Bulling B, Gerhards M, Jung F, Radtke H, Franke RP (1984) Mittelmolekulare Hydroxyäthylstärke als Volumenersatzmittel. Rheologische Wirkung bei peripherer arterieller Verschlußkrankheit. Dtsch Med Wochenschr 109: 1844.PubMedCrossRefGoogle Scholar
  494. 494.
    Kiesewetter H, Blume J, Jung F, Radtke H, Bulling B, Gerhards M, Prünte C, Reim M (1984) Hämorheologische Aspekte peripherer arterieller Verschlußkrankheiten. Wirksamkeitsuntersuchung von Naftidrofuryl. Med Welt 35: 896.Google Scholar
  495. 495.
    Kiesewetter H, Blume J, Radtke H, Gerhards M, Bulling B (1984) Zur Wirksamkeit des Diuretikums Slimin® zur Unterstützung der physikalischen Entstauungstherapie beim venösen ödem. Therapiewoche 34: 4469.Google Scholar
  496. 496.
    Kiesewetter H, Jung F, Körber N, Blume J, Radtke H, Reim M (1984) Stellenwert hämorheologischer Parameter bei der diabetischen Retinopathie. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 158.Google Scholar
  497. 497.
    Kiesewetter H, Jung F, Doenecke P, Hellstern P, Scheffler P, von Blohn G, Waldhausen P, Schwab J, Kiehl R, Wenzel E (1985) Klinische Wirksamkeit der Urokinase durch Fibrinolyse und rheologisch wirkende Fibrinogenolyse. In: Wenzel E, Hellstern P (eds) Abstracts and Handout-Poster. 29. Jahrestagung der DAB/GTH, Saarbrücken, p 131.Google Scholar
  498. 498.
    Kiesewetter H, Le Cotonnec JY, Gulati O (1985) Effect of bencianol on blood rheology (Abstract). Clin Hemorheol 5: 741.Google Scholar
  499. 499.
    Kiesewetter H, Blume J, Jung F, Bulling B, Gerhards M (1986) Rheologische Wirkung von Metoprolol bei Patienten mit essentieller Hypertonie. Klinikarzt 15: 93.Google Scholar
  500. 500.
    Kiesewetter H, Jung F (1986) Rheologische Therapie der peripheren arteriellen Verschlußkrankheit im Stadium IIb. Angio 8: 21.Google Scholar
  501. 501.
    Kiesewetter H, Jung F, Blume J, Bulling B, Franke RP (1986) Vergleichende Untersuchung von niedermolekularem Dextran-oder Hydroxyäthylstärkelösungen als Volumenersatzmittel bei Hämodilutionstherapie. Klin Wochenschr 64: 29.PubMedCrossRefGoogle Scholar
  502. 502.
    Kiesewetter H, Schneider R, Jung F (1986) Einsatz von Naftidrofuryl bei Patienten mit Basilarisinsuffizienz. Med Welt 37: 211.Google Scholar
  503. 503.
    Kiesewetter H, Schneider R, Jung F, Blume J, Gerhards M (1986) Therapie zerebraler Mikroangiopathien. Untersuchungen mit niedermolekularer Hydroxyäthylstärke mit und ohne Pentoxifyllin. Therapiewoche 36: 50.Google Scholar
  504. 504.
    Kiesewetter H, Jung F, Roggenkamp HG, Nüttgens HP, Leipnitz G, Ringelstein EB, Wenzel E, Grillmaier R (1987) Zur diagnostischen Bedeutung rheologischer Parameter in der Klinik. In: Strauer BE, Ehrly AM, Leschke M (eds) Fortschritte in der kardiovaskulären Hämorheologie (5. DGKH-Kongreß, Marburg, 1986). Münchner Wissenschaftliche Publikationen, München, p 185.Google Scholar
  505. 505.
    Kilpatrick D, Fleming J, Clyne C, Thompson GR (1979) Reduction of blood viscosity following plasma exchange. Atherosclerosis 32: 301.PubMedCrossRefGoogle Scholar
  506. 506.
    Kindl-Mascher J (1984) Untersuchungen über das Verhalten der Fließeigenschaften des venösen Blutes und des Gewebesauerstoffdruckes in der Unterschenkelmuskulatur von Patienten mit Claudicatio intermittens während einer Therapie mit Batroxobin (Defibrase). Dissertationsschrift, Frankfurt am Main.Google Scholar
  507. 507.
    Kirigaya H, Itoh H, Miyahara Y, Inada M, Korenaga M, Kanayama M, Niwa A, Taniguchi K (1982) The effects of drugs on blood viscosity (Abstract). Clin Hemorheol 2: 397.Google Scholar
  508. 508.
    Klein M, Szobor A, Bräuer H (1979) Kontrollierte Prüfung von Vincamin. Unter besonderer Berücksichtigung der Fließeigenschaften des Blutes. Med Klin 74(Sondernummer): 29.Google Scholar
  509. 509.
    Klemm J (1976) The treatment of arterial and venous circulatory disturbances with EPL. In: Peeters P (ed) Phosphatidylcholine. Springer, Berlin, p 237.Google Scholar
  510. 510.
    Klemm J, Enghofer E (1982) Strömungsgeschwindigkeit von Blut in varikösen Venen der unteren Extremitäten. Einfluß eines Venentherapeutikums (Venostasin®). Münch Med Wochenschr 124: 579.Google Scholar
  511. 511.
    Klemm J, Enghofer E (1983) Influence of Venostasin® on blood flow in varicose veins of the lower limbs (Abstract). Clin Hemorheol 3, Nr 150C.Google Scholar
  512. 512.
    Klövekorn WP, Pichlmaier H, Ott E, Bauer H, Sunder-Plassmann L, Jesch F, Messmer K (1975) Acute preoperative hemodilution in surgical patients. In: Messmer K, Schmid-Schönbein H (eds) Intentional hemodilution. Karger, Basel, p 248.Google Scholar
  513. 513.
    Klose HJ, Volger E, Brechteisbauer H, Heinrich L, Schmid-Schönbein H (1972) Microrheology and light transmission of blood. I. The photometric quantification of red cell aggregation and red cell orientation. Pflüger’s Arch 333: 126.CrossRefGoogle Scholar
  514. 514.
    Knarr W (1975) Beeinflussung der Fließeigenschaften des Blutes durch Pentoxifyllin. Dissertationsschrift, Frankfurt am Main.Google Scholar
  515. 515.
    Kobayashi S, Hamazaki T, Hirai A, Terano T, Tamura Y, Kanakubo Y, Yoshida S, Fujita T, Kumagai A (1985) Epidemiological and clinical studies of the effect of eicosapentaenoic acid on blood viscosity. Clin Hemorheol 5: 493.Google Scholar
  516. 516.
    Köhler HJ (1971) Untersuchungen über den Einfluß von wasserlöslichen Röntgenkontrastmitteln auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  517. 517.
    Köhler M, Rieger H, Sievers D, Krüpe M (1980) über die Reaktion des Kreislaufs auf eine gezielte Senkung der Blutviskosität. In: Müller-Wiefei H (ed) Mikrozirkulation und Blutrheologie. Witz-strock, Baden-Baden, p 76.Google Scholar
  518. 518.
    Köhler S (1973) Untersuchungen über den Einfluß von Diuretika auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  519. 519.
    Koga G (1913) Zur Therapie der Spontangangrän an den Extremitäten. Dtsch Z Chir 11: 371.CrossRefGoogle Scholar
  520. 520.
    Kollär L, Fendler K, Szekeres P, Kiss T (1985) Evaluation of arvin treatment with crossover double blind study (Abstract). Clin Hemorheol 5: 744.Google Scholar
  521. 521.
    Konishi M, Nobuko T, Muneki S, Manubu K, Kojiro Y, Ryu N (1985) Microhemodynamic changes before and after hemodialysis (Abstract). Clin Hemorheol 5: 576.Google Scholar
  522. 522.
    Kontras SB, Bodenbender JB, Craenen J, Hosier DM (1970) Hyperviscosity in congenital heart disease. J Pediatr 76: 214.PubMedCrossRefGoogle Scholar
  523. 523.
    Kontras SB (1972) Polycythemia and hyperviscosity syndrome in infants and children. Pediatr Clin North Am 19: 919.PubMedGoogle Scholar
  524. 524.
    Kopp WL, Beirne GJ, Burns RO (1967) Hyperviscosity syndrome in multiple myeloma. Am J Med 43: 141.PubMedCrossRefGoogle Scholar
  525. 525.
    Korabelshchikova NI, Bichko MV, Rishko NV (1985) Rheological properties of the blood in stenocardia patients in the dynamics of treatment with Obsidan, Corvaton, Corinfar. Vrach Delo 4: 19.Google Scholar
  526. 526.
    Kottmann K (1907) über die Viskosität des Blutes. Korrespondenzbl Schweizer ärzte 5: 129.Google Scholar
  527. 527.
    Koul BL, Nordhas O, Sonnenfeld T, Ekeström S (1984) The effect of pentoxifylline on impaired red cell deformability following open-heart surgery. Scand J Thorac Cardiovasc Surg 18: 129.PubMedCrossRefGoogle Scholar
  528. 528.
    Krepp HP, Beez M, Bock P (1984) Behandlung des akuten Hirninfarktes durch hypervolämische Hämodilutionstherapie. Klinikarzt 13: 597.Google Scholar
  529. 529.
    Krosch H (1959) Rheologische Untersuchungen über die Viskosität des Blutes und ihre Bedeutung für klinische Kreislaufprobleme. Habilitationsschrift, Halle/Saale.Google Scholar
  530. 530.
    Kuschinsky G, Lüllmann H (1970) Kurzes Lehrbuch der Pharmakologie und Toxikologie. Thieme, Stuttgart.Google Scholar
  531. 531.
    Kuznetsov NA, Filimonov MI, Lopukhin SY, Vasilyev VE (1983) Correction of blood rheologic properties in patients with obstructive jaundice. Khirurgiia (Mosk) 8: 96.Google Scholar
  532. 532.
    Kuzuya F, Osawa M, Maruyama S (1985) Effects of vinpocetine on blood viscosity and platelet aggregability. Today’s Ther Trends 3: 21.Google Scholar
  533. 533.
    Lakomek M, Behrens-Baumann W, Schröter W, Tillmann W (1983) Absence of increased aggregation of erythrocytes in children with diabetes mellitus (Abstract). Clin Hemorheol 3: 270.Google Scholar
  534. 534.
    Landgraf H, Ruppel C, Saeger-Lorenz K, Vogel C, Ehrly AM (1982) Verbesserung der Fließeigenschaften des Blutes von Patienten durch niedermolekulare Hydroxyäthylstärke (Expafusin®). Infusionsther Klin Ernahr 9: 202.PubMedGoogle Scholar
  535. 535.
    Landgraf H, Ehrly AM (1984) Hämorheologische Wirkungen hypervolämischer Hämodilution mit Dextran 40 und HAES 200 bei Patienten mit arterieller Verschlußkrankheit. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 138.Google Scholar
  536. 536.
    Landgraf H, Ehrly AM (1984) Wirkungen einer Clofibrat-induzierten Senkung der Fibrinogenkon-zentration im Blut bei peripheren arteriellen Durchblutungsstörungen. In: Mahler F, Nachbur B (eds) Zerebrale Ischämie. Huber, Bern, p 277.Google Scholar
  537. 537.
    Landgraf H (1984) Untersuchungen über die Wirkungen von Plasmaersatzstoffen auf die Fließeigenschaften des Blutes und die Sauerstoffversorgung der Skelettmuskulatur bei chronischer peripherer arterieller Verschlußkrankheit. Habilitationsschrift, Frankfurt am Main.Google Scholar
  538. 538.
    Landgraf H, Ehrly AM (1985) Bedeutung und Möglichkeit der Quantifizierung der Plasmaviskosität. In: Kiesewetter H, Ehrly AM, Jung F (eds) Hämorheologische Meßmethoden. Münchner Wissenschaftliche Publikationen, München, p 35.Google Scholar
  539. 539.
    Landgraf H, Moschner P, Ehrly AM (1985) Hypervolemic hemodilution (HHD) in claudicants: Hemorheological changes due to infusion of plasma substitutes (Abstract). Clin Hemorheol 5: 723.Google Scholar
  540. 540.
    Landgraf H, Ehrly AM (1986) Verhalten des Gewebesauerstoffdruckes bei peripherer arterieller Verschlußkrankheit nach hypervolämischer Hämodilution mit verschiedenen Plasmaersatzstoffen. In: Häring R (ed) DGA — Deutsche Gesellschaft für Angiologie. Referate. 5.Gemeinsame Jahrestagung der Angiologischen Gesellschaften der Bundesrepublik Deutschland, österreichs und der Schweiz, Berlin 1985. Demeter, Gräfelfing, p 304.Google Scholar
  541. 541.
    Landgraf H, Ehrly AM (1987) Verhalten hämorrheologischer Parameter und des Gewebesauerstoffdruckes im Verlauf einer hypervolämischen Hämodilution bei Patienten mit arterieller Verschlußkrankheit. In: Heilmann L, Beez M (eds) Neuere klinische Aspekte zur Hämodilution (Symp Essen, 1985). Schattauer, Stuttgart, p 115.Google Scholar
  542. 542.
    Lang GD, Lowe GDO, Walker JJ, Forbes CD, Prentice CRM, Calder AA (1984) Blood rheology in pre-eclampsia and intrauterine growth retardation: effects of blood pressure reduction with labetalol. Br J Obstet Gynaecol 91: 438.PubMedCrossRefGoogle Scholar
  543. 543.
    Langsjoen PH (1966) Blood viscosity changes in acute myocardial infarction. Postgrad Med 39: A–42.Google Scholar
  544. 544.
    Langsjoen PH, Immon TW (1967) Rheologie changes in myocardial infarction. Am Heart J 73: 430.PubMedCrossRefGoogle Scholar
  545. 545.
    Langsjoen PH, Immon TW (1968) Hemorheologic observations in acute myocardial infarction. Angiology 19: 247.PubMedCrossRefGoogle Scholar
  546. 546.
    Langsjoen PH (1973) The value of reducing blood viscosity in acute myocardial infarction. Bibl Anat 11: 180.PubMedGoogle Scholar
  547. 547.
    Lanzer G, Tilz GP (1986) Die therapeutische Blutkomponentenseparation in der klinischen Notfallmedizin. Wien Med Wochenschr 136: 134.PubMedGoogle Scholar
  548. 548.
    Larcan A, Stoltz JF (1970) Microcirculation et hémorhéologie. Masson, Paris.Google Scholar
  549. 549.
    Larcan A, Stoltz JF (1979) Médicaments à action hémorhéologique directe ou indirecte. Méthodes d’étude et essais de classement. Thérapie 34: 5.PubMedGoogle Scholar
  550. 550.
    Larcan A, Stoltz JF (1983) Classification et Physiopathologie du syndrome d’hyperviscosité. Journ Annu Diabetol Hotel Dieu: 179 (73 ref).Google Scholar
  551. 551.
    Larcan A, Stoltz JF (1983) Syndromes d’hyperviscosité sanguine — classification et comprehension physiopathologique — déductions thérapeutiques. Ann Med Interne 134: 395.Google Scholar
  552. 552.
    Larsson H, Valdemarsson S, Hedner P, Odeberg H (1985) Reversal of increased whole blood and plasma viscosity after treatment of hypothyreoidism in man. Acta Med Scand 217: 67.PubMedCrossRefGoogle Scholar
  553. 553.
    Lawson NS, Nosanchuk JS, Oberman HA, Meyers MC (1968) Therapeutic plasmapheresis in treatment of patients with Waldenström’s macroglobulinemia. Transfusion 8: 174.PubMedCrossRefGoogle Scholar
  554. 554.
    Le Devehat C, Lemoine A, Cirette B, Ramet M, Vimeux M (1980) Kinetics of variations of erythrocyte filterability and 2-3 diphosphoglycerate in diabetic patients with arteriopathy of lower limbs treated with pentoxifylline. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 683.Google Scholar
  555. 555.
    Le Devehat C, Lemoine A, Cirette B, Ramet M, Vimeux M (1980) Filterability and metabolism of erythrocytes under bencyclane in diabetic patients with macroangiopathy. Folia Angiol 28(Suppl 7): 41.Google Scholar
  556. 556.
    Le Devehat C, Cirette B, Lemoine A, Roux E, Ramet M (1981) Activite rheologique du cervoxan. Etude de la filtrabilité et de l’état métabolique du globule rouge chez le diabetique. Angeiologie 33: 189.Google Scholar
  557. 557.
    Le Devehat C, Lemoine A, Cirette B, Ramet M (1981) Pharmacological influences of pentoxifylline on red cell filterability and 2-3 diphosphoglycerate. Scand J Clin Lab Invest 41(Suppl 156): 301.CrossRefGoogle Scholar
  558. 558.
    Le Devehat C, Lemoine A, Ramet M, Cirette B, Roux E, Vimeux M (1981) Study of filterability and metabolic state of red cells in diabetics on artificial pancreas. Effects on insulin activity. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 12.Google Scholar
  559. 559.
    Le Devehat C, Lemoine A, Cirette B (1983) Activite hemorheologique du buflomédil i.v. et per os dans l’angiopathie diabétique. Angéiologie 35: 243.Google Scholar
  560. 560.
    Le Devehat C, Lemoine A (1985) Haemorheological changes induced by Troxerutine in patients affected by venous insufficiency of lower legs (Abstract). Clin Hemorheol 5: 740.Google Scholar
  561. 561.
    Le Devehat C, Lemoine A, Bertrand A (1985) Effect of good control glucose by insulin with pump on haemorheological and microcirculation parameters in diabetic patients (Abstract). Clin Hemorheol 5: 673.Google Scholar
  562. 562.
    Leiper JM, Lowe GDO, Anderson J, Burns P, Cohen HN, Manderson WG, Forbes CD, Barbenel JC, MacCuish AC (1984) Effects of diabetic control and biosynthetic human insulin on blood rheology in established diabetics. Diab Res 1: 27.Google Scholar
  563. 563.
    Leonardo G, Arpaia MR, Onza C, Del Guercio R (1984) Regarding the action of buflomedil: Haemorheological and blood chemistry aspects. Curr Ther Res 36: 1016.Google Scholar
  564. 564.
    Leonhardt H, Grigoleit HG, Reinhardt I (1977) Changes and relationships of erythrocyte flexibility and whole blood viscosity of normo-osmolar and hyperosmolar erythrocyte suspensions influenced by 3,7-dimethyl-l-(5-oxo-hexyl)-xanthine. Vasa 6: 316.PubMedGoogle Scholar
  565. 565.
    Leonhardt H, Grigoleit HG, Reinhardt I (1978) Auswirkungen von Zigarettenrauch und oralen Kontrazeptiva auf die Plasma-und Vollblutviskosität. Med Welt 29: 880.PubMedGoogle Scholar
  566. 566.
    Leonhardt H (1978) Mikrorheologische Untersuchungen an Gesunden mit Risikofaktoren. Habilitationsschrift, Berlin.Google Scholar
  567. 567.
    Lerche D, Bäumler H, Pöhlmann G, Scherf HP, Bilsing R (1983) The treatment of peripheral vascular diseases by ultraviolet blood irradiation. A hemorheological study (Abstract). Clin Hemorheol 3: 283.Google Scholar
  568. 568.
    Lerche D, Bäumler H, Winter G, Tourowski A, Meier W (1985) A hemorheological characterization of Rocornal® in case of peripheral circulatory diseases (Abstract). Clin Hemorheol 5: 726.Google Scholar
  569. 569.
    Letcher RL, Chien S, Laragh JH (1979) Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension. J Cardiovasc Pharmacol 1(Suppl 1): 8.Google Scholar
  570. 570.
    Levine MA, Hammack WJ, Frommeyer WB (1968) Treatment of macroglobulinemia with penicillamine. Clin Res 8: 54.Google Scholar
  571. 571.
    Lewis DH, Sandegård J, Kutti J, Gelin J (1972) Normovolemic hemodilution in polycythemia. Observations on capillary flow and capillary transport in skeletal muscle. In: Messmer K, Schmid Schönbein H (eds) Hemodilution. Theoretical basis and clinical application. Karger, Basel, p 133.Google Scholar
  572. 572.
    Lewy B (1898) Die Reibung des Blutes. Arch Ges Physiol 65: 447.Google Scholar
  573. 573.
    Lichtman MA, Rowe JM (1982) Hyperleukocytic leukemias: Rheological, clinical and therapeutic considerations. Blood 60: 279.PubMedGoogle Scholar
  574. 574.
    Liewendahl K, Johnsson R, Majuri H (1981) Effect of anticonvulsant drugs on red cell flexibility, adenosine triphosphatase activities and cation transport. Scand J Clin Lab Invest 41(Suppl 156): 279.CrossRefGoogle Scholar
  575. 575.
    Lim C jr, Kostrzewska E, Bergentz SE, Gelin LE (1969) Rheology of human blood following treatment with Dextran-40 and Dextran-70. Bibl Anat 10: 9.PubMedGoogle Scholar
  576. 576.
    Linderkamp O, Meiselman HJ, Wu PYK, Miller FC (1981) Blood and plasma viscosity and optimal hematocrit in the normal newborn infant. Clin Hemorheol 1: 575.Google Scholar
  577. 577.
    Linderkamp O, Hersch S, Ozanne P, Meiselman HJ (1986) Vergleich von Methoden zur Bestimmung der Erythrozytenaggregation. In: Tillmann W, Ehrly AM (eds) Hämorheologie und Hämatologie. Münchner Wissenschaftliche Publikationen, München, p 140.Google Scholar
  578. 578.
    Lindmann K (1908) Klinische und experimentelle Beiträge zur pharmakologischen Beeinflussung der Blutviskosität. Dissertationsschrift, Marburg.Google Scholar
  579. 579.
    Lindsley H, Teller D, Noonan B, Petersen M, Mannik M (1973) Hyperviscosity syndrome in multiple myeloma. Am J Med 54: 682.PubMedCrossRefGoogle Scholar
  580. 580.
    Litmanovich KY, Melnikova VN, Fregatova LM, Kargin VD, Egorova LV, Kotovshchikova MA (1985) Methods of correction of hemorheological disturbances in patients with thrombobliterating diseases of the peripheral arteries of the extremities. Vest Khir 135(7): 96.PubMedGoogle Scholar
  581. 581.
    Litwin MS, Dawidson I, Barrett J, Miller E (1981) Physiologic effect in postoperative patients of intravascular cellular aggregate dissolution caused by Dextran-40 infusion. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 66.Google Scholar
  582. 582.
    Lommel F (1904) über die Viskosität des menschlichen Blutes bei Schwitzprozeduren. Dtsch Arch Klin Med 80: 308.Google Scholar
  583. 583.
    Louis J, Voisin P, Kolopp M, Vaillant G, Gaillard S, Debry G, Stoltz JF, Drouin P (1983) Lack of acute effects of insulin in vivo on hemorheological parameters in hyperglycemic diabetic patients (Abstract). Clin Hemorheol 3: 294.Google Scholar
  584. 584.
    Lowe GDO, Campbell AF, Meek DR, Forbes CD, Prentice CRM (1978) Subcutaneous ancrod in prevention of deep-vein thrombosis after operation for fractured neck of femur. Lancet 2: 698.PubMedCrossRefGoogle Scholar
  585. 585.
    Lowe GD, Morrice JJ, Fulton A, Forbes CD, Prentice CR, Barbenel JC (1978) Subcutaneous ancrod after operation for fractured hip — A dose-ranging and feasibility study. Thromb Haemost 40: 134.PubMedGoogle Scholar
  586. 586.
    Lowe GD, Morris JJ, Forbes CD, Prentice CR, Fulton AJ, Barbenel JC (1979) Subcutaneous ancrod therapy in peripheral arterial disease: Improvement in blood viscosity and nutritional blood flow. Angiology 30: 594.PubMedCrossRefGoogle Scholar
  587. 587.
    Lowe GDO, Drummond MM, Forbes CD, Barbenel JC (1980) Increased blood viscosity in young women using oral contraceptives. Am J Obstet Gynecol 137: 840.PubMedGoogle Scholar
  588. 588.
    Lowe GDO, Barbenel JC, Forbes CD (eds) (1981) Clinical aspects of blood viscosity and cell de-formability. Springer, Berlin.Google Scholar
  589. 589.
    Lowe GDO, Barbenel JC, Forbes CD (eds) (1981) Clinical aspects of blood viscosity and cell de-formability. Section E: Therapeutic aspects of blood rheology. Springer, Berlin, p 211.Google Scholar
  590. 590.
    Lowe GDO, Drummond MM, Forbes CD, Barbenel JC (1981) Occlusive arterial disease and blood rheology. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p 133.Google Scholar
  591. 591.
    Lowe GDO, Dunlop DJ, Lawson DH, Pollock JG, Watt JK, Forbes CD, Prentice CRM, Drummond MM (1982) Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg. Angio-logy 33: 46.Google Scholar
  592. 592.
    Lowe GDO, Leiper JM, Forbes CD, Manderson WG, MacCuish AC (1982) Effects of diabetic control and biosynthetic human insulin on blood rheology in established diabetes (Abstract). Diabetologia 23: 471.Google Scholar
  593. 593.
    Lowe GDO (1984) Evaluation of rheological therapy by orally administered drugs. Clin Hemorheol 4: 159.Google Scholar
  594. 594.
    Lowe GDO (1984) Blood rheology and venous thrombosis. Clin Hemorheol 4: 571.Google Scholar
  595. 595.
    Lowe GDO, Trope GE, Small M, Alvarez E, Foulds WS, Forbes CD (1985) Treatment of retinal vein occlusion by viscosity reduction with stanozolol (Abstract). Clin Hemorheol 5: 691.Google Scholar
  596. 596.
    Lucas GS, Simms MH, Caldwell NM, Alexander SJC, Stuart J (1984) Haemorrheological effects of prostaglandin E1infusion in Raynaud’s syndrome. J Clin Pathol 37: 870.PubMedCrossRefGoogle Scholar
  597. 597.
    Lukjan H, Chyzy R, Krupinski K, Bielawiec M (1985) Red cell deformability in patients with arteriosclerosis obliterans and influence of some drugs. Abstract-Booklet 4th Europ Conf Clin Haemorheol, Siena, p 70.Google Scholar
  598. 598.
    Lusov VA, Belousov JB, Sidelmann AA, Savenkov MP, Cholodova OE, Dudaev VA (1978) The treatment of peripheral atherosclerosis with pentoxifylline. Pharmatherapeutica 2(Suppl 1): 123.Google Scholar
  599. 599.
    Luther B (1983) Klinisch-experimentelle Untersuchungen zur Blutviskosität. Z Exp Chir Transplant Künstliche Organe 16: 256.PubMedGoogle Scholar
  600. 600.
    Lutz TW, Barras JP (1983) Rheological behaviour of human blood and plasma at steady flow and oscillatory flow. Vasa 12: 121.PubMedGoogle Scholar
  601. 601.
    Lyons BH (1952) Cerebral thrombosis following mercurial diuresis. Can Med Assoc J 66: 545.PubMedGoogle Scholar
  602. 602.
    MacKenzie MR, Brown E (1968) Hypervolemia in hyperviscosity syndrome of macroglobulinemia (Abstract). Clin Res 16: 122.Google Scholar
  603. 603.
    MacKenzie MR, Brown E, Fudenberg HH (1968) Hypervolemia in the hyperviscosity syndrome of macroglobulinemia (Abstract). J Clin Invest 47: 64a.Google Scholar
  604. 604.
    MacKenzie MR, Fudenberg HH (1972) Macroglobulinemia: An analysis for forty patients. Blood 39: 874.PubMedGoogle Scholar
  605. 605.
    Mackintosh T (1969) Blood viscosity in newborn infant and diagnosis and treatment of hyperviscous states. Arch Dis Child 44: 781.PubMedCrossRefGoogle Scholar
  606. 606.
    Magora F, Hershko C, Aronson HB (1970) The effect of electrical sleep on the viscosity of blood. Br J Anaesth 42: 1085.PubMedCrossRefGoogle Scholar
  607. 607.
    Manescalchi PG, Morini R, Pasquini G, Albanese B (1983) Sulla non correlazione fra parametri della filtrazione eritrocitaria ed altri parametri emoreologici. Ric Clin Lab 13(Suppl 3): 337.PubMedGoogle Scholar
  608. 608.
    Mann G (1980) Untersuchungen über den Einfluß verschiedener Saluretika auf die Fließeigenschaften des Blutes bei Patienten mit essentieller Hypertonie. Dissertationsschrift, Frankfurt am Main.Google Scholar
  609. 609.
    Manrique RV (1979) Avaliaçao clinico-laboratorial da modificaçao da flexibilidade eritrocitária in-duzida pela pentoxifilina. Rev Bras Clin Terap 8: 572.Google Scholar
  610. 610.
    Manrique RV, Müller R (eds) (1981) Disorders of blood flow. New therapeutic aspects. Excerpta Medica, Amsterdam.Google Scholar
  611. 611.
    Manrique R (1983) Blood coagulation, rheology and coronary reocclusion after local thrombolysis in acute myocardial infarction. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.Google Scholar
  612. 612.
    Marazzini L, Soroldoni M, Clivati A, Simonati O, Ogliari L, Brasca F, Agosti R, Longhini E (1981) Effects of isovolumetric venesection on blood viscosity, on red cell deformability and on arterial flow velocity in chronic respiratory failure with secondary polycythemia. Respiration 42: 168.PubMedCrossRefGoogle Scholar
  613. 613.
    Markson A (1936) Blood viscosity in congestive heart failure. Glasgow Med J 7: 201.Google Scholar
  614. 614.
    Marshall M, Reiser R (1983) Changes of blood viscosity by indirect anticoagulation (Abstract). Clin Hemorheol 3: 244.Google Scholar
  615. 615.
    Marshall M, Reiser R (1983) Beeinflussung der Blutviskosität durch indirekte Antikoagulation. In: Nobbe F, Rudofsky G (eds) Probleme der Vor-und Nachsorge und der Narkoseführung bei invasiver angiologischer Diagnostik und Therapie. Begutachtung arterieller und venöser Gefäßschäden. Pflaum, München, p 493.Google Scholar
  616. 616.
    Marshall M (1984) Beeinflussung der Hämorheologie durch oral zu verabreichende Pharmaka. In: Heilmann L, Kiesewetter H, Ernst E (eds) Klinische Rheologie und Beta-1-Blockade. Zuckschwerdt, München, p 110.Google Scholar
  617. 617.
    Martin P (1979) Déformabilité des globules rouges et accidents vasculaires cérébraux. Intérêt de la pentoxifylline. Gaz Méd France 86: 2585.Google Scholar
  618. 618.
    Martin P, Vives P (1980) Red blood cell filtration in stroke. Effect of pentoxifylline. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 693.Google Scholar
  619. 619.
    Martin P, Vives P (1980) The effect of pentoxifylline on red cell deformability in cerebrovascular accidents. Curr Med Res Opin 6: 518.PubMedCrossRefGoogle Scholar
  620. 620.
    Mashiah A, Patel P, Schraibman IG, Charlesworth D (1978) Drug therapy in intermittent claudication: an objective assessment of the effects of three drugs on patients with intermittent claudication. Br J Surg 65: 342.PubMedCrossRefGoogle Scholar
  621. 621.
    Materazzi M, Guerrini M, Rossi C, Cappelli R, Pecchi S, Acciavatti A, Pieragalli D, Forconi S, Di Perri T (1981) Action of buflomedil on peripheral obliterative arterial disease. A rheological and metabolic study (Abstract). Clin Hemorheol 1: 488.Google Scholar
  622. 622.
    Mathieu D, Coget J, Vinckier L, Devulder B, Wattel F (1985) Red blood cell deformability and hyperbaric oxygen therapy (Abstract). Clin Hemorheol 5: 625.Google Scholar
  623. 623.
    Mátrai A, Fendler K, Horváth L (1981) Haemorheological changes after anticoagulant therapy with a heparinoid (SP 54). Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 84.Google Scholar
  624. 624.
    Matrai A, Ernst E, Eck M (1984) Hämorheologie und CO2-Bäder (Abstract). Z Phys Med Baln Med Klim 13(Sonderheft 2): 42.Google Scholar
  625. 625.
    Matrai A, Ernst E, Flute PT, Dormandy JA (1984) Blood filterability in peripheral vascular disease-red cell deformability or cell sticking? Clin Hemorheol 4: 311.Google Scholar
  626. 626.
    Matrai A, Ernst E, Dormandy JA (1985) Erythrozytenfiltrabilität: Unterscheidung zwischen Filterokklusion und Erythrozyten-Passagezeit. In: Kiesewetter H, Ehrly AM, Jung F (eds) Hämorheologische Meßmethoden. Münchner Wissenschaftliche Publikationen, München, p 117.Google Scholar
  627. 627.
    Matrai A, Ernst E (1985) Pentoxifylline improves white cell rheology in claudicants. Clin Hemorheol 5: 483.Google Scholar
  628. 628.
    Mattassi R, Cardillo B, D’Angelo F (1985) Haemorheological and clinical effects of ozone in arterial occlusive disease (Abstract). Clin Hemorheol 5: 644.Google Scholar
  629. 629.
    Mayer GA (1976) Blood viscosity and oral anticoagulant therapy. Am J Clin Pathol 65: 402.PubMedGoogle Scholar
  630. 630.
    Mayesima T (1912) Klinische und experimentelle Untersuchungen über die Viskosität des Blutes. Mittig Grenzgeb Med Chir 24: 413.Google Scholar
  631. 631.
    McCaskey GW (1908) The viscosity of the blood; its value in clinical medicine. JAMA 51: 1653.Google Scholar
  632. 632.
    Mehta AB, Goldman JM, Kohner E (1984) Hyperleucocytic retinopathy in chronic granulocytic leukaemia: The role of intensive leucapheresis. Br J Haematol 56: 661.PubMedCrossRefGoogle Scholar
  633. 633.
    Merchan R, Doná G (1984) Microcirculation and haemorheology studies of polyunsaturated phosphatidylcholine (EPL; Lipostabil®) in the aged. Clin Trials J 21: 517.Google Scholar
  634. 634.
    Merchan R, Zurita IE, Martinez JF (1985) Suloctidil: Long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions. Drug Res 35: 855.Google Scholar
  635. 635.
    Mercke CE, Kjellen E (1981) Erythrocyte deformability in patients with malignant tumours — Potential role of prostaglandins. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p56.Google Scholar
  636. 636.
    Merrill EW, Cokelet GC, Britten A, Wells RE jr (1963) Non-Newtonian rheology of human blood-Effect of fibrinogen deduced by ”subtraction ”. Circ Res 13: 48.PubMedGoogle Scholar
  637. 637.
    Merrill EW, Gilliland ER, Lee TS, Salzman EW (1966) Blood rheology: Effect of fibrinogen deduced by addition. Circ Res 18: 437.PubMedGoogle Scholar
  638. 638.
    Messmer K, Schmid-Schönbein H (eds) (1972) Hemodilution — Theoretical basis and clinical application. Karger, Basel.Google Scholar
  639. 639.
    Messmer K, Sunder-Plassmann L (1974) Hemodilution. Prog Surg 13: 208.PubMedGoogle Scholar
  640. 640.
    Messmer K, Schmid-Schönbein H (eds) (1975) Intentional hemodilution. Bibl Haematol 41.Google Scholar
  641. 641.
    Messmer K (1975) Hemodilution. Surg Clin North Am 55: 659.PubMedGoogle Scholar
  642. 642.
    Messmer K, Hammersen F (eds) (1985) Entzündung und Rheologie der Leukozyten. Karger, Basel.Google Scholar
  643. 643.
    Metoki H, Kanazawa T, Shibutani K, Izawa M, Soma Y, Onodera K (1979) A study on blood viscosity in CVA — The relationships between blood viscosity and duration after stroke and the effects of pentoxyphyllin. Acta Neurol Scand 60(Suppl 72): 622.Google Scholar
  644. 644.
    Metoki H, Kudo R, Shimanaka Y, Matsui T, Kanazawa T, Mori H, Izawa K, Shibutani K, Muraoka H, Onodera K (1983) A study on blood viscosity in cerebrovascular disease. The changes of blood viscosity during the time after stroke and the effect of Pentoxifyllin on the viscosity. Hirosaki Med J 35: 1.Google Scholar
  645. 645.
    Mikita J, Khan O, Dormandy JA, Cotton LT (1985) Does prostacyclin influence haemorrheology in Raynaud’s phenomenon? (Abstract). Clin Hemorheol 5: 751.Google Scholar
  646. 646.
    Milan R, Duric D, Trajkovic B, Radojicic B, Pekic B, Tomasevic R, Duji A (1977) Syndrome of the myeloma serum hyperviscosity treated by plasmapheresis. Med Pregl 30: 471.Google Scholar
  647. 647.
    Miller B, Heilmann L (1985) Haemorheological parameters during chemotherapy for breast cancer (Abstract). Clin Hemorheol 5: 625.Google Scholar
  648. 648.
    Miller B, Heilmann L, Callies R (1985) Hemorheological studies in mammary carcinoma. Arch Gynecol 238: 559.CrossRefGoogle Scholar
  649. 649.
    Milligan DW, Davies JA (1982) The effect of iron therapy on whole blood viscosity and calf blood flow in polycythaemia (Abstract). Br J Haematol 52: 137.Google Scholar
  650. 650.
    Milligan DW, Tooke JE, Davies JA (1982) Effect of venesection on calf blood flow in polycythaemia. Br Med J 284: 619.CrossRefGoogle Scholar
  651. 651.
    Molaro G, De Angelis V, Vettore L (1985) Effetto del dipiridamolo sui parametri emoreologici nelle sindromi sclerocitemiche e policitemiche. Ric Clin Lab 15(Suppl 1): 597.Google Scholar
  652. 652.
    Montagnani M, Civitelli R, Nami R, Agnusdei D, Falsini G, Conti F, Bianchini C, Liberatori P, Gennari C (1985) Effects of a calcium blocking agent (nifedipine) on red blood cell deformability in essential hypertension (Abstract). Clin Hemorheol 5: 713.Google Scholar
  653. 653.
    Montefusco S, Ciampitiello G, Gnasso A, Postiglione A (1984) Migliorati parametri emoreologici in pazienti iperlipidemici trattati con mucopolisaccaridi. Ric Clin Lab 14(Suppl 2): 144.Google Scholar
  654. 654.
    Montefusco S, Ciampittiello G, Gnasso A, Cicerano U, Postiglione A (1985) Miglioramento dei parametri emoreologici dopo terapia con mucopolisaccaridi. Ric Clin Lab 15(Suppl 1): 543.Google Scholar
  655. 655.
    Moratti F, Cortiana M, Taglioretti D (1983) Applicazione della filtrazione eritrocitaria nello studio della vasculopatia diabetica. Efficacia terapeutica della pentossifillina. Clin Ter 106: 19.PubMedGoogle Scholar
  656. 656.
    Moscatelli B, Marmaggi S, Traietti P, Colloca A, Fabbri M, Bologna E (1984) Blood viscosity and circulating platelets activation in polycythemic COLD patients: Effect of erythroapheresis (Abstract). Respiration 46(Suppl 1): 159.Google Scholar
  657. 657.
    Moser M, Klieber M, Winkler R (1985) Vergleichende Studien über den Einfluß von Diät, Bewegungs-und Jodbalneotherapie auf blutrheologische Parameter bei Diabetikern im Rahmen eines 4wöchigen Kuraufenthalts in Bad Hall. Wien Klin Wochenschr 97: 327.PubMedGoogle Scholar
  658. 658.
    Motta G, Ratto GB (1980) Osservazioni cliniche sull’azione reologica ed emodinamica di taluni far-maci attivi sul microcircolo. Minerva Med 71: 1367.PubMedGoogle Scholar
  659. 659.
    Moulopoulos SD, Zereg N (1968) La viscosité kinétique du sang. Arch Mal Coeur 61: 1156.PubMedGoogle Scholar
  660. 660.
    Mozzi E, Annoni F, Chiurazzi D, Rossi R, Pacini F, Martini A (1984) Azione del benfurodil emisuccinato (Eucilat®) su alcuni parametri emoreologici in pazienti portatori di arteriopatie ostruttive croniche periferiche. Minerva Cardioangiol 32: 141.PubMedGoogle Scholar
  661. 661.
    Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R (1985) Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation. J Int Med Res 13: 317.PubMedGoogle Scholar
  662. 662.
    Müller K, Haaß A, Jäger H, Wagner EM, Hellstern P (1983) Dextran und HAES, vergleichbare und unterschiedliche hämorheologische Parameter. Psycho 9: 381.Google Scholar
  663. 663.
    Müller O, Inada R (1904) Jodwirkung bei Arteriosklerose. Dtsch Med Wochenschr 30: 1751.CrossRefGoogle Scholar
  664. 664.
    Müller-Bühl U, Comberg HU, Diehm C, Allenberg J, Mörl H (1982) Hämodilutions-Therapie der arteriellen Verschlußkrankheit mit Hydroxyäthylstärke 200/0,5. Münch Med Wochenschr 10: 241.Google Scholar
  665. 665.
    Muggeo M, Calabrò A, Businaro V, Patussi L, Volpe A, Signorini GP, Crepaldi G (1983) Blood clotting, fibrinolytic and haemorheological parameters in ischaemic vascular disease: the effects of pentoxifylline in the treatment of acute cerebral vascular disease. Pharmatherapeutica 3(Suppl 1): 74.Google Scholar
  666. 666.
    Murashko VV, Yusipova TA, Strutynskii AV, Dzhanashiya PK, Shenshina AM, Sklyarova MA (1984) Effect of sodium nitrite on blood rheology, microcirculation and blood coagulation in patients with circulatory failure. Ter Arkh 56(4): 108.PubMedGoogle Scholar
  667. 667.
    Nalefski LA, Gibert NC, Sheedy JA (1950) Viscosity studies on blood following the administration of anticoagulants. J Lab Clin Med 36: 970.PubMedGoogle Scholar
  668. 668.
    Nenci GG (1985) Long-term tolerability and activity on platelet aggregation and erythrocyte deformability of indobufen in cardiovascular patients. Abstract-Booklet 4th Europ Conf Clin Haemorheol, Siena, p 184.Google Scholar
  669. 669.
    Neumann V, Cove DH, Shapiro LM, George AJ, Kenny MW, Meakin M, Stuart J (1983) Effect of ticlopidine on platelet function and blood rheology in diabetes mellitus. Clin Hemorheol 3: 13.Google Scholar
  670. 670.
    Nusbacher J (1982) Therapeutic hemapheresis. Clin Lab Med 2: 87.PubMedGoogle Scholar
  671. 671.
    O’Reilly MJG, Dodds AJ, Tolpos G, Hamilton A, Cotton LT (1979) Plasmapheresis in Raynaud’s phenomenon. In: Heidrich H (ed) Raynaud’s phenomenon. TM, Bad Oeynhausen, p 291.Google Scholar
  672. 672.
    Orr JE, Davidson RJL, Russell IF, Robertson GS (1982) A haemorheological study of althesin. Br J Anaesth 54: 1003.PubMedCrossRefGoogle Scholar
  673. 673.
    Osawa M, Maruyama S (1985) über den Einfluß von ”TCV-3B ” (Vinpocetin) auf die Blutviskosität in ischämischen zerebrovaskulären Erkrankungen. Ther Hung 33: 7.PubMedGoogle Scholar
  674. 674.
    Oski FA, Lubin B, Buchert EB (1972) Reduced red cell filterability with oral contraceptive agents. Ann Intern Med 77: 417.PubMedGoogle Scholar
  675. 675.
    Ostwald W (1924) Zur Viskosimetrie kolloidaler Lösungen. Z Physikal Chem 111: 62.Google Scholar
  676. 676.
    Ott M (1973) Untersuchungen über den Einfluß von Vasodilatantien auf die Blutviskosität. Dissertationsschrift, Berlin.Google Scholar
  677. 677.
    Ott E, Lechner H (1981) Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline. Ric Clin Lab 11(Suppl 1): 253.PubMedGoogle Scholar
  678. 678.
    Ott E, Lechner H (1983) Changes of flow properties of the blood in cerebrovascular disease and their medical treatment with pentoxifylline. J Cereb Blood Flow Metab 3(Suppl 1): 530.Google Scholar
  679. 679.
    Ott E, Lechner H (1985) The effect of budipine on the rheology of the blood. In: Gerstenbrand F, Poewe W, Stern G (eds) Clinical experiences with budipine in Parkinson therapy. Springer, Berlin, p 182.Google Scholar
  680. 680.
    Oughton J, Lawson P, Kohner EM, Barnes AJ (1983) The effect of improved metabolic control on diabetic complications and on blood rheology (Abstract). Clin Hemorheol 3: 270.Google Scholar
  681. 681.
    Paisey RB, Harkness J, Hartog M, Chadwick T (1980) The effect of improvement in diabetic control on plasma and whole blood viscosity. Diabetologia 19: 345.PubMedCrossRefGoogle Scholar
  682. 682.
    Palareti G, De Fabritiis A, Poggi M, Tricarico MG, Borgatti E, Coccheri S (1981) Haemorheological parameters in essential hypertension (EH) and early changes during antihypertensive treatments (Abstract). Clin Hemorheol 1: 495.Google Scholar
  683. 683.
    Palareti G, Poggi M, Grauso F, Tricarico MG, Rodorigo G, Coccheri S (1982) Haemorheologic changes in women during oral contraception (Abstract). Haemostasis 12: 145.Google Scholar
  684. 684.
    Palareti G, Poggi M, Limoni P, Andreoli A, Tricarico MG, Coccheri S (1983) Changes in the rheologic properties of blood in acute cerebrovascular disease: Effects of treatment with 1-eburnamonine. Int Angiol 2: 179.Google Scholar
  685. 685.
    Parnetti L, Ciuffetti G, Mercuri M, Senin U (1985) Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline. Arch Gerontol Geriatr 4: 141.PubMedCrossRefGoogle Scholar
  686. 686.
    Passero S, Bonelli G, Guerrini M, Acciavatti A, Nardini M, Battistini N (1985) Effetti del trattamento cronico con farmaci antiaggreganti sulla viscosità ematica in pazienti con malattie cerebrovascola-ri. Ric Clin Lab 15(Suppl 1): 593.Google Scholar
  687. 687.
    Pau P, Mereu S, Montisci R, Falchi S, Petruzzo P (1983) No changes in red cells deformability in Raynaud phenomenon induced by beta adrenoceptors stimulation (Abstract). Biorheology 20: 406.Google Scholar
  688. 688.
    Pavlovskii DP (1965) Effect of anticoagulants on blood viscosity, circulation time and the capillaroscopic picture. Ter Arkh 37: 367.Google Scholar
  689. 689.
    Pecker J, Vallée B, Haranger JM, Gueguen M (1978) Torental et accidents ischémiques du Système nerveux central. L’Ouest Méd 31: 1571.Google Scholar
  690. 690.
    Pennarola R, De Martino F, Barletta R, Mazzarella S, Sacco M (1983) Hemorheologic aspects among 25 cases of microangiopathy by vibrating tools treated with pentoxifylline (Abstract). Clin Hemorheol 3: 289.Google Scholar
  691. 691.
    Perego MA, Sergio G, Artale F (1981) Aspetti emoreologici in rapporto all fisiopatologia e alla clinica dell’arteriopatia ostruttiva periferica. Ric Clin Lab 11(Suppl 1): 281.PubMedGoogle Scholar
  692. 692.
    Perego MA, Sergio G, Artale F, Cramarossa L, Espureo M (1982) Traitement hémorhéologique des artériopathies obstructives périphériques. Angéiologie 34: 33.Google Scholar
  693. 693.
    Perego MA, Sergio G, Espureo M, Francisci A, Artale F (1982) Haemodynamic and haemorheological effects of buflomedil in patients with peripheral occlusive arterial disease. Curr Med Res Opin 8: 178.PubMedCrossRefGoogle Scholar
  694. 694.
    Perego MA, Sergio G, Artale F (1983) Haemorheological aspects of the pathophysiology and clinical features of peripheral occlusive arterial disease. Pharmatherapeutica 3(Suppl 1): 91.Google Scholar
  695. 695.
    Perego MA, Sergio G, Artale F, Giunti P, Danese C (1985) Effects of physical training on regional blood filtrability and platelet β-thromboglobulin in patients with peripheral arteriopathy (Abstract). Clin Hemorheol 5: 652.Google Scholar
  696. 696.
    Perego MA, Sergio G, Artale F, Giunti P, Danese C (1986) Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease. Curr Med Res Opin 10: 135.PubMedCrossRefGoogle Scholar
  697. 697.
    Perhoniemi V, Salmenkivi K, Sundberg S, Johnsson R, Gordin A (1984) Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication. Angiology 35: 366.PubMedCrossRefGoogle Scholar
  698. 698.
    Pernigotti L, Neirotti M, Gagliardo S, Musso M, Sclavo R, Bulla A (1985) Effetti immediati della somministrazione di eparina e di eparani (mesoglicano) su alcuni parametri emoreologici e dell’emostasi. Ric Clin Lab 15(Suppl 1): 537.Google Scholar
  699. 699.
    Petralito A, Miano MF, Messina S, Grimaldi LT, Malatino LS (1985) Effects of pentoxifylline on erythrocyte aggregation (Abstract). Clin Hemorheol 5: 733.Google Scholar
  700. 700.
    Pfeiffer M, Tilsner V (1978) Einfluß von Etofibrat auf die Plasmaviskosität bei Hyperlipoprotein-ämien. Med Klin 73: 60.PubMedGoogle Scholar
  701. 701.
    Pieragalli D, Guerrini M, Materazzi M, Ralli L, Forconi S, Di Perri T (1983) Protective effect of buflomedil against the exercise-induced haemorheological impairment of vascular patients (Abstract). Clin Hemorheol 3: 292.Google Scholar
  702. 702.
    Poiseuille JML (1842) Recherches expérimentales sur le mouvement des liquides dans les tubes de très petits diamètres. Compt rend 15: 1167.Google Scholar
  703. 703.
    Pola P, Flore R, Tondi P, Serricchio M, Dal Lago A, Fioroni G (1984) Terapia dell’iperviscosità e della ridotta deformabilità eritrocitaria nell’arteriopatico cronico: necessità dell’impiego di più farmaci. Giorn Ital Angiol 4: 31.Google Scholar
  704. 704.
    Pollock S, Challoner T, Thomas D, Harrison MJG (1981) The effect of venesection of red cell deformability (Abstract). Clin Hemorheol 1: 496.Google Scholar
  705. 705.
    Ponari O, Catamo A, Molina E, Mombelloni A, Tonelli C, Tardio S, Squeri M (1985) Effects of glycerol on some blood rheology parameters in patients with acute cerebral ischemia. Preliminary report (Abstract). Clin Hemorheol 5: 705.Google Scholar
  706. 706.
    Poon PYW, Dornan TL, Orde-Peckar C, Mullins R, Bron AJ, Turner RC (1982) Blood viscosity, glycaemiccontrol and retinopathy in insulin-dependent diabetes. Clin Sci 63: 211.PubMedGoogle Scholar
  707. 707.
    Porro F, Pastori P, Lanzoni M, Curti L, Fanelli M (1985) Hemorheology in acute ischemic stroke: Influence of isovolemic hemodilution (Abstract). Clin Hemorheol 5: 669.Google Scholar
  708. 708.
    Porro F, Pastori M, Traverso G, Lanzoni M, Pastori P (1985) Isovolemic hemodilution in advanced chronic obstructive lung disease. A preliminary hemorheologic study (Abstract). Clin Hemorheol 5: 727.Google Scholar
  709. 709.
    Powles R, Smith C, Kohn J, Hamilton Fairley G (1971) Method of removing abnormal protein rapidly from patients with malignant paraproteinaemias. Br Med J 3: 664.PubMedCrossRefGoogle Scholar
  710. 710.
    Pre’Denning du A, Watson JH (1906) The viscosity of blood. Proc R Soc B 78: 328.CrossRefGoogle Scholar
  711. 711.
    Preston FE, Cooke KB, Foster ME, Winfield DA, Lee D (1978) Myelomatosis and the hyperviscosity syndrome. Br J Haematol 38: 517.PubMedCrossRefGoogle Scholar
  712. 712.
    Preston FE, Sokol RJ, Lilleyman JS, Winfield DA, Blackburn EK (1978) Cellular hyperviscosity as a cause of neurological symptoms in leukaemia. Br Med J 1: 476.PubMedCrossRefGoogle Scholar
  713. 713.
    Pretolani E, Battistini G, Iosa G, Tonti D, Zoli I (1983) II ciclonicato nella terapia medica delle arteriopatieperiferiche. Giorn Ital Angiol 3: 268.Google Scholar
  714. 714.
    Pronk EAS, Klein F, Eikerbout F, Radema H, Cleton FJ (1969) Therapy of macroglobulinemia. Acta Med Scand 186: 273.PubMedCrossRefGoogle Scholar
  715. 715.
    Pruzanski W, Watt JG (1972) Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Ann Intern Med 77: 853.PubMedGoogle Scholar
  716. 716.
    Putnam TC, Kevy SV, Replogle RL (1967) Factors influencing the viscosity of blood. Surg Gynecol Obstet 124: 547.PubMedGoogle Scholar
  717. 717.
    Rakita L, Gillespie DG, Sancetta SM (1965) The acute and chronic effects of phlebotomy on general hemodynamics and pulmonary functions of patients with secondary polycythemia associated with pulmonary emphysema. Am Heart J 70: 466.PubMedCrossRefGoogle Scholar
  718. 718.
    Randi ML, Fabris F, Crociani ME, Battocchio F, Girolami A (1985) Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease. Drug Res 35: 1847.Google Scholar
  719. 719.
    Reich L, Feizi T, Winchester R, Wechsler B, Walzer P, Wright P (1973) Effects of large scale plasmapheresis performed on patients with macroglobulinemia. Proc Am Assoc Cancer Res 14: 68.Google Scholar
  720. 720.
    Reid HA, Chan KE, Thean PC (1963) Prolonged coagulation defect (defibrination syndrome) in malayan viper bite. Lancet 1: 621.PubMedCrossRefGoogle Scholar
  721. 721.
    Reid HL, Barnes AJ, Lock PJ, Dormandy JA, Dormandy TL (1976) A simple method for measuring erythrocyte deformability. J Clin Pathol 29: 855.PubMedCrossRefGoogle Scholar
  722. 722.
    Reid HL, Dormandy JA, Barnes AJ, Lock PJ, Dormandy TL (1976) Impaired red cell deformability in peripheral vascular disease. Lancet 1: 666.PubMedCrossRefGoogle Scholar
  723. 723.
    Replogle RL, Meiselman HJ, Merrill EW (1967) Clinical implications of blood rheology studies. Circulation 36: 148.PubMedGoogle Scholar
  724. 724.
    Reynolds O (1883) An experimental investigation of the circumstances which determine whether the motion of water shall be direct or sinuous and the law of resistance in parallel channels. Philos Trans R Soc 174: 935.CrossRefGoogle Scholar
  725. 725.
    La Ricerca in Clinica e in Laboratorio 15 (1985) (Suppl 1).Google Scholar
  726. 726.
    Rieger H (1976) Zur Physiologie und Pathophysiologic der Blutplättchen unter Theologischen Aspekten. Habilitationsschrift, Aachen.Google Scholar
  727. 727.
    Rieger H, Leyhe A, Schmid-Schönbein H, Schoop W, Schneider R, Malotta H (1977) Isovolämische Hämodilution bei peripherer arterieller Verschlußkrankheit. Konzepte, Methoden und vorläufige Ergebnisse. In: Alexander K, Cachovan M (eds) Diabetische Angiopathien. Witzstrock, Baden-Baden, p354.Google Scholar
  728. 728.
    Rieger H, Schoop W, Schmid-Schönbein H, Schneider R, Malotta H (1977) Isovolemic hemodilution (IHD) in peripheral vascular occlusive disease (PVOD). Concepts, methods and preliminary results. Microvasc Res 13: 267.CrossRefGoogle Scholar
  729. 729.
    Rieger H, Köhler M, Schoop W, Schmid-Schönbein H, Roth FJ, Leyhe A (1979) Hemodilution (HD) in patients with ischemic skin ulcers. Klin Wochenschr 57: 1153.PubMedCrossRefGoogle Scholar
  730. 730.
    Rieger H (1982) Neues in der konservativen Therapie arterieller Durchblutungsstörungen. Med Welt 33: 576.PubMedGoogle Scholar
  731. 731.
    Ritzmann SE, Coleman SL, Levin WC (1960) The effect of some mercaptanes upon a macrocryogelglobulin; modifications induced by cysteamine, penicillamine and penicillin. J Clin Invest 39: 1320.PubMedCrossRefGoogle Scholar
  732. 732.
    Ritzmann SE, Thurm RH, Truax WE, Levin WC (1960) The syndrome of macroglobulinemia: Review of the literature and a report of two cases of macrocryogelglobulinemia. Arch Intern Med 105: 939.PubMedGoogle Scholar
  733. 733.
    Ritzmann SE, Daniels JC, Levin WC (1970) Paralymphomatous disease — Syndrome of macroglobulinemia. In: Leukemia-Lymphoma. Year Book Medical, Chicago, p 169.Google Scholar
  734. 734.
    Roba J, Roncucci R, Lambelin G (1977) Pharmacological properties of suloctidil. Acta Clin Belg 32: 3.PubMedGoogle Scholar
  735. 735.
    Rogen SA (1940) Viscosity in cardiac failure. Modification by administration of calcium gluconate. Lancet 1: 780.CrossRefGoogle Scholar
  736. 736.
    Romberg E (1904) über Arteriosklerose. Verh Kongr Inn Med 21: 60.Google Scholar
  737. 737.
    Roncucci R, De Hertogh R, Dormandy JA, Doumont J, Gurevich V, Lambelin G, Lansen J, Rottiers R, Souridis E, Van Stalle F, Versee L (1979) Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients. Drug Res 29: 682.Google Scholar
  738. 738.
    Rose MS, Ernst E, Lee R, Hill P, Rainsbury R, Kirkham JS (1981) Effects of hydroxychloroquine on transoperative haemorheological events (Abstract). Clin Hemorheol 1: 501.Google Scholar
  739. 739.
    Rosenblatt G, Stokes J, Bassett DR (1965) Whole blood viscosity, hematocrit and serum lipid levels in normal subjects and patients with coronary heart disease. J Lab Clin Med 65: 202.PubMedGoogle Scholar
  740. 740.
    Rosenkrantz TS, Oh W (1982) Cerebral blood flow velocity in infants with polycythemia and hyperviscosity: Effects of partial plasma exchange transfusion with Plasmanate. J Pediatr 101: 94.PubMedCrossRefGoogle Scholar
  741. 741.
    Rosenthal A, Nathan DG, Marty AT, Button LN, Miettinen OS, Nadas AS (1970) Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation 42: 297.PubMedGoogle Scholar
  742. 742.
    Rossi C, Pastorelli M, Romeo R, Acciavatti A, Pieragalli D, Galigani C, Pecchi S, Cappelli R, Guer-rini M, Forconi S, Di Perri T (1985) Aspects of microcirculatory activity of buflomedil (Abstract). Clin Hemorheol 5: 736.Google Scholar
  743. 743.
    Rousselle D, Gaillard S, Voisin P, Pointel JP, Debry G, Drouin P, Stoltz JF (1980) Blood viscosity and erythrocyte filterability in diabetic patients controlled via an artificial pancreas. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 411.Google Scholar
  744. 744.
    Rudofsky G, Brock FE, Ulrich M, Nobbe F (1979) Clinical evaluation of flunarizine: Walking distance, ergometric performance and hemodynamic and biochemical effects. Angiology 30: 470.PubMedCrossRefGoogle Scholar
  745. 745.
    Ruggiero HA, Castellanos H, Caprissi LF, Caprissi ES (1982) Heparin effect on blood viscosity. Clin Cardiol 5: 215.PubMedGoogle Scholar
  746. 746.
    Ryabov GA, Semenov VN, Kosyrev AB, Bunin VM, Pospelov VV, Knyazev IV, Shafransky YA, Sundukov AN (1983) The influence of haemosorption on rheology of the blood. Anesteziol Reanimatol 3: 17.Google Scholar
  747. 747.
    Saitta A, Castaldo M, Bonaiuto M, Di Cesare E, Barbera N, Trifiletti A, Pizzoleo MA (1983) Aspetti emoreologici ed emocoagulativi in corso di trattamento con buflomedil cloridrato. Rass Med Int 4: 549.Google Scholar
  748. 748.
    Sarno A, Ferrara F, Catania A, Frazzetta F, Capobianco D, Caimi G (1982) Comportamento del pattern emoreologico in soggetti con ipertensione essenziale trattati con beta-bloccanti. Clin Ter 103: 267.PubMedGoogle Scholar
  749. 749.
    Sarno A, Caimi G (1985) L’approccio farmacologico in emoreologia. Ric Clin Lab 15(Suppl 1): 479.PubMedGoogle Scholar
  750. 750.
    Sarno A, Galluzzo A, Romano A, Giordano C, Sinagra D, Botta RM, Capobianco D, Caimi G (1985) Diabetici di I tipo trattati con insulina umana: Valutazione emoreologica durante monitorag-gio con biostator. Ric Clin Lab 15(Suppl 1): 607.Google Scholar
  751. 751.
    Satewachin II, Iljin VN, Schestakov VA, Alexandrova NP, Rodionov SV, Danilova LM, Iljin SG (1978) The use of pentoxifylline in a combined regimen for the prevention of re-thrombosis in major blood vessels. Pharmatherapeutica 2(Suppl 1): 109.Google Scholar
  752. 752.
    Savi L, Dal Lago A, Serricchio M, Pola P (1979) Action du naftidrofuryl sur les viscosites sanguine et plasmatique et sur la fibrinogéenémie. La Vie Méd 4: 285.Google Scholar
  753. 753.
    Schäbitz J, Brema C, Teichmann W (1982) Zur Einflußnahme von Röntgenkontrastmitteln auf die Blutviskosität. Dtsch Gesundheitswesen 37: 2006.Google Scholar
  754. 754.
    Schäbitz J (1983) Influence of roentgenologic contrast media on blood rheology (Abstract). Clin Hemorheol 3: 306.Google Scholar
  755. 755.
    Schlichting K, Heidrich H (1976) Effect of isoxsuprine on blood viscosity. Vasa 5: 51.PubMedGoogle Scholar
  756. 756.
    Schmid-Schönbein GW, Engler RL (1987) No-reflow in the microcirculation. The granulocyte tragedy. In: Hartmann A, Kuschinsky W (eds) Cerebral ischemia and hemorheology. Springer, Berlin, p 464.Google Scholar
  757. 757.
    Schmid-Schönbein H (1970) Rheologische Eigenschaften von Erythrozyten. Habilitationsschrift, München.Google Scholar
  758. 758.
    Schmid-Schönbein H, Gallasch G, von Gosen J, Volger E, Klose HJ (1976) Red cell aggregation in blood flow. I. New methods of quantification. Klin Wochenschr 54: 149.PubMedCrossRefGoogle Scholar
  759. 759.
    Schmid-Schönbein H, Rieger H, Hess H (1977) Quantitative Erfassung der Effekte fibrinolytischer Therapie auf das Fließverhalten des Blutes. Klin Wochenschr 55: 111.PubMedCrossRefGoogle Scholar
  760. 760.
    Schmid-Schönbein H (1978) Die Erhaltung der Fließfähigkeit des Blutes durch O-(β-Hydroxy-ethyl)-rutoside. In: Voelter W, Jung G (eds) O-(β-Hydroxyethyl)-rutoside — Experimentelle und klinische Ergebnisse. Springer, Berlin, p 129.CrossRefGoogle Scholar
  761. 761.
    Schmid-Schönbein H (1981) Was ist eine Mikrozirkulationsstörung bei chronisch-degenerativer Gefäßerkrankung? Arzneimittelforschung 31: 1999.PubMedGoogle Scholar
  762. 762.
    Schmid-Schönbein H, Messmer K, Rieger H (eds) (1981) Hemodilution and flow improvement. Karger, Basel.Google Scholar
  763. 763.
    Schmid-Schönbein H, Rieger H (1981) Isovolaemic haemodilution. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p 211.Google Scholar
  764. 764.
    Schmid-Schönbein H, Malotta H, Driessen G, Kiesewetter H, Teitel P (1983) A test profile for routine laboratories in clinical haemorheology (Abstract). Clin Hemorheol 3: 555.Google Scholar
  765. 765.
    Schmid-Schönbein H (1985) Antithixotrope Therapie bei arteriellen Verschlußerkrankungen: Was leisten “rheologische Maßnahmen ” bei unvermindert bestehender Obliteration? Wien Med Wochenschr 135: 368.PubMedGoogle Scholar
  766. 766.
    Schmitt HJ (1977) Entwicklung und Darstellung einer Methode zur Messung der Erythrozytenaggre-gation. Dissertationsschrift, Frankfurt am Main.Google Scholar
  767. 767.
    Schmittner I (1974) Einfluß von 6a-Methylprednisolon und Xantinolnicotinat auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  768. 768.
    Schneider R, Kiesewetter H (1982) Parenterale Pentoxifyllin-Applikation bei ischämischem Insult. Dtsch Med Wochenschr 107: 1674.PubMedCrossRefGoogle Scholar
  769. 769.
    Schneider R, Schmid-Schönbein H, Kiesewetter H (1983) The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results. Eur Neurol 22(Suppl 1): 98.PubMedCrossRefGoogle Scholar
  770. 770.
    Schneider R, Körber N, Brockmann M, Kiesewetter H (1986) The haemorheological treatment of lacunar strokes: Studies with pentoxifylline (Trental 400). In: Trübestein G (ed) Konservative Therapie arterieller Durchblutungsstörungen. Thieme, Stuttgart, p 321.Google Scholar
  771. 771.
    Schooneman F, Pointel JP, Streiff F, Gaillard S, Drouin P, Stoltz JF (1980) Study of rheological properties of blood in various pathological situations following therapeutical plasma exchange (Preliminary study). In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 607.Google Scholar
  772. 772.
    Schooneman F, Gaillard S, Paulus F, Streiff F, Stoltz JF (1983) Macro-and microrheological variations observed during plasma exchange in cases of monoclonal disglobulinemia (Abstract). Clin Hemorheol 3: 335.Google Scholar
  773. 773.
    Schooneman F, Paulus F, Gaillard S, Streiff F, Stoltz JF (1985) Macro-and microrheological variations observed during plasma exchange in cases of monoclonal disglobulinemia. Clin Hemorheol 5: 51.Google Scholar
  774. 774.
    Schooneman F, Gaillard S, Paulus F, Stoltz JF, Streiff F (1985) Variations hémorhéologiques au cours de 50 dysglobulinémies monoclonales traitées par échanges plasmatiques. Rev Méd Interne 6: 487.PubMedCrossRefGoogle Scholar
  775. 775.
    Schubotz R, Mühlfellner O (1977) The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane. Curr Med Res Opin 4: 609.PubMedCrossRefGoogle Scholar
  776. 776.
    Schülke K, Hartel W (1966) Vergleichende Untersuchungen über das Verhalten der Plasmaviscosität und des Blutvolumens nach Gabe von hoch-und niedermolekularen Dextranen. Langenbecks Arch Klin Chir 316: 623.CrossRefGoogle Scholar
  777. 777.
    Schürmann W, Eberhardt R, Pfafferott C, Volger E (1986) Zusammenhang zwischen der antiangi-nösen Wirkung und der Erythrozytenfiltrabilität und-aggregation von Nifedipin (Abstract). Z Kardiol 75(Suppl 1): 80.Google Scholar
  778. 778.
    Schulz CEJ, Richter W, Naujoks J (1977) Blutviskosität und Innenohrschwerhörigkeit. Laryngol Rhinol Otol (Stuttg) 56: 328.Google Scholar
  779. 779.
    Schwab PJ, Fahey JL (1960) Treatment of Waldenström’s macroglobulinemia by plasmapheresis. N Engl J Med 60: 574.CrossRefGoogle Scholar
  780. 780.
    Schwab PJ, Fahey JL (1960) Beneficial effects of serum viscosity reduction in two patients with Waldenström’s macroglobulinemia. Clin Res 8: 55.Google Scholar
  781. 781.
    Schwab PJ, Okun E, Fahey JL (1960) Reversal of retinopathy in Waldenström’s macroglobulinemia by plasmapheresis. Arch Ophthalmol 64: 515.PubMedGoogle Scholar
  782. 782.
    Schwartzkopff W, Roetz R (1978) Verträglichkeit und Wirkungen von Sinteroid®. Therapiewoche 28: 2437.Google Scholar
  783. 783.
    Schwedoff T (1890) Recherches expérimentales sur la cohesion des liquides. J Physique Théorétique Appliquée 9: 34.CrossRefGoogle Scholar
  784. 784.
    Scott Blair GW (1974) An introduction to biorheology. Elsevier Scientific, Amsterdam.Google Scholar
  785. 785.
    Seaman GVF, Engel R, Swank R, Hissen W (1965) Circadian periodicity in some physicochemical parameters of circulating blood. Nature 207: 833.PubMedCrossRefGoogle Scholar
  786. 786.
    Segel N, Bishop JM (1966) The circulation in patients with chronic bronchitis and emphysema at rest and during exercise, with special reference to the influence of changes in blood viscosity and blood volume on the pulmonary circulation. J Clin Invest 45: 1555.PubMedCrossRefGoogle Scholar
  787. 787.
    Seiffge D (1980) Methods for the investigation of drug-influence on aggregation and deformability of red blood cells (RBC). In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 657.Google Scholar
  788. 788.
    Seiffge D, Berthold R, Berthold F (1983) Effect of pentoxifylline on sickle cell thalassaemia: Haemorheological and clinical results. Klin Wochenschr 61: 1159.PubMedCrossRefGoogle Scholar
  789. 789.
    Selvetelia L, De Caterina M, Caso R, Amato B, Bracale G (1985) Variazioni emoreologiche ed emo-coagulative dopo piretoterapia in pazienti con arteriopatia ad impronta flogistica. Ric Clin Lab 15(Suppl 1): 571.Google Scholar
  790. 790.
    Sengespeik HC, Güntner M, Raz D, Linderkamp O (1984) Hämorheologische Effekte von Intralipid. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 190.Google Scholar
  791. 791.
    Sergio G, Artale F, Espureo M, Francisci A, Astorre P, Perego MA (1981) Haemorheological improvement by pentoxifylline and buflomedil in patients with peripheral occlusive arterial disease (Abstract). Clin Hemorheol 1: 504.Google Scholar
  792. 792.
    Sgries B, Haedicke C, Altmann S, Stangel W, van den Berg E, Hartmann F (1980) Blood viscosity and peripheral blood flow in patients with polycythemia vera — The influence of therapeutic eryth-rocytopheresis. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 405.Google Scholar
  793. 793.
    Shabanov AH, Gudynskaja CJ, Komov DV (1967) Changes in blood viscosity in patients with endarteriitis obliterans. Lab Delo 12: 713.Google Scholar
  794. 794.
    Shanghai Cooperative Group for the study of tanshinone IIA: Therapeutic effect of sodium tanshi-none IIA sulfonate in patients with coronary heart disease. A double blind study. J Tradit Chin Med 4: 21.Google Scholar
  795. 795.
    Shigehiro S, Kakubari Y, Muramatsu J, Kato Y, Kawabata K, Kikawada R (1979) Casson viscosity of blood in ischemic heart disease — Decrease of casson viscosity by ticlopidine (Abstract). Biorheology 16: 494.Google Scholar
  796. 796.
    Shirinova MN, Goldfarb YS, Burykina IA, Makarenko ON (1983) Non specific detoxication mechanisms in the use of hemosorption for the treatment of burn toxemia and sepsis. Gematol Transfuziol 28: 32.PubMedGoogle Scholar
  797. 797.
    Siekmann U, Heilmann L, Ludwig H (1983) The use of low molecular dextran in cases with micro-circulatory disorders in pregnancy (Abstract). Clin Hemorheol 3: 273.Google Scholar
  798. 798.
    Siekmann U, Heilmann L (1984) Der Einsatz von Beta-Rezeptoren-Antagonisten in der Geburtshilfe: klinische und rheologische Ergebnisse mit Metoprolol. In: Heilmann L, Kiesewetter H, Ernst E (eds) Klinische Rheologie und Beta-1-Blockade. Zuckschwerdt, München, p 159.Google Scholar
  799. 799.
    Simons LA, Hickie JB, Balasubramaniam S (1985) On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Atherosclerosis 54: 75.PubMedCrossRefGoogle Scholar
  800. 800.
    Sirs JA, Rampling MW, Dupont PA (1979) The effect of infusions of arvin into rabbits on blood rheology (Abstract). Microvasc Res 18: 282.Google Scholar
  801. 801.
    Skovborg F, Nielsen AV (1969) Variation in whole-blood and plasma viscosity in acidotic diabetics. Bibl Anat 10: 145.PubMedGoogle Scholar
  802. 802.
    Slonim A, Cristal N, Erez R, Shainkin-Kestenbaum R (1981) The effect of nifedipine, a calcium antagonist on red blood cell filterability (Abstract). Clin Hemorheol 1: 506.Google Scholar
  803. 803.
    Smith E, Kochwa S, Wassermann L (1965) Aggregation of IgG globulin in vivo. Am J Med 39: 35.PubMedCrossRefGoogle Scholar
  804. 804.
    Smud R, Sermukslis B, Kartin D (1976) Changes in blood viscosity induced by pentoxifylline. Pharmatherapeutica 1: 229.Google Scholar
  805. 805.
    Solerte SB, Carnevale Schianca GP, Adamo S, Viola C, Baldi S, Sgarro V, Ferrari E (1983) Diabeticmicroangiopathy: preventive therapeutical approach with pentoxifylline (Abstract). Clin Hemorheol 3: 290.Google Scholar
  806. 806.
    Solerte SB, Adamo S, Viola C, Bozzetti A, Di Santi M, Ferrari E (1985) Pentoxifylline reduces microalbuminuria in microproteinuric diabetic patients (Abstract). Clin Hemorheol 5: 734.Google Scholar
  807. 807.
    Solerte SB, Ferrari E (1985) Diabetic retinal vascular complications and erythrocyte filtrability: results of a 2-year follow-up study with pentoxifylline. Pharmatherapeutica 4: 341.PubMedGoogle Scholar
  808. 808.
    Somer T (1966) The viscosity of blood, plasma and serum in dys-and paraproteinemias. Acta Med Scand 180 (Suppl 456).Google Scholar
  809. 809.
    Somer T (1975) Hyperviscosity syndrome in plasma cell dyscrasias. Adv Microcirc 6: 1.Google Scholar
  810. 810.
    Somer T, Ditzel J (1981) Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström’s macroglobulinemia. Bibl Haematol 47: 242.PubMedGoogle Scholar
  811. 811.
    Spürk P, Habbaba A, Angelkort B (1985) Improvements of blood-fluidity and walking-distance in patients under i. v.-therapy with pentoxifylline (Abstract). Clin Hemorheol 5: 731.Google Scholar
  812. 812.
    Staedt U, Genth KR, Gaa J, Ritz R (1986) Hämodilution bei Patienten mit akuter zerebraler Durchblutungstörung mit niedermolekularem Dextran (Dex 40) und mittelmolekularer Hydroxyethylstärke (HES 200). Therapiewoche 36: 2485.Google Scholar
  813. 813.
    Staedt U, Schwarz M, Bayerl JR, Tornow K, Heene DL (1986) Hämodilution bei akuter zerebraler Ischämie. Neurologischer Score und hämorheologische Parameter vor und nach 10tägiger Behandlung mit 10% Dex 40 und 10% HES 200/0,5 (II). Med Welt 37: 695.Google Scholar
  814. 814.
    Staedt U, Schwarz M, Heene DL (1986) Hämodilution bei akuter zerebraler Ischämie. Hämorheologische Parameter vor und während Infusion von 10% Dex 40 und 10% HES 200/0,5 (I). Med Welt 37: 660.Google Scholar
  815. 815.
    Stangel W, Haedicke C, Sgries B, Altmann S, van den Berg E, Hartmann F (1979) Influence of erythrocytapheresis on blood viscosity and peripheral blood flow in patients with polycythemia vera (Abstract). Symp Blood Cells Hemorheol 16: 502.Google Scholar
  816. 816.
    Sternitzky R, Scige K (1985) Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease. Curr Med Res Opin 9: 602.PubMedCrossRefGoogle Scholar
  817. 817.
    Stödter KH (1978) Einfluß von Adrevil auf die Fließeigenschaften menschlichen Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  818. 818.
    Störnier B, Kleinschmidt K, Loose D, Kremer K (1977) Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs. Curr Med Res Opin 4: 588.CrossRefGoogle Scholar
  819. 819.
    Stornier B, Kleinschmidt K, Loose D, Kremer K (1978) Rheologische Veränderungen des Blutes bei chronisch arteriellen Verschlußkrankheiten durch Vasodilatantien. Dtsch Med Wochenschr 103: 694.CrossRefGoogle Scholar
  820. 820.
    Störnier B, Störmer K, Kremer K (1978) Die Veränderung der Blutviskosität während der aortofemoralen Bypassoperation unter besonderer Berücksichtigung niedriger Schergeschwindigkeiten. Biorheology 15: 37.Google Scholar
  821. 821.
    Störmer K, Störmer B, Loose D, Engels G, Kremer K (1976) Einfluß von Kontrastmittel auf die Blutviskosität nach Katheterangiographie. Vasa 5: 239.PubMedGoogle Scholar
  822. 822.
    Stoltz JF, Drouin P, Gaillard S, Rousselle D, Vera JC, Pointel JP (1979) Variations de la viscosité sanguine de sujets diabétiques insulino-dépendants équilibrés par pancréas artificiel. Ann Biol Clin 37: 191.Google Scholar
  823. 823.
    Stoltz JF, Drouin P (eds) (1980) Hemorheology and diseases. Doin, Paris.Google Scholar
  824. 824.
    Stoltz JF, Larcan A (1980) Drugs affecting hemorheological parameters. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 651.Google Scholar
  825. 825.
    Stoltz JF, Schooneman F, Streiff F (1981) Hemorheological parameters and plasma exchanges. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 107.Google Scholar
  826. 826.
    Stoltz JF (1981) Drugs affecting blood rheology — a review. Scand J Clin Lab Invest 41(Suppl 156): 287.CrossRefGoogle Scholar
  827. 827.
    Stoltz JF (1982) Main determinants of red cell deformability. Clinical and pharmacological applications. Clin Hemorheol 2: 163.Google Scholar
  828. 828.
    Stoltz JF (1983) Les determinants de la rheologie sanguine: implications therapeutiques. Actua Chim Thér 10: 29.Google Scholar
  829. 829.
    Stoltz JF (1984) Blood rheology: etiology of hyperviscosity syndromes. Int Angiol 3: 13.Google Scholar
  830. 830.
    Stoltz JF (1985) Données fondamentales en hémorhéologie. II. Les syndromes d’hyperviscosité. Biomed Pharmacother 39: 282.PubMedGoogle Scholar
  831. 831.
    Stoltz JF, Schooneman F, Paulus F, Streiff F (1985) Micro-and macrorheological variations observed in 50 patients suffering from monoclonal dysglobulinemia and treated with plasma exchange procedures (Abstract). Clin Hemorheol 5: 728.Google Scholar
  832. 832.
    Stoltz JF (ed) (1986) Hémorhéologie et agrégation érythrocytaire. Médicates Internationales, Paris.Google Scholar
  833. 833.
    Strand T, Asplund K, Eriksson S, Hägg E, Lithner F, Wester PO (1984) A randomized controlled trial of hemodilution therapy in acute ischemic stroke. Stroke 15: 980.PubMedCrossRefGoogle Scholar
  834. 834.
    Strano A, Davì G, Novo S, Avellone G, Pinto A (1981) Valutazione clinica degli effetti della pentossiflllina in pazienti effetti da disturbi circolatori periferici cronici. Ric Clin Lab 11(Suppl 1): 303.PubMedGoogle Scholar
  835. 835.
    Strano A, Novo S, Davì G, Avellone G, Mandalà V (1982) Effects of sorbinicate and nicotinic acid on blood viscosity, red cell deformation and platelet function. Pharmacol Res Commun 14: 639.PubMedCrossRefGoogle Scholar
  836. 836.
    Strano A, Avellone G, Davi G, Mandala V, Raneli G (1983) Ticlopidine induced haemorheological changes in patients suffering from atherosclerosis obliterans of the lower limbs (Abstract). Clin Hemorheol 3: 290.Google Scholar
  837. 837.
    Strano A, Avellone G, Pinto A, Mandala V, Adamo L (1983) Pentoxiphylline induced haemorheological changes in patients suffering from atherosclerosis obliterans (Abstract). Clin Hemorheol 3: 291.Google Scholar
  838. 838.
    Strano A, Daví G, Novo S, Avellone G, Pinto A (1983) Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders. Pharmatherapeutica 3(Suppl 1): 117.Google Scholar
  839. 839.
    Strano A, Davi G, Avellone G, Novo S, Pinto A (1984) Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 35: 459.PubMedCrossRefGoogle Scholar
  840. 840.
    Strano A (1985) The rationale for haemorheological treatment of peripheral occlusive arterial disease (POAD) (Abstract). Clin Hemorheol 5: 755.Google Scholar
  841. 841.
    Strano A, Avellone G, Novo S, Fasulo S, Di Garbo V (1985) Modificazioni di alcuni parametri emoreologici indotte dal trattamento con pentossifillina in pazienti affetti da pregresso infarto del miocardio. Ric Clin Lab 15(Suppl 1): 621.Google Scholar
  842. 842.
    Strano A, Davì G, Avellone G, Novo S, Pinto A (1986) Double-blind, crossover study of the clinical efficacy and the haemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. In: Trübestein G (ed) Konservative Therapie arterieller Durchblutungsstörungen. Thieme, Stuttgart, p 113.Google Scholar
  843. 843.
    Strauer BE, Fateh-Moghadam A, Kment A, Samtleben W, Volger E (1981) Use of plasmapheresis and immunosuppressive therapy in coronary microangiopathies. Bibl Haematol 47: 213.PubMedGoogle Scholar
  844. 844.
    Strauer BE (1983) Koronare Durchblutungsstörungen aus Theologischer Sicht. Therapiewoche 33: 841.Google Scholar
  845. 845.
    Strauß W (1975) Hämorheologische Wirkungen einer längerfristigen Gabe des Diuretikums Furosemid im Rahmen einer antihypertensiven Therapie. Dissertationsschrift, Frankfurt am Main.Google Scholar
  846. 846.
    Stuart J, Kenny MW (1981) Sickle-cell disease and vascular occlusion. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p 109.Google Scholar
  847. 847.
    Stuart J, Stone PCW, Bareford D, Caldwell NM, Davies JE, Baar S (1985) Evaluation of leucocyte removal methods for studies of erythrocyte deformability. Clin Hemorheol 5: 137.Google Scholar
  848. 848.
    Stufano N, Sabbà C, Altomare E, Conese A, Palasciano G, Albano O (1983) Erythrocyte filtration and glycemic control in diabetes mellitus (Abstract). Clin Hemorheol 3: 322.Google Scholar
  849. 849.
    Sturani C, Palareti G, Poggi M, Schiavina M, Torricelli P, Papiris S (1985) Effects of pentoxifylline (Px) on cardiopulmonary hemodynamics and haemorheologic parameters at rest and during exercise in chronic cor pulmonale (Abstract). Clin Hemorheol 5: 732.Google Scholar
  850. 850.
    Sugai S (1972) IgA pyroglobulin, hyperviscosity syndrome and coagulation abnormality in a patient with multiple myeloma. Blood 39: 224.PubMedGoogle Scholar
  851. 851.
    Sunder-Plassmann L, Klövekorn WP, Holper K, Hase U, Messmer K (1971) The physiological significance of acutely induced hemodilution. Proceedings of the 6th European Conference on Microcirculation, Aalborg (1970). Karger, Basel, p 23.Google Scholar
  852. 852.
    Swank RL (1951) Changes in blood produced by fat meal and by intravenous heparin. Am J Physiol 164: 798.PubMedGoogle Scholar
  853. 853.
    Talpos G, White JM, Horrocks M, Cotton LT (1978) Plasmapheresis in Raynaud’s disease. Lancet 1: 416.PubMedCrossRefGoogle Scholar
  854. 854.
    Tekeres M, Sarosi I, Juricskay I, Losoncsy H, Nagy I (1982) Effect of longterm ticlopidine therapy on the rheological properties of blood (Abstract). Haemostasis 12: 120.Google Scholar
  855. 855.
    Terekhov NT, Starikov AV, Kushko OV, Karpenko W (1982) Effect of hemosorption on the Theological properties of the blood and some indices of intoxication in patients with diffuse peritonitis. Klin Khir 3: 31.PubMedGoogle Scholar
  856. 856.
    Theiss W, Volger E, Wirtzfeld A, Keisel I, Blömer H (1980) Gerinnungsbefunde und Theologische Messungen bei Streptokinasebehandlung des akuten Myokardinfarktes. Klin Wochenschr 58: 607.PubMedCrossRefGoogle Scholar
  857. 857.
    Thomas DJ, Du Boulay GH, Marshall J, Pearson TC, Ross Russell RW, Symon L, Wetherley-Mein G, Zilkha E (1977) Cerebral blood-flow in polycythaemia. Lancet 2: 161.PubMedCrossRefGoogle Scholar
  858. 858.
    Thomas DJ, Marshall J, Ross Russell RW, Wetherley-Mein G, Du Boulay GH, Pearson TC, Symon L, Zilkha E (1977) Effect of haematocrit on cerebral blood-flow in man. Lancet 2: 941.PubMedCrossRefGoogle Scholar
  859. 859.
    Thulesius O, Gjöres JE (1972) Studies on blood viscosity in chronic venous insufficiency, with regard to treatment with flavonoids. Angiologica 9: 390.PubMedGoogle Scholar
  860. 860.
    Tilsner V, Greul W (1975) Erfahrungen mit der defibrinierenden Therapie mit Arwin®. Folia Angiol 23: 407.Google Scholar
  861. 861.
    Toikawa H, Tsushima N, Sakakura M, Kaba M, Konishi M, Nakayama R, Yasunaga K (1985) Effect of prazosin on microcirculation system (Abstract). Clin Hemorheol 5: 577.Google Scholar
  862. 862.
    Toti G, Agosti R, Cherubini P, Farini P, Clivati A, Longhini E (1985) Normovolemic hemodilution in surgery (Abstract). Clin Hemorheol 5: 688.Google Scholar
  863. 863.
    Trevan JW (1918) The viscosity of blood. Biochem J 12: 60.PubMedGoogle Scholar
  864. 864.
    Tsyganyi AA, Karpenko W, Krishtof AN, Pritula SY (1982) The influence of plasma replacers on the rheological properties of the blood, suspension stability of the erythrocytes and microcirculation in patients operated for mitral stenosis. Anesteziol Reanimatol 4: 38.Google Scholar
  865. 865.
    Tuddenham EGD, Whittaker JA, Bradley J, Lilleyman JS, James DR (1974) Hyperviscosity syndrome in IgA multiple myeloma. Br J Haematol 27: 65.PubMedCrossRefGoogle Scholar
  866. 866.
    Turczynski B, Znamirowska D (1985) Effect of adrenergic beta receptor blockaders on blood viscosity after their short-term use in patients with arteriosclerosis. Polski Tygodnik Lekarski (Warszawa) 40(17): 481.Google Scholar
  867. 867.
    Tymms DJ (1982) Improvement in blood viscosity following continuous subcutaneous insulin infusion in type 2 (non-insulin-dependent) diabetic patients (Abstract). Diabetologia 23: 207.Google Scholar
  868. 868.
    Uchimura I (1983) Effect of treatment on retinal circulation, platelet aggregation and blood viscosity in insulin-dependent and noninsulin-dependent diabetics. Bull Tokyo Med Dent Univ 30: 17.PubMedGoogle Scholar
  869. 869.
    Urai L, Makláry E, Kolonies I, Novák L (1983) Effect of pentoxifylline (Trental) on haemorheological factors and the circulation in peripheral occlusive arterial disease. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.Google Scholar
  870. 870.
    Vakaliuk IP (1984) Efficacy of Corvaton in non-stable stenocardia. Vrach Delo 11: 18.PubMedGoogle Scholar
  871. 871.
    Van den Berg E, Haedicke C, Sgries B, Altmann S, Stangel W, Hartmann F (1980) Einfluß der Erythrozytopherese auf das Hyperviskositätssyndrom bei Polycythaemia vera — Klinik, Viskosität und arterielle Durchblutung. In: Müller-Wiefel H, Barras JP, Ehringer H, Krüger M (eds) Gefäßersatz. Witzstrock, Baden-Baden, p 119.Google Scholar
  872. 872.
    Van den Berg E, Haedicke C, Sgries B, Stangel W, Altmann S, Hartmann F (1983) Klinik und Therapie des Hyperviskositätssyndroms. Vasa 12(Suppl 10): 1.Google Scholar
  873. 873.
    Van Stalle F, Lambelin G (1981) Suloctidil: review of its effects on platelet survival time, platelet activation and blood viscosity (Abstract). Clin Hemorheol 1: 509.Google Scholar
  874. 874.
    Vaya A (1985) RBC deformability in patients with cerebrovascular disease. Influence of pentoxifylline and dipyridamole (Abstract). Clin Hemorheol 5: 734.Google Scholar
  875. 875.
    Vinazzer H (1971) Zur Wirkung von Arvin auf die Blutgerinnung. Wien Z Inn Med 52: 378.PubMedGoogle Scholar
  876. 876.
    Vittoria A, Guerrini M, Pieragalli D, Del Bigo C, Martelli G, Franchi M, Messa G, Blardi P, Galigani C, Di Perri T (1983) Azione dell’acetilsalicilato di lisina sulle alterazioni emoreologiche indotte dallo sforzo ischemico in pazienti vasculopatici. Ric Clin Lab 13(Suppl 3): 315.PubMedGoogle Scholar
  877. 877.
    Völker D, Martin M (1973) Verhalten der Blutviscosität unter Defibrase und der kombinierten Therapie mit Defibrase und Streptokinase. Verh Dtsch Ges Inn Med 79: 1338.PubMedGoogle Scholar
  878. 878.
    Völker D (1974) Rheologische Veränderungen unter oraler Langzeittherapie mit Bencyclan. Therapiewoche 24: 2901.Google Scholar
  879. 879.
    Völker D (1975) Rheologische Veränderungen unter der Therapie mit Defibrase. In: Martin M, Schoop W (eds) Aktuelle Probleme in der Angiologie, Bd 26; p 171.Google Scholar
  880. 880.
    Völker D (1976) Haemorheological investigations in patients with vascular disease undergoing treatment with pentoxifylline. Pharmatherapeutica 1: 154.Google Scholar
  881. 881.
    Völker D (1979) Orale Therapie mit Bencyclan. Z Allg Med 55: 182.Google Scholar
  882. 882.
    Völker R, Eichler K (1965) Nebenwirkungen von Diuretika auf Rheodynamik und Blutgerinnung. Dtsch Med Wochenschr 90: 2150.PubMedCrossRefGoogle Scholar
  883. 883.
    Vogeler C (1973) Untersuchungen über die medikamentöse Beeinflussung der Filtrabilität des Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  884. 884.
    Voisin P, Kolopp M, Rousselle D, Gaillard S, Pointel JP, Stoltz JF, Debry G, Drouin P (1982) Influence du contrôle métabolique sur la viscosité sanguine et l’activité plaquettaire chez les diabétiques insulino-dépendants. Nouv Rev Fr Hématol 24: 187.PubMedGoogle Scholar
  885. 885.
    Vojnikovic B (1984) Hyperviscosity in whole blood, plasma and aqueous humor decreased by Doxium (calcium dobesilate) in diabetics with retinopathy and glaucoma: A double-blind controlled study. Ophthalmic Res 16: 150.PubMedCrossRefGoogle Scholar
  886. 886.
    Volger E (1980) Experimentelle und klinische Untersuchungen über die Rheologie des Blutes bei kardiovaskulären Erkrankungen und deren Risikofaktoren. Habilitationsschrift, München.Google Scholar
  887. 887.
    Volger E (1983) Klinische Hämorheologie und Diabetes mellitus. In: Ehrly AM (ed) Klinische Hämorheologie: Eine Bestandsaufnahme. Zuckschwerdt, München, p 62.Google Scholar
  888. 888.
    Volger E, Theiss W (1983) Rheological consequences of systemic Streptokinase therapy in acute myocardial infarction. In: Trübestein G, Etzel F (eds) Fibrinolytische Therapie. Schattauer, Stuttgart, p 455.Google Scholar
  889. 889.
    Von Rhede van der Kloot EJH, Jacobs MJHM, Weber H, Lemmens HAJ (1985) Plasma filtration in patients with Raynaud’s phenomenon. Clin Hemorheol 5: 79.Google Scholar
  890. 890.
    Wade JPH (1983) Transport of oxygen to the brain in patients with elevated haematocrit values before and after venesection. Brain 106: 513.PubMedCrossRefGoogle Scholar
  891. 891.
    Walker CHM, Mackintosh TF (1972) The treatment of hyperviscosity syndromes of the newborn with hemodilution. In: Messmer K, Schmid-Schönbein H (eds) Hemodilution — Theoretical basis and clinical application. Karger, Basel, p 271.Google Scholar
  892. 892.
    Walker RT, Matrai A, Dormandy JA, Flute PT (1983) Haemorheological and functional changes in intermittent claudication following plasmapheresis with Haemocell (Abstract). Clin Hemorheol 3: 338.Google Scholar
  893. 893.
    Walker RT, Dormandy J (1984) Plasma exchange in peripheral vascular disease. Arch Emerg Med 1(Suppl): 23.Google Scholar
  894. 894.
    Walker RT, Matrai A, Bogar L, Dormandy JA (1985) Serotonin and the flow properties of blood. J Cardiovasc Pharmacol 7(Suppl 7): 35.CrossRefGoogle Scholar
  895. 895.
    Waller DG (1982) Whole blood viscosity following cardioselective beta-adrenoceptor blockade in hypertension. Clin Hemorheol 2: 243.Google Scholar
  896. 896.
    Waller D, Nicholson H, Roath S (1983) The acute effects of nifedipine on red cell deformability in angina pectoris (Abstract). Clin Hemorheol 3: 294.Google Scholar
  897. 897.
    Waller DG, Nicholson HP, Roath S (1984) The acute effects of nifedipine on red cell deformability in angina pectoris. Br J Clin Pharmacol 17: 133.PubMedGoogle Scholar
  898. 898.
    Waller DG, Roath OS (1986) Nifedipine and red cell deformability in angina. Clin Hemorheol 6: 275.Google Scholar
  899. 899.
    Wallis PJW, Skehan JD, Newland AC, Wedzicha JA, Mills PG, Empey DW (1986) Effects of erythrapheresis on pulmonary haemodynamics and oxygen transport in patients with secondary polycythaemia and cor pulmonale. Clin sci 70: 91.PubMedGoogle Scholar
  900. 900.
    Warstat T (1974) Untersuchungen über den Einfluß von niedermolekularem Dextran auf die Filtrabilität des Blutes in 8 μm-Filtern. Dissertationsschrift, Frankfurt am Main.Google Scholar
  901. 901.
    Wasilewski A (1962) Zur Pathophysiologic und Therapie der kardialen Dekompensation unter Berücksichtigung der Viskositätsänderung des Blutes. Med Klin 57: 599.PubMedGoogle Scholar
  902. 902.
    Watson WC (1957) Lipaemia, heparin and blood viscosity. Lancet 2: 366.CrossRefGoogle Scholar
  903. 903.
    Watzek C, Wagner O, Draxler V, Gilly H, Schwarz S, Sporn P, Steinbereithner K, Zekert F (1978) Der Einfluß normovolämischer Hämodilution unter Verwendung von Hydroxyäthylstärke auf Kreislauf und Organfunktionen bei gefäßchirurgischen Eingriffen. Wien Klin Wochenschr 90: 224.PubMedGoogle Scholar
  904. 904.
    Watzlaw P (1978) Untersuchungen über den Einfluß von Actovegin und Doxium auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.Google Scholar
  905. 905.
    Weber G (1979) Kontrolle therapeutischer Effekte im Bereich der Mikrozirkulation. In: Hild R, Spaan G (eds) Therapiekontrolle in der Angiologie. Witzstrock, Baden-Baden, p 336.Google Scholar
  906. 906.
    Weber G, Kreisel T, Peter S, Künzel J (1980) A double-blind placebo controlled crossover study in patients with peripheral vascular diseases, using a new capillary viscometer. Angiology 31: 1.PubMedCrossRefGoogle Scholar
  907. 907.
    Weber H, von Rhede van der Kloot E, Jacobs MJ, Schmid-Schönbein H, Lemmens HAJ (1983) Plasma filtration therapy in patients with Raynaud’s phenomenon — 2. Haemorheological aspects (Abstract). Clin Hemorheol 3: 338.Google Scholar
  908. 908.
    Weber H, Schmid-Schönbein H, Lemmens HAJ (1985) Plasmapheresis as a treatment of Raynaudattacks: Microrheological differential diagnosis and evaluation of efficacy. Clin Hemorheol 5: 85.Google Scholar
  909. 909.
    Wedzicha JA, Rudd RM, Apps MCP, Cotter FE, Newland AC, Empey DW (1983) Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. Br Med J 286: 511.CrossRefGoogle Scholar
  910. 910.
    Wedzicha JA, Cotter FE, Rudd RM, Apps MCP, Newland AC, Empey DW (1984) Erythrapheresis compared with placebo apheresis in patients with polycythaemia secondary to hypoxic lung disease. Eur J Respir Dis 65: 579.PubMedGoogle Scholar
  911. 911.
    Weinberger I, Fuchs J, Rappaport M, Rotenberg Z, Joshua H, Agmon J (1985) Effect of sublingual isosorbide dinitrate and nifedipine on plasma viscosity, fibrinogen and hematocrit in patients with myocardial infarction. Abstract-Booklet Int Symp Cardiovasc Pharmacother, Geneva, Switzerland, Abstract 340.Google Scholar
  912. 912.
    Wells R (1970) Syndromes of hyperviscosity. N Engl J Med 283: 183.PubMedCrossRefGoogle Scholar
  913. 913.
    Wells R (ed) (1973) The microcirculation in clinical medicine. Academic Press, New York.Google Scholar
  914. 914.
    Welsh WH (1911) Viscosity of the blood. Heart 3: 118.Google Scholar
  915. 915.
    West N (1984) Hyperviscosity syndrome in IgE myeloma. Br Med J 289: 1539.CrossRefGoogle Scholar
  916. 916.
    Whittacker SRF, Winton FR (1933) The apparent viscosity of the blood flowing in the isolated hind-limb of the dog and its variation with corpuscular concentration. J Physiol (Lond) 78: 339.Google Scholar
  917. 917.
    Williams C, Rodriguez M, Llan de Rosos O, Pederson J, Rankin L, Llach F (1983) Blood viscosity (V), systemic vascular resistance (SVR) and blood pressure (BP) changes during hemodialysis (HD) (Abstract). Kidney Int 23: 165.Google Scholar
  918. 918.
    Wintrich H, Rudofsky G, Maier J (1983) The influence of IHD on hemodynamic and rheological parameters in patients with arterial occlusive disease (Abstract). Clin Hemorheol 3: 310.Google Scholar
  919. 919.
    Witte S, Anadere I, Chmiel H (1983) The influence of a gingko biloba extract on the increased vis-coelasticity of blood by complete stroke (Abstract). Clin Hemorheol 3: 291.Google Scholar
  920. 920.
    Wodniok M (1981) Untersuchungen über die Wirkung zweier Diuretika auf die Fließeigenschaften des Blutes bei Patienten mit essentieller Hypertonie. Dissertationsschrift, Frankfurt am Main.Google Scholar
  921. 921.
    Wolf RE, Alperin JB, Ritzmann SE, Levin WC (1972) IgG-K multiple myeloma with hyperviscosity syndrome — Response to plasmapheresis. Arch Intern Med 129: 114.PubMedCrossRefGoogle Scholar
  922. 922.
    Wolfe JHN, Blackford HN, Waller D, Chapman MB, Prout WG (1983) Does haemodilution benefit patients with intermittent claudication? (Abstract). Clin Hemorheol 3: 310.Google Scholar
  923. 923.
    Wolfe JHN, Waller DG, Chapman MB, Blackford HN, Prout WG (1985) The effect of hemodilution upon patients with intermittent claudication. Surg Gynecol Obstet 160: 347.PubMedGoogle Scholar
  924. 924.
    Woodcock BE, Smith E, Lambert WH, Morris Jones W, Galloway JH, Greaves M, Preston FE (1984) Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J 288: 592.CrossRefGoogle Scholar
  925. 925.
    Wrabetz-Wölke A, Altmann S, Deicher H, Stangel W (1980) Changes in whole blood and plasma viscosity after plasmapheresis in patients with hyperviscosity syndrome (Abstract). In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 605.Google Scholar
  926. 926.
    Yamagata J, Shiozawa K, Shiokawa J (1980) Therapeutic plasma exchange for rheumatic disease. In: Sieberth HG (ed) Plasma exchange. Schattauer, Stuttgart, p266.Google Scholar
  927. 927.
    Yamaguchi H (1984) Therapeutic study of reduced red cell deformability in peripheral vascular disease (Abstract). Angio Arch 7: 51.Google Scholar
  928. 928.
    Yao ST, Shoemaker WC (1966) Plasma and whole blood viscosity changes in shock and after dex-tran infusion. Ann Surg 164: 973.PubMedCrossRefGoogle Scholar
  929. 929.
    Yasunaga K, Kumada K, Matsuda K (1979) Coagulation studies on the patients treated with Defi-brase®, a snake venom batroxobin. Jpn Arch Int Med 26: 465.Google Scholar
  930. 930.
    Zederfeldt B (1965) Rheological disturbances and their treatment in clinical surgery. In: Copley AL (ed) Symposium on Biorheology. Part 4 of the Proceedings of the Fourth International Congress on Rheology, Brown University, Providence, Rhode Island, 1963. Interscience, New York, p397.Google Scholar
  931. 931.
    Zerefos NS, Boletis J, Stathakis C, Alexopoulos J, Xefteri E, Katsilabros N, Daikos G (1983) Successful kidneys transplantation corrects the impaired blood viscosity of chronically hemodialyzed patients (Abstract). Kidney Int 23: 298.Google Scholar
  932. 932.
    Zijlstra WG (1960) Syllektometrie. In: Kramer K (ed) Oxymetrie — Theorie und klinische Anwendung. Thieme, Stuttgart, p 117.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Albrecht Michael Ehrly
    • 1
  1. 1.Zentrum der Inneren Medizin, Abt. für AngiologieKlinikum der J.W.Goethe-UniversitätFrankfurt am Main 70Deutschland

Personalised recommendations